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Cystic fibrosis (CF) is the most common fatal autosomal recessive genetic disease
with over 50 000 people affected worldwide. It is characterised by defective chloride
ion transport and excessive mucus production which have a range of clinical
consequences varying in severity between individuals. Over 400 disease-causing
mutations have been described to date, with one mutation, the AF508 mutation,
accounting for approximately 70% of all CF mutant chromosomes. There appears to
be little correlation between disease severity and genotype beyond pancreatic
function, and the influence of environmental factors and genetic background is still to
be determined.
Many experiments have been conducted both in vitro and ex vivo, investigating the
pathophysiology of this disease. However, CF is a complex systemic disease affecting
different organs and tissues to varying degrees, and an animal model is therefore of
great value. Various mouse models have been described for CF, in which most or all
Cftr gene expression is abolished. Whilst these animals are valuable to CF research,
they do not provide answers to fundamental questions pertaining to the
phenotype/genotype relationship, and the mechanisms by which different mutations in
Cftr culminate in the wide spectrum of clinical features. In addition, animal models
bearing mutations which give rise to mislocalised but partially functional mutant
protein, including the AF508 mutation, would be invaluable for the testing and
development of relocation strategies.
This thesis describes an attempt to create mouse models for CF bearing precise, CF-
associated mutations as the only alteration to the murine Cftr gene, through use of the
'Hit and Run' gene targeting technique in mouse embryonal stem (ES) cells. This
involves an initial targeting step in which an insertional targeting vector bearing the
mutation to be introduced integrates through homologous recombination into Cftr. A
negative selection then follows, enriching for those cells which have subsequently
excised the vector and either reverted to the wild type genotype, or have been
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converted to the desired genotype of the introduced mutation in the correct location
as the only alteration to the gene.
Vectors incorporating CF-associated mutations were introduced into ES cells and
found to target Cftr at a higher frequency than had been previously reported for this
region of the murine CF gene. Selection against the integrated vector in these
targeted 'hit' clones was conducted with the unexpected result of 100% of resistant
clones retaining the vector and the selection cassette. Close examination of these
clones discovered no gross rearrangements, but a failure of methylation-sensitive
restriction enzymes to cut within this region which could be induced or removed by
growing the clone in negative or positive selection respectively. Further investigation
of this phenomenon led to the conclusion that expression of the selection cassette was
being modulated by methylation, and loss of the negative selection gene expression by
this mechanism was occurring far more frequently than the desired loss through
vector excision. The 'run' procedure was modified in view of this to reduce the high
methylation-induced background, and clones were subsequently obtained which had
survived the selection through vector excision.
The methylation hypothesis provides an explanation for the unsuccessful attempts in
this lab and perhaps others, to introduce subtle mutations into Cftr utilising techniques
which involve a negative selection step. A modification of the 'hit and run' procedure
which takes account of this phenomenon has demonstrated that it should be possible
to overcome the problems encountered to date, and successfully generate mouse
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This thesis describes an attempt to create mouse models for cystic fibrosis (CF) by
gene targeting. In contrast to previous CF mouse models, the mice generated in this
study should bear precise mutations associated with the disease in man. The study of
mice bearing subtle, clinically relevant CF mutations should allow further elucidation
of many aspects of this multifactorial disease. The following introduction seeks to
give an overview of the nature of CF, and provide some insight into the many aspects
of the disease which remain unresolved. A more complete description is presented in
appendix 1.
Cystic fibrosis (CF) is the most common fatal autosomal recessive genetic disease of
the Caucasian population with about 1 in 2000 live births affected, and therefore a
carrier frequency of around 1 in 22. It is characterised by defective chloride ion
transport and excessive mucus production in exocrine tissues which leads to a variety
of clinical consequences (Boat et al. 1989).
1.1.1 Clinical and Pathological Features
The range and severity of symptoms associated with CF varies considerably and
consequently so does the age of diagnosis. Previously, CF patients did not usually
survive their teenage years and were cared for by paediatric specialists.
Improvements in the care and management of CF have led to a concurrent
improvement in life expectancy and it has been projected that a CF patient born in
1990 can expect an average life span of 40 years, double that of 20 years ago (Elborn
et al. 1991).
Meconium ileus, a failure to pass meconium following birth, occurs in 5-10% of CF
cases and is virtually diagnostic for the disease. It is thought to result from failure of
pancreatic secretion leading to non-digestion of intraluminal contents also perhaps
combined with dehydration, resulting in a bowel obstruction. Beyond the newborn
period, bowel obstruction with incompletely digested contents can also occur and is
termed 'meconium ileus equivalent'.
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In many cases of CF, an absence of pancreatic secretions is observed as a
consequence of obstruction of the pancreatic ducts with inspissated mucus followed
by dilation and ultimately destruction of acinar cells and their replacement with fibrous
tissue. The lack of pancreatic digestive enzymes leads to a variety of digestive
disorders such as steatorrhoea, which are often manifested as a failure to gain weight.
Diabetes, although endocrinic in nature, is sometimes a complication of CF and has
been attributed to disturbance of islet architecture by acinar destruction and fibrosis.
Pancreatic insufficiency in CF is rarely fife-threatening and can be managed to a
certain extent by pancreatic enzyme supplementation.
Lung infection and the subsequent tissue damage are the major cause of premature
death in CF (Elbom and Shale 1990). There is great variation in age of onset, severity
and course of lung disease between affected individuals. Although antibiotic
treatment may suppress infection to a certain extent, it cannot easily be eradicated and
there is an inevitable decline in lung function with time. Lung disease in CF arises as a
result of the production of excessive viscous mucus which cannot be cleared from the
lungs and so provides an environment which is easily colonised by opportunistic
pathogens. Histological abnormalities such as submucosal gland hypertrophy and
mucus cell hyperplasia are detectable within the first few days of fife, prior to micro¬
organism colonisation, indicating that mucus accumulation is the primary event.
Repeated endobronchial infection initiates a continuous inflammatory response
involving both humoral and cellular responses. Prolonged stimulation of host
defences by micro-organisms and their antigenic by-products leads to the
accumulation of cytotoxic by-products such as oxidants, proteases and lipid products,
all of which are damaging to the pulmonary epithelia. Infection of this damaged tissue
re-stimulates the inflammatory response leading to a vicious circle of infection,
inflammation, and lung injury. Chronic pulmonary infection and lung injury eventually
culminate in respiratory failure associated with pulmonary hypertension and cor
pulmonale.
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Fertility is much reduced in CF patients, especially in the male. Greater than 95% of
males have altered Wolffian duct structures, commonly congenital bilateral absence of
the vas deferens (CBAVD), and are therefore azoospermic (Denning et al. 1968.,
Kaplan et al. 1968). Female CF patients are generally more fertile than males with
around 75% able to sustain pregnancies (Cohen et al. 1980). Poor health status and
thick cervical mucus often hinder conception, and the physical stress imposed by
pregnancy is often detrimental to the health of the mother (Boat 1989., Kotloff et al.
1992).
Other complications of CF can include cirrhosis of the liver and arthropathy (a form
of joint disease). The psychosocial consequences of living with a life-threatening and
incurable disease which imposes a demanding daily regime of physiotherapy and drug
therapy are far reaching. The poor prognosis of patients contracting the highly
infective Pseudomonas cepacia (recently renamed Burkholdaria cepacia), has led to
the segregation of patients with positive sputum cultures both inside and outside of
the hospital environment (Smith et al. 1993., Govan et al. 1993). This is particularly
stressful, since patients had previously been encouraged to socialise, and many
facilities and associations have been set up to encourage this. Living with infertility
can also have psychological complications, especially if the patient is in relatively
good health.
Diagnosis of CF is usually suggested from the clinical features and then confirmed by
the sweat test (Gibson and Cooke 1959), and/or a test for immunoreactive trypsin
(IRT) (Ryley et al. 1981). The concentration of chloride in sweat is determined with
the sweat test, an elevated concentration being indicative (but not diagnostic) of CF.
The IRT test was developed primarily for screening neonates where difficulty in
obtaining sufficient quantities of sweat is often experienced. This uses immunoassay
techniques to measure the presence of immunoreactive trypsin in the blood which is
caused by leak-back of trypsin from an obstructed pancreas.
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1.1.2 The Basic Defect In CF.
The first insight into the basic biochemical defect of CF arose in 1981 when Knowles
et al. reported that the potential differences (PD) across nasal and airway epithelia in
CF patients of all ages and stages of the disease were elevated, approximately twice
that of normal controls. The application of amiloride, an inhibitor of active sodium
absorption, resulted in a decrease in PD in both normal and CF epithelia. However
this decrease was much greater in CF epithelia, indicating that sodium absorption was
also elevated in CF. The role of chloride transport in CF became apparent in 1983
when Quinton demonstrated abnormally low chloride permeability in CF sweat ducts.
This would result in poor sodium chloride reabsorption from sweat and thus accounts
for the high sweat salt concentration characteristic of CF. This result was quickly
followed by demonstration of reduced chloride permeability in CF nasal mucosa
(Knowles etal. 1983).
Since these early studies, reduced chloride permeability has been shown in most
affected epithelia (Welsh 1990), and increased sodium transport in airway epithelia
(Knowles et al. 1986., Cotton et al. 1987). The defective chloride permeability was
localised to the apical membrane (Widdicombe et al. 1985), and results in vivo
confirmed by experimentation with primary and immortalised cultures of CF epithelial
cells in vitro (Stutts et al. 1985., Jetten et al. 1989). Use of the patch-clamp
technique to measure chloride conductance across epithelial membranes demonstrated
that P-adrenergic-stimulated cAMP-induced activation of chloride channel activity
was defective in CF (Frizzell et al. 1986). Further studies suggested that the block in
cAMP-mediated activation of CF chloride channels lay distal to induction of cAMP-
dependent protein kinase activation, and might be a defect in the chloride channel
itself or an associated regulatory protein (Schoumacher et al. 1987., Li et al. 1988).
In September 1989, the study of CF changed dramatically with the cloning of the CF
gene (Rommens et al. 1989., Riordan et al. 1989., Kerem, et al. 1989). Initially,
homology to a family of transport proteins suggested that the gene product, the cystic
fibrosis conductance regulator (CFTR), was itself a transporter and not a chloride
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channel (Hyde et al. 1990., Ringe and Petsko, 1990). The subsequent availability of
CFTR cDNA spawned a host of expression studies involving the expression of CFTR
in many different cell types in vitro which suggested that CFTR was in fact a chloride
channel (Rich et al. 1990., Kartner et al. 1991., Bear et al. 1991., Anderson et al.
1991., Tabcharani et al. 1991), as expression of CFTR in these cells coincided with
the appearance of regulated chloride channel activity not previously detected.
This classification of CFTR as a chloride ion channel created more controversy. An
ion channel has certain unique features, including ion selectivity, single channel
conductance, and blocker sensitivity, by which it can be identified. However,
previous studies had not all agreed on the 'signature' of the CFTR chloride channel.
Some studies reported a 30pS-50pS outwardly rectifying chloride channel (ORCC),
and others a much smaller lOpS chloride channel with a linear current-voltage
relationship (reviewed in Frizzell and Cliff 1991). Three different chloride
conductances had been identified in chloride-secreting epithelial cells (Cliff and
Frizzell, 1990), and it was unclear which was defective in CF (the possibility of CFTR
being responsible for more than one conductance deemed unlikely).
Definitive proof that CFTR was indeed a chloride channel came from the
reconstitution studies of Bear et al. (1992), who studied the function of highly
purified CFTR when incorporated into an artificial liposome bilayer. The chloride
channel activity thus demonstrated ended not only speculation on the function of
CFTR, but also the role of ORCC in CF, as the chloride channel exhibited the lOpS
current and the linear current-voltage relationship of the non-rectifying channel.
Therefore it was concluded that the ORCC probably had little to do with the CFTR
chloride channel, and that earlier observations were 'unfortunate' (Higgins and Hyde,
1991).
This state of affairs remained until Egan et al. (1992) published evidence that not only
are CFTR and the ORCC distinct chloride channels, but CFTR can regulate the
ORCC. They arrived at this conclusion from the observation that the ORCC could
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not be activated by protein kinase A in cells lacking CFTR, but this activation was
restored on expression of CFTR. Subsequent studies on CF 'knockout' mice which
lack CFTR (discussed later), reported the presence of ORCC in mouse epithelial cells
indicating that CFTR and ORCC are indeed distinct chloride channels (Gabriel et al.
1993). The failure of protein kinase A to regulate ORCC in these epithelial cells
lacking CFTR further supports the suggestion that they are regulated by CFTR.
Therefore, the basis of CF is defective chloride ion transport by the lOpS chloride ion
channel which has a linear current-voltage relationship. A defect in this chloride ion
channel may have many indirect but far-reaching effects, including defective
regulation of other chloride ion channels.
1.1.3 Cloning The CF Gene
The CF gene was successfully cloned by a method known as 'positional cloning' or
'reverse genetics', which searches for linkage of a chromosomal region with the
disease in question, and does not require a knowledge of the biochemical nature of the
disease.
The first steps towards assignment of the CF gene to a particular chromosome arose
when linkage was demonstrated to the enzyme paraoxonase (Eiberg et al. 1985),
followed by linkage to the polymorphic marker DOCR1-917 (Tsui et al. 1985).
Linkage to further polymorphic markers refined the critical region until two were
identified which were separated by 10 kb, and were shown to flank the CF gene
(Beaudet et al. 1986., Rommens et al. 1988). Using these markers as the starting
points, Collins et al. (1987) used the chromosome jumping technique to move
between the markers. Chromosome jumps 'filled in' with chromosome walking led
them to a region which had maximum linkage disequilibrium with CF. Within this
region a search was conducted for sequences which showed cross-species
conservation indicative of functional DNA. This produced a candidate gene segment
encoding a 6.2 kb transcript which had a short sequence of open reading frame
preceded by a CpG island, and therefore some of the hallmarks of a gene (Rommens
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et al. 1989). A search of a sweat gland cDNA library resulted in the identification of
a 6.5 kb transcript with a pattern of expression that was restricted to exocrine tissues.
Sequentially isolated cDNAs eventually led to a series of overlapping clones
containing the entire coding region of the gene (Riordan et al. 1989). This gene was
encoded by 250 kb of DNA, with 27 exons, and from which a protein of 1480 amino
acids was translated. Expression was found to be higher in those tissues severely
affected in CF, but no size difference was detected in the CF transcript. Confirmation
that this was indeed the CF gene was demonstrated by the presence of mutations in
this gene of individuals with CF which were absent in unaffected controls. This gene
was validated as the CF gene as it fulfilled three essential criteria;
1. The gene was in the correct location and had no detectable recombination
with the disease.
2. The nature of the gene product was consistent with the disease and had an
appropriate pattern of expression.
3. Consistent mutations were found within this gene. The disequilibrium for
one particular haplotype had suggested a common mutation, and the AF508
mutation was subsequently found to be present on 70% of CF
chromosomes.
1.1.4 The Structure OfCFTR
Sequence analysis of the CF gene, named the Cystic Fibrosis Transmembrane
Conductance Regulator (CFTR) predicted an encoded protein of 1480 amino acids
with a molecular mass of 168 kd. The main structural features of this protein (Figure
1.1) deduced from amino acid sequence analysis were characteristic of a membrane
bound protein due to the presence of two hydrophobic repeated motifs consisting of
six oc-helical sequences, typical ofmembrane spanning domains (MSD) (Riordan et al.
1989). Each membrane spanning domain is followed by a large hydrophilic region
predicted to he on the cytoplasmic side of the membrane, which has sequences
resembling nucleotide binding domains (NBDs). These structural characteristics of
CFTR have similarities to a family of ATP-dependent transport proteins called the
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ATP binding cassette proteins (ABC). The most notable similarity being to the
multiple drug resistant (MDR) proteins and the yeast STE6 protein, all of which
import or export molecules across cell membranes in a process requiring ATP
hydrolysis (Higgins 1989). There is one feature of CFTR which appears to be unique,
that of the presence of a highly charged hydrophilic region lying in the middle of the
protein in the cytoplasmic domain, the R domain. This region contains many polar
residues and has multiple potential phosphorylation sites.
Figure 1.1 The proposed structure of CFTR
Schematic representation of the 3-dimensional structure of CFTR (taken from Dorin
and Porteous 1991). The transmembrane domains are represented as cylindrical units,
and N-GLY indicates a potential glycosylation site. The first nucleotide binding
domain is denoted as Al, the second by A2, and the regulatory R domain is labelled
R.
1.1.5 The Function Of CFTR
CFTR is a chloride channel. This is the conclusion that has been reached over the
period since the CF gene was cloned. There has been much debate over the function
of CFTR, and even now that there is general agreement on the role of CFTR as a
chloride channel, the prospect of additional functions for CFTR has arisen.
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If CFTR is a chloride channel, how does it carry out this function? It is thought that
the transmembrane domains form a pore across the plasma membrane through which
ions can pass. Alteration of the amino acids within this domain alters the anion
selectivity of this channel (Anderson et al. 1992), indicating that the transmembrane
domain both selects and conducts ions across the membrane.
The R domain, which lies between the two membrane spanning domains, is a feature
of CFTR which is not shared by any known ABC protein. It is thought to regulate
the chloride channel activity of CFTR, as its deletion generates chloride channels
which are constitutively open (Rich et al. 1991). It has been proposed that CFTR
channel activity is inhibited by a conformational change in the R domain, resulting in
'plugging' of the ion pore (Rich et al. 1991., Kartner et al. 1991., Cheng et al. 1991).
The R domain is highly charged, and potential phosphorylation sites have been
identified which if mutated, prevent cAMP dependent phosphorylation and activation
of the chloride channel (Cheng et al. 1991). However, phosphorylation of the R
domain alone does not activate the chloride channel, as binding of ATP by the
nucleotide binding domains also appears to be required (Anderson et al. 1991).
The nucleotide binding domains (NBDs) which follow each membrane spanning
domain, share extensive homology with the NBDs of other ABC transporter proteins
(Higgins 1989). They contain Walker A and B sequences which interact with
nucleotides (Walker et al. 1982), and have been shown to interact with ATP to
regulate the opening and closing of CFTR chloride channels (Thomas et al. 1991.,
Anderson et al. 1991., Hartman et al. 1992). It has been found that there is a
concentration of missense mutations in the first NBD, and a lack of a similar cluster in
the second NBD, suggesting a difference in functional importance (Kerem et al.
1990., Cutting et al. 1990). Missense mutations are particularly informative as only
one amino acid is altered in the mutant protein, and the observation that almost all
missense mutations in CFTR occur in regions which are conserved between human,
mouse and cow emphasise their functional significance (Dean et al. 1990., Diamond et
al. 1991). This is supported by the expression studies of Gregory et al. (1991), which
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studied the effect of CF mutations on the maturation and function of CFTR in Cos
cells. They found that missense mutations in the first NBD almost always resulted in
a lack ofmaturation or functional activity, but there was rarely any adverse effect seen
with mutations in the second NBD. Anderson and Welsh (1992) described further
evidence for the functional non-equivalency of NBD1 and NBD2. They demonstrated
that ATP can bind to both NBDs, but that ADP binds to NBD2 only. This resulted in
inhibition of chloride channel activity, which was abolished by mutations in NBD2.
They suggested that ADP inhibits CFTR by competing with ATP at NBD2, and that
the ATP : ADP ratio may be more important than absolute ATP concentration for
regulating CFTR. Quinton and Reddy (1992) developed this hypothesis further by
demonstrating that nonhydrolysable ATP analogues could stimulate CFTR in human
sweat ducts following activation by cAMP, suggesting that binding rather than
hydrolysis of ATP was required for CFTR chloride channel activity. Coupled with the
observation that intracellular ATP concentrations must be around physiological
concentrations for activation by this apparent non-hydolysable mechanism, this has led
to the idea that by binding ATP and ADP, CFTR is either 'sensing' the energy level of
the cell (ATP vs. ADP), or the cellular ATP concentration itself and it is this which
regulates CFTR activity (Wine and Silverstein 1992).
Therefore it does appear that CFTR is a chloride channel, but does it have additional
functions and are chloride ions the only molecules transported? The closely related
human multidrug resistance P-glycoprotein has many structural similarities with
CFTR, and belongs to the same group of ABC proteins. This protein has been found
to be bifunctional, acting both as a pump which actively transports cytotoxic drugs
out of the cell, and as a volume-regulated chloride channel (Valverde et al. 1992., Gill
et al. 1992). By analogy, this raises the possibility of a dual function for CFTR.
Hasegawa et al. (1992) demonstrated that CFTR can form a multifunctional aqueous
channel capable of transporting anions, water and small solutes, and this was followed
by evidence that fluid transport across airway epithelia was indeed defective in CF
(Jiang et al. 1993). Tabcharani et al. (1993), have shown that CFTR functions as a
multi-ion pore, transporting more than one anion simultaneously. In addition, they
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demonstrated that some naturally occurring CF mutations associated with a mild
phenotype, reduces the channel to a single ion pore with a concurrent 50% reduction
in conductance. Therefore it appears that CFTR may have more roles than simply
transporting chloride ions.
CFTR has also been implicated in other cellular functions. Bradbury et al. (1992)
observed an absence of cAMP-dependent regulation of endocytosis and exocytosis in
pancreatic cells derived from a CF patient, which was restored upon transfection with
wildtype CFTR cDNA. This suggests a role for CFTR in regulation of membrane
recycling which is an important way for cells to control both secretion and placement
of proteins on their surface (Baringa, 1992). Barasch et al. (1991), reported that
acidification of intracellular organelles such as the Golgi network, prelysosomes and
endosomes was also defective in CF cells, and Lukacs et al. (1992) have reported that
CFTR is present and functional in endosomes. The possibility that CFTR may be
multifunctional may be important for understanding the relationship between this
single gene defect and the many facets of this disease, as many of the clinical
manifestations cannot be directly attributed to a simple defect in chloride ion
transport. In particular, the abnormal composition of CF mucus which lacks sialic
acid in the oligosaccharides, and the increased sulphation does not correlate directly
with abnormal chloride ion transport (Baringa 1992., Richardson and Alton 1993),
and might be more easily attributed to defective acidification of intracellular
organelles.
1.1.6 CF Mutations
1.1.6.1 The spectrum ofCF mutations
Following identification of the CF gene, a consortium was formed, The Cystic
Fibrosis Genetic Analysis Consortium, consisting of 90 laboratories from 26
countries. This was set up to coordinate the accumulation of information on the
identification of new mutations and their population frequencies, resulting in a large
pool of information. To date, over 400 disease mutations have been identified (The
Cystic Fibrosis Genetic Analysis Consortium 1994), almost half of which are missense
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mutations. Non-sense, frameshift, and splice site mutations occur in roughly equal
proportions, but few large deletions have been reported. No promoter mutations have
been found, although this probably reflects a bias of mutation detection methods
rather than an absence of such mutations.
Of all mutant CF chromosomes examined so far, 67% have been found to carry a
three base pair (phenylalanine) deletion at position 508 (AF508). The frequency of
this mutation varies in each population, and there is a clear Northwest to Southeast
gradient of its frequency across Europe (De Braekeleer and Daigneault 1992), with
the highest frequency reported in Copenhagen and Stockholm (CF Genetic Analysis
Consortium 1990). The presence of the AF508 mutation at the high frequency of
1.4% (2% of chromosomes carry a CF mutation, 70% of which are the AF508
mutation) might be attributed to a founder effect, or alternatively, may imply an
advantage to being a carrier, termed 'heterozygote advantage' (Knudson et al. 1967).
This could be ascribed directly to the presence of a single CF mutation, or to an
advantage conferred by closely linked loci (Wagner and Cavalli-Sforza 1975). It has
been proposed that CF heterozygotes may have an advantage in surviving Cholera,
which is characterised by excessive secretion of chloride and fluid in the intestine in
response to the Cholera toxin (Rodman and Zamudio 1991). This was tested by
Gabriel et al. (1994) using a mouse model for CF. They observed that mice
homozygous for a null mutation in CFTR did not secrete fluid in response to Cholera
toxin, but mice heterozygous for the null mutation secreted only 50% of the fluid
volume lost by wildtype mice in response to the toxin. This reduced response in
heterozygotes implies that they may be better able to survive the diarrhoea and
resultant water loss associated with Cholera.
Different mutations can predominate in different populations, e.g. 87% of CF
mutations in the Danish population are AF508 (The Cystic Fibrosis Genetic Analysis
Consortium 1994), whereas only 22% are accounted for by AF508 in the Ashkenazi
Jewish population where the W1282X mutation predominates (approximately 60% of
CF chromosomes, Shoshani et al. 1992., Lerer et al. 1992). The isolated nature of
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some communities contributes to the high frequency of certain CF mutations within
these communities which is not seen in the general population, as demonstrated by the
Hutterite community where the otherwise extremely rare M1101K mutation accounts
for 69% of CF chromosomes (Zielenski et al. 1993).
1.1.6.2 Screening for CF mutations
The large number of CF mutations and their variant frequencies makes detection of
100% of mutations within a population impossible, and therefore presents a dilemma
for advocates of population screening programmes. Initially screening could detect
only 70% of CF carriers thus identifying only 50% of at risk couples, a level that
many found unacceptably low (Roberts 1990., Beaudet 1990., Gilbert 1989).
Significant improvements have been made in the detection of CF mutations in various
populations (Shoshani et al. 1992., Super and Schwarz 1992., Cheadle et al. 1992),
with the highest rate of detection of 98% reported by Ferec et al. (1992) in a Celtic
population.
1.1.6.3 Correlation ofgenotype with phenotype
There is a great range of symptoms and degrees of severity associated with CF, and
their correlation with a particular genotype has often been attempted. The ability to
predict the course and severity of the disease for each individual would be of
enormous value both for informed decision-making following a positive prenatal
diagnosis for CF, and for counselling and care of an affected individual. A recent
report from The Cystic Fibrosis Genotype-Phenotype Consortium (1993) attempted
to correlate the phenotypes of approximately 62% of CF patients with their genotype.
They concluded that 'the only prognostic value of genotypic information is for the
prediction of pancreatic status'. The association that has become apparent is the
correlation of so called 'severe' alleles and pancreatic insufficiency (PI) (Kristidis et al.
1992). One such severe allele is AF508 which, in the homozygous state, has been
frequently correlated with pancreatic insufficiency (Kerem et al. 1990., Santis et al.
1990., Pignatti 1991). When CF individuals are homozygous for a severe mutation or
have two different severe mutations, then they are usually PI. Individuals with a
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severe and a 'mild' mutation e.g. R117H, are usually pancreatic sufficient (Johansen et
al. 1991., Kristidis et al. 1992., Osboume et al. 1992., Ferec et al. 1993). The mild
mutation being dominant over the severe mutation. Four mutations have been
designated severe, these are AF508, G542X, R553X, and W1282X, and prenatal and
prognostic counselling for homozygotes and compound heterozygotes should advise
of longterm PI (CF Genotype-Phenotype Consortium, 1993). A reduced risk of
meconium ileus has been reported for the G551D mutation (Hamosh et al. 1992).
Homozygosity for AF508 has also been associated with an earlier age of diagnosis
(Kerem et al. 1990., Hamosh et al. 1992), but has not been found to correlate with
severity of pulmonary disease (Santamaria et al. 1992., Santis et al. 1990). The
conclusion of the CF Genotype-Phenotype Consortium is that severity and course of
pulmonary disease are not predicted by genotype, and they suggest that factors other
than CF genotype affect the pulmonary phenotype. Kiesewetter et al. (1993) reported
that the variation of the phenotype of CF patients carrying at least one R117H
mutation in association with another CF mutation correlated with the chromosomal
background. Correlation between CF mutations and other aspects of CF have been
attempted but no clear picture has emerged. Dodge (1991) cautions that the
contribution of non-genetic factors must not be overlooked, especially as identical
twins with different health status' have been reported, and that there will always be
great variability in exposure to infection.
1.1.6.4 The effect ofCF mutations on CFTR function
The consequences of the AF508 mutation on CFTR function have been studied
extensively. Cheng et al. (1990) studied the expression of mutant AF508 CFTR
cDNA in Cos cells and observed that mature CFTR was absent in these cells. Instead,
an incompletely glycosylated form was detected which they suggested was a result of
incomplete CFTR processing in the endoplasmic reticulum (ER), resulting in its
degradation and therefore absence at the correct cellular location. The AF508 allele
has been shown to be expressed at the same level as the normal allele in the
respiratory tract (Trapnell et al. 1991) indicating that transcription of mutant CFTR is
not defective. Further study into the processing and intracellular location of AF508
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CFTR produced conflicting results. Studies examining the maturation and function of
mutant CFTR expressed in transfected cells in vitro (Gregory et al. 1991., Dalemans
et al. 1992), agreed with those of Cheng et al. (1990). Nevertheless, other studies
detected correct localisation of AF508 CFTR in the plasma membrane (Sarkadi et al.
1992), and chloride channel activity when AF508 cDNA was expressed in Xenopus
oocytes (Drumm et al. 1991), Vero cells (Dalemans et al. 1991), and Sf9 insect cells
(Bear et al. 1992). A subsequent publication was able to reconcile these differences
by demonstrating that the processing of mutant CFTR is temperature sensitive
(Denning et al. 1992). They showed that processing of AF508 CFTR reverts to wild
type as the temperature is lowered, thereby explaining the differences seen in
processing and localisation in experiments using oocytes and insect cells which are
typically conducted at lower temperatures. The anomalous results of the experiments
using Vero cells were obtained in a very high expression system and therefore might
be a result of some protein escaping ER 'quality control mechanisms' and reaching the
plasma membrane where it could generate some chloride channel activity. This was
confirmed by an important observation that the AF508 mutation was also mislocalised
in sweat gland biopsies taken from CF patients (Kartner et al. 1992). This led to
speculation that the basis of defective CFTR channel activity of AF508 mutants might
be entirely attributable to its mislocalisation, which if overcome, might have sufficient
activity to correct the defect. This was confirmed by Li et al. (1993) who
demonstrated that AF508 mutant CFTR exhibited phosphorylation-regulated chloride
channel activity similar to that of wildtype CFTR when reconstituted into lipid
bilayers. Yang et al. (1993) followed this by showing that incubation of L cells
transfected with AF508 cDNA at 26°C for 48 hours elicited an electrophysiological
response which was absent in cells incubated at the higher temperature of 37°C. This
observation is of great importance for the treatment of CF, as it implies that if AF508
CFTR could be relocated to the plasma membrane, the mutant protein should exhibit
enough chloride channel activity to ameliorate or even correct the CF defect.
Although defective processing is also observed with other CF mutations, this is not
the sole mechanism by which CF-causing mutations exert an effect. Welsh and Smith
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(1993) have divided CF mutations into four classes based upon their effect on CFTR
biosynthesis and function (table 1.1, and figure 1.2):
Class I includes all CF mutations which result in defective protein production. This
might be due to the presence of premature termination signals, the production of
unstable mRNA, or severely truncated or aberrant protein which is unstable and
quickly degraded. All mutations of this type have the net result that no detectable
CFTR protein is produced.
Class II mutations are those which fail to progress through the biosynthetic pathway
and traffic to the correct cellular location, and includes the AF508 mutation. The
basis of the defect caused by this class of mutations is the absence of CFTR at the
plasma membrane.
Class IH mutations are processed correctly, and do reach the plasma membrane, but
exhibit defective regulation of the chloride channel activity. These mutations have
been found to be located in the nucleotide binding domains, and NBD1 in particular,
which is consistent with its proposed greater participation in the regulation of CFTR
than NBD2.
Class IV mutations affect the conductance of CFTR and have found to be located in
MSD1. These are mutations which do not affect the processing or localisation of the
mutant protein, but reduce the CFTR current.
There appears to be some correlation between the mechanism by which CF mutations
disrupt CFTR function and the severity of pancreatic disease (Welsh and Smith 1993).
Sheppard et al. (1993) have shown that mutant CFTR containing mutations
associated with mild pancreatic disease retains significant apical chloride channel
activity when expressed in epithelial cells. This residual chloride channel activity
would explain the dominant nature of mild mutations when combined with a severe
allele in compound heterozygotes.
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Table 1.1 Classes of CFTR Mutations That Cause CF
CLASS DEFECT EXAMPLES DOMAIN FREQUENCY CLINICAL
STATUS
I NO PROTEIN
Nonsense mutations G542X NBD1 3.4 PI
Frameshil't mutations 3905 insT NBD2 2.1 PI
Splice site mutations 621+G—»T MSD1 1.3 PI
U PROCESSING AI506/7 NBD1 0.5 PI
AF508 NBD1 67.2 PI
S549I NBD1 RARE
S549R NBD1 0.3 PI
A559T NBD1 RARE
N1303K NBD2 1.8 PI
in REGULATION G551D NBD1 2.4 PI
G551S NBD1 RARE PS
G1244E NBD2 RARE PI
S1255P NBD2 RARE PI
G1349D NBD2 RARE PI
IV CONDUCTION R117H MSD1 0.8 PS
R334W MSD1 0.4 PS
R347P MSD1 0.5 PS
(Taken from Welsh and Smith 1993).
Frequency of mutations is expressed as percentage of all CF mutations.
NBD refers to nucleotide binding domain, MSD membrane spanning domain, PI
pancreatic insufficiency, and PS pancreatic sufficiency.
18
Biosynthesis and Function of CFTR in an Epithelial Cell
M. Welsh & A. Smith etal.. Cell Vol 73, 1993
Figure 1.2 The biosynthesis and function of CFTR in an epithelial cell.
Glycosylation of the protein is indicated by the branched structure, MSD1 and MSD2
refer to the membrane spanning domains, and R to the regulatory R domain. The pink
regions flanking the R domain are the nucleotide binding domains. The cross
represents the block in the biosynthesis or function of CFTR.
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1.1.7 The Expression Of CFTR
Cell-specific expression of CFTR was studied by Trezise and Buchwald (1991) using
labelled antisense RNA probes for in situ analysis on rat tissue sections. They found
that CFTR was specifically expressed in the ductal cells of the pancreas and salivary
glands, and that there were decreasing gradients of expression in the intestine along
the crypt-villus, proximal-distal axes. CFTR expression was also detected at low
levels in the mucosa and submucosa of the bronchi and bronchioles of the lung, with
the highest expression being detected in the sub-mucosal glands. Expression in the
testis was found to be regulated during the cycle of the seminiferous epithelia, and
implies that CFTR plays a role in spermatogenesis thereby contributing to CF
infertility.
The localisation of CFTR has been studied immunocytochemically using antibodies
raised against CFTR. Great difficulty has been experienced in raising antibodies to
CFTR and in achieving a uniform pattern of expression. Crawford et al. (1991) found
abundant CFTR in epithelial cells including those lining the sweat ducts, small
pancreatic ducts, and intestinal crypts. The level of CFTR in lung epithelia was again
found to be surprisingly low, but was abundant in kidney tubule epithelia. The protein
appeared to be restricted to the apical membranes of cells, a feature also described by
Cohn et al. 1991., Denning et al. 1992., and Zeitlin et al. 1992., which, along with
tissue distribution is consistent with its proposed role as a chloride channel.
Expression of CFTR during foetal development has also been studied using in situ
techniques to detect mRNA (Tizzano et al. 1993., Trezise et al. 1993). This
demonstrated expression of CFTR in all major organs known to be affected in CF,
with an expression pattern which broadly matched that of the adult. However, these
studies also identified some interesting differences between adult and foetal CFTR
expression. The level of CFTR expression in the foetal lung epithelium was higher
than that seen in adults, and led to the suggestion that CFTR might fulfil a different
role in the aqueous environment of the foetal lung (Tizzano et al. 1993). In addition,
there was a conspicuous lack of expression in the foetal sub-mucosal glands, which is
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the site of highest expression in the adult. Expression of CFTR in reproductive tissues
varied between males and females. No expression was detected in the first and
second trimester of foetal development in females, however significant expression was
apparent in uterine, cervix and fallopian tube epithelia in the third trimester. In males,
a low level of expression was detected in the epididymis epithelia at all stages.
However, no expression of CFTR was detected in ovary or testis at any stage of
foetal development.
Although CFTR has been shown to be expressed in all tissues affected by the disease
process of CF, the levels of expression do not appear to correlate with the degree of
pathology. However, there is no reason to presume that the major sites of disease
pathology would exhibit the highest levels of expression, as each tissue and organ
might have differential expression requirements (Porteous and Dorin 1993).
Alternatively, the variation in disease pathology might be more a reflection of varying
tissue vulnerability to defective chloride transport, or the consequent luminar
blockage.
1.1.8 Cross Species Analysis
Cross species analysis of CFTR sequences has demonstrated a high level of
conservation indicating that CFTR has been highly conserved throughout evolution.
Murine CFTR has an overall identity to human of 78.3% at the amino acid level,
which increases to 89.6% if conservative changes are included (Yorifuji et al. 1991.,
Kelley et al. 1992). Analysis of rat CFTR indicates a nucleotide sequence identity of
80.5%, and an amino acid sequence identity of 75.5% (Trezise et al. 1992), which is
similar to that of 77.4% reported for Xenopus laevis at the amino acid level, and 72%
for dogfish CFTR (Marshall et al. 1991). Analysis and comparison of many diverse
species such as mouse, rat, Guinea pig, rabbit, sheep, cow, pig, dogfish, marmoset,
and Xenopus laevis, has identified that the highest levels of sequence conservation are
always seen in the regions encoding the first membrane spanning domain and the first
nucleotide binding domain (Marshall et al. 1991., Gasparini et al. 1991., Yorifuji et
al. 1991., Diamond et al. 1991., Kelley et al. 1992., Trezise et al. 1992., and Tucker
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et al. 1992). The region which is consistently least conserved across species is the R
domain. This endorses the predictions of CFTR functional assays which suggest that
MSD1 and NBD1 play an important role in regulation of CFTR chloride channel
activity through specific interactions, whereas regulation of CFTR by the R domain
occurs through a 'steric' non-specific mechanism. In addition it has been observed
that in dogfish, mouse, and cow, most of the missense CF-causing mutations in
humans occur at conserved sites. This high level of cross species conservation, and in
particular conservation of the sites of human missense mutations, augurs well for
studying the disease in an animal model.
1.2 MODELLING HUMAN GENETIC DISEASE IN AN
ANIMAL SYSTEM
1.2.1 The Value Of Animal Models
Animals have been used extensively in science to improve our knowledge in many
different ways. By our study of animals we have widened our understanding of many
natural biological processes and extrapolated from these to the mechanisms of
disease. To increase the usefulness of these studies in furthering our understanding of
disease etiology, it would be desirable to obtain animals which exhibit many if not all
of the features of a human genetic disease. Study of some diseases in man is often
limited by the restricted access to human tissue which often means that very few of
the physiological changes underlying many diseases can be ascertained. Tissues are
often only available at autopsy by which time the destructive final stages of the disease
can leave few clues to its etiology. These same restrictions however do not hold for
animals, and access can be gained to organs and tissues at all stages of the disease
process. Furthermore, the study of human genetic disorders is frequently hampered
by the contribution to the disease phenotype of many features which can not be fully
identified and evaluated. These might be the influence of environmental factors, or
genetic background, or even compliance with prescribed therapy. Use of laboratory
animals which have been inbred to isogenicity should eliminate any variation due to
genetic background, and their maintenance in a controlled environment should allow
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any environmental influence to be stabilised. Therefore the many variables of human
disease study can be removed or controlled by use of laboratory animals. In addition,
the typically shorter life cycle and increased fecundity of many animals compared to
humans would allow a greater number of affected individuals to be studied thereby
attaching a greater level of significance to any conclusions which might be drawn.
Use can be made of the techniques for culturing organs, tissues, and cells in vitro,
however these systems can never be directly analogous to the situation in vivo and are
often subject to artefactual effects.
Many useful animal models of human genetic disease possess mutations which have
arisen spontaneously (Kolberg 1992), however this relies on recognition of the mutant
animal and the phenotype which parallels a human condition. The generation of these
spontaneous mutations are likely to be relatively rare events, and models are only
likely to be found for diseases with very characteristic and easily identifiable
phenotypes. Consequently few recessive lethal mutations have been detected this way
as these are by their nature difficult to detect. An alternative strategy is to increase
the probability of mutation in the gene of interest by exposing animals to known
mutagens. This again relies on screening a very large number of animals,
identification of a characteristic phenotype and relating this to the human disease in
question. This too has the problem that the nature of the causative mutation is often
difficult to define, and can limit the usefulness of such a model.
1.2.2 Choice Of Animal And Technology
When choosing an animal in which to model a human disease it is important to
consider the likelihood that the disease in this animal will be analogous to that of the
human condition. The biology of the chosen species should be well characterised and
indicate that it has a similar metabolism to man. To this end the comparability of the
tissue architecture and the possibility of compensatory mechanisms must be taken into
account. Moreover, if the genome of an experimental animal is to be manipulated to
model a human genetic disease, use of a species in which the genetics have been well
characterised would be expedient. The gene and/or the region to be manipulated
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should show a high degree of sequence and functional conservation to that of the
human gene implying the similarity of a mutant phenotype.
However a choice based on the above criteria must also be balanced against other
considerations such as the convenience and cost of housing different species, and the
ease of handling. Primates are an obvious choice due to their close evolutionary
relationship to man, however many primate species are endangered, and they are
typically expensive to maintain and difficult to work with. Their low fecundity means
that the period taken to breed mutant animals in significant numbers could be
unacceptably long, and indeed some maintain that studies of primates have little
advantage over humans (Lathe and Mullins 1993). Rodents are frequently the animals
of choice as they are relatively cheap to maintain, have comparable biology, and high
fecundity. For this reason, both rodent biology and genetics have been studied
extensively.
Other considerations include the availability of suitable technology for the species of
choice. The choice of an appropriate technology would depend upon the nature of
the genetic defect in man. For dominant mutations, technologies can be utilised which
simply add a copy of the mutant allele to the genome. By introducing the human
DNA (transgene) into the germ line of an animal, the mutant allele can be passed on
to many animals simply by breeding. The vector can be designed to give the
transgene specific features such as tissue specific expression (or lack of), and also to
vary the level of expression. A transgenic mouse model for Retinoblastoma was
produced in this manner by expressing a viral oncogene in the retina of mice (Windle
et al. 1990). The transgene is usually introduced into an early stage embryo to
maximise the chances of it integrating into the genome of cells destined to become
germ cells. The most common method is to use microinjection to introduce the DNA
into a fertilised egg, which typically results in the stable integration of a head-to-tail
array of the transgene at a random site in the host genome. This occurs at a
sufficiently high frequency to establish it as a useful technique but has the
disadvantage that the site and nature of the integration cannot be predicted. There
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can be a huge variation in copy number of the transgene which affects its level of
expression, and the random nature of the transgene integration means that there is
also the possibility that the integration site influences the resulting phenotype. Some
sites of integration can abolish transgene expression, and integration into an essential
gene can result in a lethal phenotype. Therefore although this method is suitable for
modelling some diseases in an animal, the imprecise nature of the transgene insertion
makes it unsuitable for others. In addition, this technology is only suitable for
addition of genetic material and not of use for studying loss of function mutations.
Many human genetic diseases however, are not a result of a dominant mutation and
therefore cannot be created by addition of a mutant allele. This thesis is concerned
with modelling one such human genetic disease, cystic fibrosis, in an animal system.
This is a recessive genetic disease which along with other diseases of this type arises
through mutation of both alleles of a gene. To produce an animal model for this
disease, both alleles of the gene must be selectively mutated resulting in loss of
function of the resultant gene product. There is currently only one method available
for achieving this precisely, gene targeting in embryonic stem (ES) cells. The
manipulation of DNA by gene targeting can be applied to most if not all animals, but
the technology to create an animal which bears this targeted alteration is only possible
through the use of ES cells. Furthermore, it is only currently possible to generate
animals from murine ES cells. There have been reports of ES cell isolation for a few
other species such as rat (Iannaccone et al. 1994), rabbit (Graves and Moreadith
1993) and mink (Sukoyan et al. 1993), however no animal entirely derived from these
ES cells has as yet been reported. Despite this lack of choice, the mouse should still
be a good choice in which to model cystic fibrosis as it fits many of the criteria for
choosing an animal model. Mice are both cheap and easy to house, and can produce
many large litters in a relatively short period. Their biology is comparable to that of
man, and their genetics have been studied extensively. Sequence analysis has shown
that there is a high degree of conservation between murine and human CFTR with an
overall identity at the amino acid level of 78.3%, which rises to 89.6% if conservative
changes are included (Yorifuji et al. 1991., Kelley et al. 1992). In addition, almost
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all of the CF-causing mutations reported in man occur at sites which are conserved in
the mouse. This suggests that mutation of any of these conserved regions in CFTR is
likely to be of equal functional significance to both man and mouse. Smith et al.
(1992) have shown that wildtype mice have similar ion transport properties to those
of normal human subjects, implying that a genetic mouse model for CF would be
likely to display a similar clinical phenotype.
1.2.3 Embryonal Stem Cell Technology
Embryonal stem (ES) cells are cells which have been isolated from the inner cell mass
of a 3.5 day mouse blastocyst (Evans and Kaufman, 1981., Martin 1981). When
maintained under stringent conditions, ES cells retain the normal pluripotent
phenotype of the embryonal cells from which they originated, over many passages and
following genetic manipulation. On return to the blastocyst environment, pluripotent
ES cells can recommence their embryonic development and contribute to the tissues
of the resulting offspring including the germ cells (Bradley et al. 1984). This unique
property of ES cells enables them to be maintained in vitro where they are accessible
to genetic manipulation, and then returned to a blastocyst to generate mice which can
be bred to obtain animals which are homozygous for the introduced alteration. The
animals resulting directly from such manipulated blastocysts usually have a genetic
contribution from both the host blastocyst and the reimplanted ES cells, and are said
to be chimaeric. The ES cell derived component can vary enormously between
different tissues of the resulting chimaera, but contribution to the germ cells is
required for the mutation to be passed through the germ line to generate mice which
are homozygous for the planned alteration. Originally, embryonal carcinoma (EC)
cells were used, which are cells isolated from embryonal teratocarcinomas (Solter et
al. 1970). However these were found to have a restricted pattern of differentiation
and a poor ability to colonise the tissues when introduced into a blastocyst (Mintz and
Illmensee 1975).
Due to their pluripotent nature, ES cells are particularly problematic to culture in
vitro. Many known and unknown factors can stimulate them to differentiate,
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especially any stress encountered in their culture conditions. Differentiation is
undesirable as it is irreversible and renders cells incapable of further growth and
blastocyst colonisation. Originally, ES cells were cultured on feeder layers of growth-
arrested fibroblasts (Martin, 1975). Differentiation of ES cells was mostly inhibited
with this system, and in some part appeared to be mediated by a diffusible factor, as
medium alone conditioned by feeder cells was found to also inhibit differentiation
(Smith and Hooper 1983). This diffusible factor was also found to be present in
medium conditioned by Buffalo rat liver cells (Smith and Hooper 1987). Further
analysis of this factor (named Differentiation Inhibitory Activity-DIA) led to its
characterisation and found it to be identical to a known myeloid leukaemia inhibitory
factor (LIF) (Williams et al. 1988., Smith et al. 1988). A recombinant form of
LIF/DIA was produced by transient expression in Cos-7 cells which could support the
maintenance of ES cells in the absence of feeder layers (Smith et al. 1988).
Following genetic manipulation in vitro, pluripotent ES cells carrying a desired
alteration can be used to generate mutant mice by the scheme presented in figure 1.3.
The first step is to return the altered ES cells back to the blastocoel environment. The
most commonly used method utilises microinjection to deliver the cells to the
blastocoel where they become incorporated into the inner cell mass (Bradley 1987).
This technique is technically demanding and utilises expensive equipment. Recently a
less technically demanding method of introducing cells into the blastocyst has been
developed which takes advantage of the natural aggregation properties of
preimplantation embryos (Wood et al. 1993 ., Nagy and Rossant 1993). With this
method, clumps of eight to twelve ES cells are cultured in close proximity to eight cell
stage morulae which have had the zona pellucida enzymatically removed. The ES
cells become internalised and incorporated into the morulae which go on to from
blastocysts in vitro. Due to the simplicity of this technique, a large number of
chimaeras can be generated in a short period of time. Another new development in
this field, is the possibility to generate mice which are completely derived from ES
cells (Nagy and Joyner 1993). This technique uses tetraploid embryos to provide the
extra-embryonic structures required by the embryo, which ES cells themselves are
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unable to generate. This method has the advantage that dominant mutations, or
mutations which are already homozygous in the ES cells, do not need to be passed
through the germ line of chimeras, however it also has the major disadvantage that
mice derived from ES cells in this manner have to be delivered by Caesarean section
as they usually die shortly after birth. In addition, only a few of the ES cell lines
which generate germ line chimaeras by blastocyst injection can generate completely
ES cell derived embryos by this technique.
Once the manipulated ES cells have been introduced into blastocysts by whatever
method, they are implanted into the uterus of pseudopregnant host females where they
go on to complete normal embryonic development. Pigmentation markers are often
used to give some visual representation of the contribution of the ES cells to the
resulting chimaeras. A common combination is to introduce ES cells carrying non-
pigmented or reduced pigment markers into blastocysts from a more heavily
pigmented strain. Any contribution of the ES cells to the melanocytes of the skin will
be seen as a lightening of the coat colour, and contribution to eye seen as loss of
pigmentation. Although this provides some indication of ES cell contribution it does
not give any information as to the contribution to the germ cells, which is the most
important feature if the mutation is to be passed through the germ line. However a
chimaera with a high degree of ES cell coat colour contribution is also likely to have
some contribution to the germ cells. Isoenzyme analysis can also be utilised, but
again does not furnish information regarding germ cell contribution. Another
observation of ES cell contribution can be obtained from the sex distortion ratio.
Most ES cell lines in use were derived from male embryos and therefore have an XY
phenotype. Male ES cells are usually preferred, as female ES cells are prone to losing
an X chromosome during culture in vitro to become an XO genotype. In addition
they have the advantage that male ES cell contribution to the developing gonadal
ridge results in expression of the Y chromosome-specific SRY sex determining gene.
If expressed at a sufficient level, this dosage-dependent protein can result in the sex
conversion of a female embryo to male (Koopman et al. 1991). The resulting male
animal will only be able to make sperm from the male ES cell contribution as female
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XX cells are unable to undergo spermatogenesis. Therefore the chances of a
chimaera passing the ES cell mutation through the germ line is much greater in these
animals which have no contribution to the germ line from the host blastocyst. Also
any distortion of the expected 50:50 ratio of male to female chimaeras gives some
indication that sex conversion has occurred, indicating ES cell germ line contribution.
By breeding chimaeras with ES cell contribution, it should be possible to obtain
animals which have inherited the ES cell mutation which has been passed through the
germ line. These animals will be heterozygous for this mutation, and by breeding
these together it should be possible to generate animals homozygous for the mutation.

















Figure 1.3 Generating transgenic mice from ES cells.
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1.2.4 Gene Targeting
In order to make use of ES cell technology, a method must be available to mutate the
gene of interest in ES cells in vitro. The most commonly used method is gene
targeting and is dependent upon a cells intrinsic ability to mediate recombination
between homologous DNA sequences. This process was first demonstrated in the
yeast Saccharomyces cerevisiae, when a LEU2 deficient mutant was transformed by
integration of a plasmid carrying wildtype LEU2 sequences. This plasmid was shown
to have integrated into the target sequence through a single homologous reciprocal
exchange (Elinnen et al. 1978). Transforming DNA was subsequently found to
integrate into the genome of yeast exclusively through recombination with
homologous sequences (termed homologous recombination) and was used as an
efficient method of replacing or disrupting many endogenous genes (Scherer and
Davis 1979., Shortle et al. 1982). Orr-Weaver et al. (1981) showed that DNA ends
are highly recombinogenic, and therefore the frequency of homologous recombination
could be stimulated by introducing a double strand break in the transforming DNA.
In addition, integration of a plasmid carrying a gap in the region of homology usually
resulted in repair of the gap using the chromosome sequences as the template. These
observations led Szostak et al. (1983) to suggest that homologous recombination was
mediated through direct interaction of the free DNA ends of the homologous
sequences, and they proposed the 'double-strand-break repair' model to account for
the mechanism of integration through homologous recombination (figure 1.4). This
model proposes that the double strand break in the homologous sequence is enlarged
through the action of endonucleases to expose 3' single-stranded termini. One of
these free 3' ends then invades a homologous region of the chromosome DNA,
displacing a small D loop. This D loop is enlarged by repair synthesis until sequences
to the other 3' end are exposed allowing this free end to also anneal. Repair synthesis
completes the gap repair process, and branch migration results in the formation of two
Holliday junctions. Depending on the resolution of the Holliday junction, gap repair










Figure 1.4 The double-strand-break repair model.
(a) Double strand cut in DNA. (b) Invasion of 3'end displacing D loop, (c)
Enlargement of D loop, (d) Repair syntheis from other 3' end completes gap
repair. Branch migration results in formation of two Holliday junctions.
Resolution of junctions leads to either (e) non-crossover, or (f) crossover
configurations. Taken from Szostak et al. (1983).
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Various experiments have demonstrated that mammalian cells are also capable of
mediating homologous recombination between newly introduced DNA molecules and
chromosomal regions of homology. Lin et al. (1984) demonstrated that the TK
sensitivity of mouse L cells containing a mutant tk gene could be restored through
homologous recombination with exogenous DNA bearing a different mutation. A
similar experiment was conducted by Thomas et al. (1986) who demonstrated the
correction of defective neomycin genes in mouse L cells by homologous
recombination. Demonstration of this phenomenon at an endogenous locus was
shown by Smithies et al. (1985) by targeting the (3 globin gene in erythroleukaemia
cells. As in yeast, the frequency of homologous recombination was found to be
increased if the transforming DNA was linear (Folger et al. 1982., Lin et al. 1984.,
Valancius and Smithies 1991). Likewise any gaps in the region of homology carried
by the incoming DNA are corrected using the chromosome as the template (Valancius
and Smithies 1991). Analysis of the sites of homologous recombination has shown
that DNA integrates into the target site in a very precise manner whilst retaining the
fidelity of the target sequence (Zheng et al. 1991). However unlike the situation in
yeast, mammalian cells have a greater propensity for non-homologous recombination,
which is the predominant event (Roth et al. 1985).
1.2.4.1 Targeting vectors
Gene targeting has developed into a widely used method of mutating DNA at a
precise chromosomal location in a predetermined manner. Improvements in our
understanding of the mechanism of homologous recombination have led to
refinements in vector design and the type of mutation which can be created. There
are two basic types of targeting vector which differ in their mechanism of integration,
and by careful design these vectors can be used to introduce a whole range of
different mutations. Both vector types incorporate basic features such as regions of
homology to the target site to mediate homologous recombination, which are carried
on a plasmid backbone. As transfection efficiency is often low, a positive selectable
marker is commonly included to facilitate the isolation of transfected cells.
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One of these types of targeting vectors is an insertional or (O) type vector. These are
linearised within the region of homology to the target site and integrate via a single
reciprocal recombination event stimulated by free ends as predicted by the double-
strand-break repair hypothesis (Figure 1.5). The entire targeting vector is inserted
into the target site through this mechanism of integration and results in a duplication
of the homologous sequences separated by the plasmid sequences. As the sequences
of the target site are simply disrupted with this type of integration, there is the
possibility that wildtype mRNA might be generated as a consequence of alternative
splicing and exon skipping. This phenomenon has been observed at a low level in
mice in which targeting was predicted to create a null allele at the N-myc locus
(Moens et al. 1992) and at the Cftr locus (Dorin et al. 1994), although absolute null
mutations have been generated using insertional vectors (Deng et al. 1992., O'Neal et
al. 1993). The frequency of homologous recombination has been reported to be
higher with this type of targeting vector, than with the alternative replacement type
vector (Hasty et al. 1991., Dickinson et al. 1993), although not all targeting data
supports this hypothesis (Deng and Capecchi 1992).
The second basic vector type is the replacement (Q) vector, which integrates into the
target site by a different mechanism to that of insertion vectors. This vector is
constructed so that the linear homologous targeting sequences are interrupted by the
plasmid backbone, and unlike insertion vectors, are linearised outside the region of
homology. Integration of a replacement vector occurs as a result of a double
reciprocal crossover event between the vector and the homologous chromosomal
sequences (figure 1.5). The non-homologous plasmid sequences at the ends of the
vector molecule are lost during homologous recombination events, as the vector
integrates into the targeted site replacing the endogenous sequences. The major
consequence of homologous recombination with a replacement type vector is loss of
the endogenous homologous chromosomal sequences and their replacement with
those of the targeting vector, including the plasmid backbone. This loss of
chromosomal sequences means that a null allele is almost guaranteed if the
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replacement event spans all or part of one or more exons, as there is no chance of
generating wildtype mRNA through alternative splicing.
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Figure 1.5 The integration patterns of insertion and replacement vectors.
Disruption of the hprt gene by homologous recombination with targeting vectors.
(A). Replacement of hprt sequences on integration of a replacement (XI) type vector
through a double crossover event. (B). Insertion of an insertional (O) type targeting
vector into hprt creating a partial duplication. The positive selection carried by the
vectors is indicated by Neor (Neomycin), and G418 refers to the selective agent
employed. Taken from Capecchi (1989).
Basic insertion and replacement targeting vectors carry a positive selectable marker
which facilitates selection of transfected cells. This selection however does not
discriminate between targeted (homologous recombinants) and non-targeted clones
which are usually only identified after DNA analysis. By taking advantage of the
different consequences of homologous and non-homologous recombination on the
structure of integrated replacement vectors, Mansour et al. (1988) have developed a
modified replacement vector to enrichment for targeted clones. This type of
replacement vector carries a negative selectable gene such as hsvtk at one or both
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ends of the vector, and is called a positive-negative selection (PNS) vector (figure
1.6). During homologous recombination, the ends of a replacement vector including
the hsvtk sequences will be lost and are not incorporated, whereas they are retained
and integrate along with the vector in a non-homologous recombination event.
Therefore by applying the negative selection to the cells along with the positive
selection which selects for transfected cells, it is possible to also select against
randomly targeted clones which should die as they would still retain and express the
negative selection gene. In practice, use of a PNS targeting vector enriches for, but
does not exclusively select, homologous recombinants. The most commonly reported
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Figure 1.6 The positive-negative selection (PNS) procedure.
(A) Homologous recombination of a PNS replacement vector with the target site
results in loss of the negative selection gene (hsvtk), as integration occurs through
homologous sequences. This enables cells to survive the negative selection (Ganc).
(B) Random integration occurs through the ends of the linear molecule, and results in
retention of hsvtk sequences. Cells transfected by random integration are
consequently sensitive to Gancyclovir (Gancs). The positive selection indicated in this
diagram is Neomycin indicated by neor, and the selective agent is G418.
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1.2.4.2 Generating subtle mutations by gene targeting.
Integration of a targeting vector into a gene through homologous recombination
usually results in a major disruption of the coding sequences with the positive
selection gene often acting as the mutagen. Although major gene disruptions can
make a valuable contribution to our understanding of gene function, the study of
subtle changes at the nucleotide level are important for a more complete functional
analysis. There are a number of strategies which have been devised to introduce
subtle mutations into a gene without the concurrent introduction of plasmid sequences
including selectable markers. The majority of these incorporate a gene targeting step
using either of the basic vector types at some stage in the process of introducing the
mutation.
Mutation of the Hox 1.1 locus is one of the few examples of gene targeting utilising a
vector which did not cany a selectable marker. Zimmer and Grass (1989) introduced
a 20 base pair sequence into this locus without the inclusion of any vector sequences
by introducing the DNA into the cell nucleus by microinjection and then screening for
the correctly targeted cells by PCR. This is not a very common method for
introducing subtle mutations as it does not include any enrichment for transfection or
homologous recombination, and therefore unless this occurs at a high frequency (such
as in 3% of transformants as reported by Zimmer and Gruss), it would entail screening
a large number of clones to identify those bearing the desired alteration. To the
author's knowledge, this experiment has not been successfully repeated at any locus.
The simultaneous transformation of cells with two vectors, one carrying a selectable
marker and the other the mutant sequence, is another method of indirectly selecting
for transfected cells. This method relies on the observation that some cells
transformed with two unlinked DNA fragments can integrate both independently into
the genome. By screening those cells which have integrated the selectable marker it is
envisaged that some cells will be identified that have also incorporated the mutant
DNA sequence into the target site through homologous recombination. Although
such a targeted cell should also contain the selectable marker, this is likely to be
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integrated at a site remote from that of the gene of interest. This method has been
used to introduce mutations into the hprt locus (Reid et al. 1991., Davis et al. 1992).
However it has the disadvantage that although non-targeted cells were frequently
transformed with both vectors, correctly targeted cells rarely integrated a second
DNA molecule (Reid et al. 1991). In addition, as the selectable marker integrates
randomly into the genome, the possibility that the site of this integration might disrupt
some other gene function and contribute to the phenotype cannot be excluded.
A two step recombination technique utilising insertion vectors has been successfully
used to introduce subtle mutations in ES cells. This technique was first described by
Scherer and Davis (1979) as a method of introducing subtle mutations into the yeast
Saccharomyces cerevisiae, and was subsequently applied to mammalian cells by
Valancius and Smithies (1991) who called it the 'in-out' targeting strategy, and Hasty
et al. (1991) who referred to it as 'hit and run' targeting. For simplicity, it shall be
referred to as 'hit and run' gene targeting from this point forward. The first stage of
this technique targets the region of interest with a modified insertional vector bearing
the mutation to be introduced within the homologous targeting sequences (figure 1.7).
As well as the usual positive selectable marker, a 'hit and run' targeting vector
incorporates a negative selection gene such as the hsvtk gene. Insertion of the 'hit and
run' targeting vector into the target site creates a duplication of the homologous
sequences separated by the plasmid sequences of the vector. Following identification
of correctly targeted clones the negative selection is applied which selects against the
integrated 'hit and run' targeting vector. This selection aims to select for targeted cells
which have subsequently lost the targeting vector by intrachromosomal recombination
through one of the duplicated regions of homology. The consequence of such a
recombination event would be excision of the vector plasmid sequences along with
one of the duplicated regions of homology. Depending upon the location of the
crossover, vector excision could simply recreate the 'hit and run' targeting vector
reverting the cell back to a wildtype genotype, or could excise the endogenous
duplicated sequence along with the vector sequences, leaving the mutant sequence in
its place as the only alteration to the target site. The end point of this two step
39
method is therefore the introduction of a subtle mutation into the target site without
the presence of any plasmid sequences. The disadvantages of this method is that it
requires cells to undergo two rounds of selection which increases the passage number
and the opportunity for cells to lose their germ line competence. However, germline
transmission was not found to be compromised when this technique was used to
introduce a 14 bp insertion into the Hoxb-4 gene (Ramirez-Solis et al. 1993). This
targeting technique has been used successfully to introduce subtle mutations into the
hprt locus (Hasty et al. 1991., Valancius and Smithies 1991), the Hoxb-4 locus
(Ramirez-Solis et al. 1993), and the murine type I collagen gene (Wu et al. 1994).
These experiments reported 'run' event frequencies ranging from 3.8 X 10~3 (Hasty et
al. 1991) to 8 X 10~7 (Valancius and Smithies 1991).
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Figure 1.7 'Hit and Run' gene targeting strategy.
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A two step method for introducing subtle mutations has also been devised using
replacement vectors, called the double replacement targeting strategy. This strategy
was proposed by Reid et al. (1990) and first used successfully by Stacey et al. (1994).
This strategy involves replacement of target sequences by homologous recombination
with a replacement type targeting vector. The integrated replacement vector is then
targeted with sequences carrying further homology to the target site which includes
the mutation to be introduced. Selection against the integrated targeting vector which
carries a negative selectable marker allows cells to be obtained in which homologous
recombination between the homologous sequences of the second vector and the target
site has replaced the integrated vector. The net result of this being the replacement of
the endogenous sequences of the target site with those bearing a subtle mutation.
Askew et al. (1993) used a similar two step strategy called 'tag-and-exchange'
targeting. With this method a vector which had inserted into the target site was
replaced by mutated homologous sequences. These methods have the advantage that
the same 'marked' allele created by the first targeting step can be replaced by many
different mutant homologous sequences in subsequent targeting experiments and so
need only to be targeted once. However, it is not advisable to use just one targeted
line to generate all transgenic animals as there is always the possibility that this might
have an additional mutation which could affect the phenotype of the resulting mice.
Other novel ways of engineering subtle mutations have been devised. Deng et al.
(1993) used a replacement type vector to replace exon 10 of the murine Cftr gene
with a mutant exon bearing the AF508 mutation, with the vector sequences being
present in the non-coding intron. This method has the disadvantage that the final
structure of the targeted site includes plasmid sequences and an expressing selectable
marker which may interfere with expression of the endogenous gene. Use of the
QxdloxP recombinase system has also been proposed as a means of removing vector
sequences following targeting of mutations to regions of interest (Baringa 1994).
With this system, the region of interest would be targeted with a replacement vector
bearing the mutation to be introduced. The presence of lox P flanking the plasmid
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sequences would lead to its subsequent deletion on expression of the Cre enzyme
within the cell, leaving only a 34 bp sequence in the intron.
It is also possible to combine classical transgenic techniques with gene targeting to
study a mutant protein. Transgenic mice produced by microinjection of non-targeted
DNA can express a mutant form of a gene at a site remote from the endogenous gene.
By crossing these mice with those which have had the endogenous alleles inactivated
by gene targeting, it is possible to get the mutant transgene onto a null background.
In these animals, the mutant protein of the transgene will be present as the only
product from this gene, and although not directly analogous to a subtle mutation,
should give some valuable information on the nature of the mutant gene product.
1.2.5 Animal Models For Human Genetic Disease Produced By Gene Targeting
The first human genetic disease to be modelled in the mouse through use of ES cells
was Lesch-Nyhan syndrome. This inherited disease is caused by a deficiency of the
enzyme hypoxanthine phosphoribosyltransferase (HPRT) and is characterised by
mental retardation and behavioural abnormalities such as self-mutilation (Lesch and
Nyhan 1964). Utilisation of a selection against hprt, enabled ES cells lacking a
functional hprt allele to be obtained which had arisen spontaneously (Hooper et al.
1987), or as a consequence of retroviral insertion from random mutagenesis (Kuehn et
al. 1987). These ES cells were used to generate mice lacking any HPRT activity
which it was anticipated might closely model the human disease. However, although
mice homozygous for the null allele did not exhibit any HPRT activity, they displayed
none of the defects associated with the human condition and were as far as could be
determined, phenotypically normal. It appeared that the mouse is less dependant upon
HPRT for purine salvage than humans, and predominately uses another enzyme,
adenine phosphoribosyltransferase (APRT) for this process. Therefore an absence of
the enzyme HPRT has much more severe consequences for humans than mice. This
was borne out by a later study which showed that these HPRT deficient mice could be
induced to exhibit some of the hallmarks of Lesch-Nyhan syndrome by inhibition of
APRT activity (Wu and Melton 1993). Following administration of APRT inhibitors,
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the mutant mice displayed self-injurious behaviour, principally through over-
grooming, reminiscent of that displayed by Lesch-Nyhan patients.
The first reported animal model for a human genetic disease created by gene targeting
was for Gaucher's disease (Tybulewicz et al. 1992). A targeted disruption of the
murine glucocerebrosidase gene generated mice deficient in the enzyme responsible
for sphingolipid glucocerebroside degradation, the cause of Gaucher's disease in
humans. This produced a severe phenotype in homozygous mice which died within
twenty four hours of birth, and is analogous to the more severely affected, type two
acute neuronopathic subset of Gaucher's patients who also die shortly after birth.
Mutation and allele loss of the p53 tumour-supressor gene has been associated with
tumours in a wide range of human organs and is also associated with an inherited
increased cancer-susceptibility syndrome called Li-Fraumeni syndrome. The p53
protein is implicated in cell cycle control and was therefore thought to be essential for
embryonic development. However when the gene was inactivated by gene targeting
in ES cells, it produced viable, phenotypically normal homozygotes (Donehower et al.
1992). This suggests that in these mice, the function predicted to be carried out by
p53 was accomplished by other proteins. This may indicate that p53 does not have a
role in cell cycle control during development, or that other proteins or pathways were
able to compensate for its deficiency in these mice. Although developmentally
normal, these mice exhibit a higher than normal susceptibility to spontaneous tumours
and this phenotype may be analogous to that of the Li-Fraumeni syndrome.
The phenotype resulting from a targeted gene alteration cannot always be predicted
and many different factors may influence the physiological consequences. As with
p53 and HPRT, cells might possess other pathways or mechanisms which could
compensate for the loss of activity resulting from the introduced mutation. This
compensatory effect might also come from other sources. The transforming growth
factor TGF-(3l was thought to have a vital role during development and therefore a
null allele was predicted to be an embryonic lethal mutation in homozygotes.
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However, mice homozygous for a mutation introduced by gene targeting were
indistinguishable from wildtype littermates at birth, but developed histological
abnormalities 7 days later (Shull et al. 1993). Subsequent studies have shown that
this phenotype is a result of a maternal source of TGF-pl 'rescuing' the phenotype of
the targeted gene disruption up until birth (Letterio et al. 1994). Yagi et al. (1994)
found a variation in the survival of homozygotes for a null allele created in the fyn
tyrosine kinase gene, which depended upon the genotype of the parents. The
homozygous offspring of heterozygous parents had no phenotype, whereas the
homozygous pups of homozygous parents died through an inability to suckle. This
was found to be due to the inability of the homozygous pups to stimulate lactation in
the female, which was not a problem in mixed genotype litters, as littermates with a
wildtype allele could activate lactation in the mother, thus enabling the homozygotes
to survive. If the targeted gene has an essential phenotype during embryonic
development, a high ES cell contribution to organs and tissues of a chimaera might
induce an embryonic lethal phenotype. This was seen in chimaeras produced by
microinjection of ES cells containing a null mutation in the X-linked, methylated DNA
binding protein MeCP2 (Tate et al. 1994). The higher the ES cell contribution, as
judged by expression of a reporter gene carried by the targeting construct, the more
abnormal the embryo development in utero. The results of these and other targeting
experiments have therefore demonstrated that it is often not possible to predict the
phenotype resulting from a targeted gene alteration.
1.2.5.1 Mouse models for cystic fibrosis
There have been four models for cystic fibrosis created by gene targeting in ES cells
to date. All four of these targeting strategies sought to disrupt Cftr function through
integration of a targeting vector.
Roller et al. (1991) created a targeted disruption of Cftr by targeting the region
around exon 10 with a PNS replacement vector. This targeting vector replaced part
of exon 10 with selectable markers, and incorporated a stop mutation in the 3'
homologous targeting sequences. Mice homozygous for the disrupted gene exhibited
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a severe phenotype with a large number dying before or around weaning (Snouwaert
et al. 1992). A high percentage of these perinatal deaths were caused by intestinal
obstruction and blockage, similar to the meconium ileus condition seen in humans.
However, meconium ileus only occurs in approximately 10% of CF cases and
therefore this condition is exacerbated in the mouse. These mice exhibited many of
the features of CF such as the alteration of mucous and serous glands, and obstruction
of these glands with thickened mucus. Electrophysiological assays demonstrated a
defect in chloride ion transport which was analogous to the defect seen in humans
(Clarke et al. 1992). Both male and female mice homozygous for the null mutation
were fertile in contrast to the human condition, where females have reduced fertility
and only 5% ofmales are fertile.
A similar null mutation was created by Ratcliff et al. (1992). They also replaced some
of the sequences around exon 10 using a PNS replacement vector. Mice homozygous
for this mutation also exhibited the severe intestinal disease exhibited by the
'knockout' mice of Snouwaert et al. (1992), (Colledge et al. 1992., Ratcliff et al.
1993), with approximately 80% dying within one week of birth. The phenotype of
these mice was very similar overall to that of the other CF mice created by targeting
with a replacement vector, with mucus accumulation reported in many glands
Another disruption of Cftr was created, this time using an insertion vector to target
the region around exon 3 (O'Neal et al. 1993). Insertion of this vector created a
duplication of exon 3 separated by plasmid sequences, which produced a similar
severe phenotype in homozygotes to that created by the mutation of exon 10 by
replacement vectors. As with the other mouse models, a high rate of perinatal death
was observed with 40% dying within the first week from intestinal obstruction.
Mucus accumulation was again observed in the crypts of the small intestine and in
many glands.
All of the above CF mouse models exhibited a similar phenotype of severe intestinal
disease which was more pronounced than in the human condition.
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Electrophysiological assays confirmed the chloride channel defect characteristic of
CF, however very little if any disease was noted in the main sites of disease in man,
namely the lungs and the pancreas. Clarke et al. (1994) found a correlation between
the presence of an alternative, calcium-regulated chloride channel and the absence of
disease in the 'knockout' mice of Snouwaert et al. In organs severely affected in
these mice, such as the intestine, no chloride transport by this alternative channel
could be detected, whereas it was present in the mildly affected pancreas and
pulmonary epithelia. This suggests that in some tissues of the mouse, this calcium-
regulated channel can compensate for absence of CFTR resulting in a lack of
pathology in these organs of the null mice.
A different mutation was created by Dorin et al. (1992) using an insertion vector to
target exon 10. Integration of this targeting vector created a partial duplication of
exon 10 fused in frame to a gene for neomycin resistance. The presence of the poly A
tail of the neomycin gene and the occurrence of stop mutations in all three reading
frames in the plasmid sequences were predicted to cause premature termination of
transcription, causing a null mutation. However the phenotype of mice homozygous
for this mutation was milder than that described by other groups, with a reduced
incidence of meconium ileus (10%), more in line with that reported for the disease in
humans (Dorin et al. 1992). These mice also exhibited the defective chloride ion
transport of CF and could be distinguished from their normal littermates solely on this
basis. Again there was an absence of pancreatic disease, and a detailed study of the
chloride ion conductance detected significant chloride transport by the calcium-
regulated chloride channel in the pancreas of these mice (Gray et al. 1994). These
mice have improved long term survival, and in contrast to those with a severe
phenotype, can be distinguished in tracheal Ussing chamber studies from their
wildtype littermates. In addition, lung disease can be precipitated following bacterial
challenge (Dorin et al. 1994). The milder intestinal phenotype of these mice is due to
the residual wildtype mRNA present in these mice (approximately 10%), and is
perhaps analogous to one of the milder class of human CF-causing mutations. Mutant
CFTR bearing these types of mutations retains some degree of function, typically 15-
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30% of wildtype (Sheppard et al. 1993), and manifests as severe lung disease but with
pancreatic sufficiency. In addition, CF patients with a similar 'leaky' mutation have
recently been described who also display approximately 8% residual wildtype CFTR
mRNA, and exhibit severe lung disease (Highsmith et al. 1994). A similar phenotype
amelioration has been described by Moens et al. (1992). They also created a 'leaky'
insertional mutation to ameliorate the embryonic lethal phenotype of a null mutation
in the N-Myc gene (Sawai et al. 1991). Homozygotes for the leaky insertion mutation
survived to birth, in contrast to the death at mid-gestation of the null homozygotes.
These mouse models for CF are a valuable resource for CF research. The similarities
and differences in the phenotypes when compared to the human condition should yield
important information regarding the aetiology of the disease. The identification of the
apparent compensatory effect of the calcium-regulated chloride channel in some
tissues in these mice may have important consequences for future CF therapy. By
studying the electrophysiology of these mice which lack any CFTR, a deficit in
function of another chloride channel has been identified indicating a link between the
two (Gabriel et al. 1993). The hypothesis of an increased resistance to the cholera
toxin in CF heterozygotes to account for an 'heterozygote advantage' effect has been
given credence by testing the effects of this toxin in CF mice (Gabriel et al. 1994).
One of the most valuable applications of the CF mouse models will be for testing new
therapies. Already studies have been reported in which potential gene therapies for
humans were evaluated in the mice (Hyde et al. 1993., Alton et al. 1993., Grubb et al.
1994). The opportunity to evaluate therapies in a CF mouse is of great benefit, and
approval for phase I trial in humans were subsequently obtained based upon the
promising results of Alton et al. The CF mouse models have therefore already been
of great benefit to the CF community.
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1.3 PROJECT AIM
The aim of this project was to create mouse models for cystic fibrosis which bear
precise CF-associated mutations as the only alteration to the murine Cftr gene.
Cystic fibrosis has already been modelled in the mouse by disruption of Cftr with
vector sequences which produce absolute or 'leaky' null mutations. These animals
have displayed many hallmarks of the disease and are a valuable resource for CF
research. The majority of CF-causing mutations in humans however, do not create
null alleles. Over 400 CF-associated mutations have been described to date, and the
predominant mutation (AF508), present on approximately 70% of CF chromosomes,
is a three base pair deletion. The severity of CF varies enormously between affected
individuals and a correlation with genotype has only been found for pancreatic
involvement, and not for the lung disease which is the major cause of premature
death. Therefore the study of 'knockout' mutant mice cannot resolve some of the
important issues surrounding CF, such as the effect of different mutations on CFTR
function and the genotype phenotype relationship. The availability of mice which bear
precise, clinically relevant mutations and therefore more closely model the human
disease, might allow some of these important issues to be addressed. The inbred
background and the controlled environment of the laboratory mouse would allow the
contribution of these factors to the disease phenotype to be ascertained. It would also
be of interest to determine if the presence of a mutant protein had a different
phenotypic consequence to the complete absence as seen in the null mice. In addition,
these mice could be used for testing potential therapies. Those which posses
mutations causing the partially functional mutant protein to become mislocalised
(including the most common AF508 mutation) would be invaluable for testing
relocation strategies.
I aim to introduce CF-associated mutations into the murine Cftr gene by using the 'hit
and run' gene targeting technique in ES cells. This targeting technique was chosen as
it typically introduces a precise mutation into the target site without any
accompanying vector sequences. Furthermore it utilises insertion type targeting
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vectors which have already been used in our lab to achieve high frequency targeting of
the murine Cftr gene in ES cells. Mice generated by these techniques would then be
used to study many aspects of the disease, and especially to test strategies for
relocating mutant proteins subject to biosynthetic arrest. These mice should be a






2.1 EMBRYONAL STEM CELL CULTURE
2.1.1 Cell Lines
The embryonal stem (ES) cells used in this study were either E14 ES cells (Handyside
et al. 1989), a kind gift from Dr Martin Hooper, or CGR8 ES cells, a kind gift from
Dr Austin Smith. Both of these cell lines have an XY karyotype, were derived from
the mouse strain 129/Ola and carry the following marker alleles:
Agouti (A) Locus: wild type (Aw)
Albino (c) Locus: chinchilla (cc^)
Pink Eye (P) Locus: pink-eyed dilution (p)
2.1.2 Culture Media And Solutions
General considerations
In the choice of culture media and reagents, a number of precautions were taken to
avoid the exposure of ES cells to agents which may induce differentiation. Glassware
detergent constitutes one such agent and therefore all medium and solutions were
either obtained from commercial sources, or made up in detergent-free containers.
Disposable, sterile pipettes (Costar) were used throughout. The quality of the water
used in solutions is also an important consideration. All solutions prepared in-house
utilised ultrapure water from an Elgastat UHP reverse osmosis filtration system.
Solutions were sterilised either by autoclaving at 121°C for 20 minutes, or by
filtration through a 0.2(im sterile filter (Gelman). Prior to use, all solutions were pre-
warmed to 37°C.
Medium
Both the E14 and the CGR8 cell lines were routinely maintained in Glasgow's
modification of Dulbecco's Medium (GMEM) obtained as a single strength solution,
initially from Flow-ICN laboratories and later from Gibco-BRL. This medium was
supplemented as follows:
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15% batch-tested foetal calf serum (FCS, Initially supplied by Globepharm
Ltd and subsequently by Gibco-BRL)
0.3% glutamine (Gibco-BRL)
1 mM sodium pyruvate (Sigma)
0.1 mM MEM non-essential amino acids(Sigma)
0.1 mM (3-mercaptoethanol (Sigma)
The above medium was also supplemented with Leukaemia Inhibitory Factor (LIF)
where the ES cells were to be maintained in the absence of feeder layers (section
2.13). As a rule, medium was supplemented at least 24 hours prior to use, and its
sterility checked by incubating 1 ml overnight at 37°C in 10 ml Tryptose Phosphate
Broth (Oxoid).
Phosphate buffered saline (PBS)
PBS was made up by dissolving one calcium and magnesium-free PBS tablet (Gibco-
BRL) in 100 ml of ultrapure water. Sterilisation was by autoclaving.
Trypsin-EDTA solution
This was obtained as a sterile solution at ten times normal strength, consisting of
0.5% trypsin and 0.2% EDTA in 0.9% Sodium chloride (Sigma). This was routinely
stored at -20°C, diluted to normal strength in sterile PBS when required, and stored at
4°C for up to two weeks.
Gelatin solution
A sterile solution of 0.1 % gelatin was used to coat surfaces prior to the culture of ES
cells in the presence or absence of feeder layers. This was prepared by adding the
appropriate amount of tissue culture grade, porcine skin gelatin (Sigma) to ultrapure
water and autoclaving. The sterile solution was stored at 4°C.
53
2.1.3 Production Of Leukaemia Inhibitory Factor (LIF)
ES cells can be maintained in an undifferentiated state in vitro in the absence of feeder
layers if LIF (also known as Differentiation Inhibitory Activity-DLA) is added to the
culture medium (Smith et al. 1988). Recombinant LIF was produced by
overexpression of LIF cDNA in the eukaryotic expression vector pC10-6R, (a kind
gift from Dr Austin Smith), in Cos-7 monkey kidney cells. The Lipofection method of
transfection was used, as in our hands it routinely gives high frequency and often
multicopy transfection. Lipofectin (Gibco-BRL) was the lipofection agent employed,
and consists of a 1:1 (w/w) mixture of the cationic lipid (N[l-(2,3-dioleyloxy)propyl]-
N,N,N-trimethylammonium chloride) (DOTMA) and dioleoyl
phosphotidylethanolamine (DOPE). This reagent forms cationic liposomes, and can
interact with the negatively charged DNA to form liposome-DNA complexes capable
of delivering DNA into a cell upon fusion with the cell membrane.
2.1.3.1 Transfection ofCos-7 cells
1. Cos-7 cells were grown to 70-80% confluence in 225 cm2 vented-cap tissue
culture flasks (Costar), as described in section 2.2.3.
2. The cells were washed twice with serum-free DMEM and covered with 40 ml of
serum-free DMEM for incubation.
3. For each flask, 120 pg pC10-6R plasmid was diluted to a total volume of 300pl
with sterile distilled water, and gently mixed with 440 pi Lipofectin (Gibco-
BRL).
4. The DNA-liposome mixture was left to incubate at room temperature for 15
minutes to allow the formation of DNA-Lipofectin complexes, after which time
it was added slowly, dropwise to the culture medium.
5. Following a 6 hour period of incubation at 37°C, 40 ml of DMEM containing
20% FCS was added to the flask, reducing the overall FCS concentration to
10%.
6. After further incubation al 37°C for 48 hours, the LIF-containing medium was
harvested, centrifuged at 1000 tpm (Sorvall Coolspin centrifuge) to remove any
debris, and filter-sterilised.
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7. The LIF was aliquoted and stored at -70°C.
2.1.3.2 Titration ofLIF activity
In order to determine the lowest concentration at which LIF effectively inhibited the
differentiation of ES cells, a dilution series was set up and evaluated as follows:
1. Twenty pre-gelatinised 25 cm2 tissue culture flasks were seeded with 5xl05 cells
per flask.
2. The following dilutions of LIF were added to flasks in duplicate, 0, 1/100,
1/250, 1/500, 1/750, 1/1000, 1/2000, 1/5000, 1/10 000. LIF of a known activity
was added at an effective concentration to two flasks as a positive control.
3. Cells were cultured for two weeks and then assessed for differentiation by fixing
with methanol and staining with Giemsa (BDH) diluted 1 in 10 in Gurr's buffer
(BDH).
4. The highest dilution which supported the undifferentiated growth of ES cells
was used as the working concentration. This concentration was commonly
1/500-1/1000 dilution.
2.1.4 Preparation of Feeder Layers
ES cells were maintained, whenever possible, on feeder layers of mitotically
inactivated mouse primary embryonic fibroblasts (PEFS). Both E14 and CGR8 ES
cell cultures were found to display a lower degree of differentiation when grown on
feeder layers. The methods of feeder layer preparation employed were adapted from
Robertson (1987) and were as follows:
1. A female Swiss albino mouse was sacrificed at thirteen to fourteen days of
pregnancy.
2. The abdomen was swabbed with 70% ethanol, and the uterine horns dissected
out using sterile instruments and aseptic technique.
3. The uterus was placed into cold PBS (approximately 4°C) on ice for transfer to
tissue culture facilities.
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4. The uterine horns were placed in a 100 mm petri dish in 10 ml of prewarmed
PBS and the embryos dissected away form the uterus and the foetal membranes,
and quickley killed by decapitation.
5. The embryos were transferred to a fresh plate containing 10 ml of PBS and soft
tissues such as the heart and liver were dissected out from the embryonic tissue
using sterile, fine watchmakers forceps.
6. Each embryo was then placed into an individual well of a 24 well plate
containing 1 ml of Trypsin-EDTA, and finely minced using sterile, fine iris
scissors.
7. This embryonic tissue was incubated at 37°C for 5 minutes to facilitate its
enzymatic disaggregation by trypsin.
8. When this had occurred, the trypsin was neutralised by addition of 1 ml of
DMEM. The supernatant was collected from all of the wells, pooled, and made
up to 50 ml with DMEM.
9. After standing for 5 minutes to allow large pieces of cellular debris to settle out,
the cell suspension was seeded into a 175 cm2 tissue culture flask and incubated
at 37°C in 5% C02 for 24 hours.
10. The following day, the medium was changed to remove cellular debris, and the
fibroblasts incubated further until confluent.
11. Once confluent, the cells were split between twenty 175 cm2 tissue culture flasks
and incubated again until confluency was achieved.
At this stage the fibroblasts were harvested and mitotically inactivated by one of two
methods:
2.1.4.1 Mitotic Inactivation OfPEFS By Gamma Irradiation.
This was the preferred method of mitotic inactivation as it was inexpensive, and there
is no danger of carryover of mitotic inhibitor as with the Mitomycin C method.
A single cell suspension of fibroblasts in 4 ml of DMEM was placed into a sterile
bijou bottle and lowered over a 60Co gamma radiation source. The cells were exposed
56
to a dose of 3000 rads determined by length of exposure to the source (approximately
55 minutes), and then prepared for freezing at -180°C by the usual method (section
2.1.11).
2.1.4.2 Mitotic inactivation by Mitomycin C.
The medium was aspirated from confluent flasks of fibroblasts and replaced with 40
ml DMEM containing 10 |ig/ml of mitomycin C (Sigma). The cells were incubated
for 2 to 3 hours, the medium was then aspirated, and the cell monolayer washed three
times with PBS. The fibroblasts were harvested and prepared for freezing at -180 °C
by the usual method (section 2.1.11.1).
Each batch of PEFS was tested for mitotic inactivation by plating out a small number
of cells at a sub-confluent density and growing these on for seven days to ensure
confluency was not achieved. The inactivated fibroblasts were stored in a liquid
nitrogen freezer at -180°C until required. When required, the PEFS were recovered
from liquid nitrogen by the standard procedure (section 2.1.11.2), seeded into a
gelatinised flask and cultured in GMEM. It was not strictly necessary to establish a
PEF monolayer prior to seeding ES cells, and the PEFS could be seeded at the same
time or even at a later date.
2.1.5 Maintenance of ES Cells.
2.1.5.1 General considerations
ES cells were routinely maintained in the absence of antibiotics and therefore the
sterile integrity of the equipment and reagents used, as well as the sterile technique of
the operator, were of paramount importance. To this end, all manipulations of ES
cells were carried out in a Biomat class II laminar flow cabinet which was swabbed
with 70% ethanol prior to, and after use. Anything to be introduced into this sterile
environment was also swabbed with ethanol. To minimise the risk of contamination
from the operator, a dedicated lab coat was always worn as well as latex gloves which
were swabbed frequently with ethanol.
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Tissue culture flasks for culturing ES cells were obtained from Costar and had a 0.2 |a
m filter incorporated into the cap for extra sterility. All multiwell plates were
obtained from Falcon, and 100 mm plates from Costar.
To maintain the desired pluripotential phenotype, ES cells were grown at relatively
high densities and fed daily (or when the acidity of the medium dictated). ES cells
grew rapidly, dividing every 18-24 hours, and were routinely sub-cultured at 3-4 day
intervals.
2.1.5.2 Sub-culture ofES cells.
ES cells were passaged as soon as confluency was achieved to avoid medium
exhaustion and cell death.
1. A confluent 25 cm flask was typically passaged by aspirating the medium and
washing the cells with 5 ml of PBS.
2. After removal of the PBS, 0.5 ml of Trypsin-EDTA was added and the flask
incubated at 37°C for 5 minutes.
3. Cells were dislodged from the flask bottom by gently tapping the flask and were
examined under low magnification on an inverted light microscope to ensure that
a single cell suspension had been achieved, (cellular aggregates are undesirable
as these can differentiate to form endoderm-like cells).
4. The trypsin was inactivated by addition of 9 ml of GMEM, and the cell
suspension spun down in a sterile universal tube (Sterilin) at 1000 rpm (Sorvall
Coolspin).
5. The supernatant was aspirated, and the cells resuspended in 10 ml of GMEM.
6. Cell density was determined using a haemocytometer, and cells were plated into
a pre-gelatinised 25 cm2 flask (plus or minus PEFS) at a density of lx 106 cells.
7. These were grown in an incubator at 37°C in an atmosphere of 5% carbon
dioxide.
For larger or smaller scale cultures the volumes were scaled up or down
proportionately.
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2.1.6 Karyotype Analysis of ES Cells
It is important to routinely check the karyotype of ES cells as cell populations can
drift and aneuploid cells can become selected over periods of continuous culture. ES
cells were routinely checked for the correct chromosome number (40) by the
preparation and staining of mitotic spreads. In the later stages of this project this was
earned out by Fiona Kilanowski. The method employed is essentially that of
Robertson (1987) and was as follows:
1. An exponentially dividing culture of ES cells in a 25 cm2 flask was mitotically
inactivated by adding 0.02 (ig Colcemid (Sigma) to the medium and incubating
for one hour.
2. The cells were harvested and spun down by the usual procedure (section 2.1.5).
3. After aspiration of the medium, the cells were resuspended initially in 1 ml of
0.56% Potassium chloride (KC1), and then 6 ml of KC1.
4. The cells were left to stand for 10 minutes at room temperature, and then spun
down at 500 rpm (Sorvall Coolspin).
5. KC1 was removed and replaced with ice-cold fixative consisting of 3 volumes of
methanol to 1 volume of glacial acetic acid.
6. After standing at room temperature for a further 5 minutes, the fixative was
changed another 3 times and the cells were resuspended in a final volume of 1
ml.
7. Chromosome spreads were prepared by dropping one drop of the cell suspension
from a Pasteur pipette (at height of approximately 10 cm) onto a microscope
slide which had been pre-cleaned in ethanol.
8. Slides were air-dried and stained by immersion for 15 minutes in 3% Giemsa
stain (BDH) diluted in PBS.
9. Two rinses in distilled water were used to remove the excess stain, and the slides
air dried before examination under a microscope.
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2.1.7 Mycoplasma Detection
It is important to ensure that ES cells are free from mycoplasma contamination as
infected cells do not grow well and contribute poorly to the germ line of chimaeras
(Bradley 1987). Mycoplasma contamination is commonly transmitted by poor aseptic
technique or the use of contaminated reagents, and is often concurrent with bacterial
or fungal infection. To facilitate early detection of contamination, all ES cell culture
was carried out in the absence of antibiotics which can mask contamination by
keeping it at a low level. All reagents were bought from commercially tested sources,
and LIF made 'in house' was tested prior to use.
Each ES cell line was tested regularly for mycoplasma contamination by one of the
following methods:
(i) Hoechst staining
This method utilises Hoechst stain, a fluorescent stain which binds specifically to
DNA, to indicate the presence of mycoplasma infection of ES cells. Mycoplasma
testing was earned out by Mr Bill Christie using the method of Chen (1977). This
involved the culture of cells on a glass microscope slide which were then fixed,
stained, and examined using fluorescence microscopy. Mycoplasma infection was
indicated by the presence of fluorescent bodies in the cytoplasm and nucleus of the
cell.
(ii) Direct culture
The presence of mycoplasma was also detected by the presence of characteristic
mycoplasma colonies when contaminated cell suspensions were plated out onto media
which is selective for mycoplasma. This method of testing was also earned out by Mi-
Bill Christie using the method described by Barile (1973).
(iii) PCR analysis
In the later stages of this work, all mycoplasma testing was carried out by Fiona
Kilanowski using Stratagene's Mycoplasma PCR primer kit. This utilised
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mycoplasma-specific primers to amplify mycoplasma DNA during a PCR reaction on
cell extracts. It included positive and internal controls and provided a very quick,
simple and sensitive method of mycoplasma detection.
1. Cultures to be tested were grown to near confluence and 100 pi of medium
removed into a microfuge tube for testing. This was placed in a heat block at 95°C
for 5 minutes
2. The boiled cell extract was mixed with 10 |il of StrataClean resin (Stratagene) and
spun briefly to pellet the resin.
3. An aliquot of the supernatant was removed, diluted 1:10 in UV-irradiated sterile
distilled water, and 10 pi used for the PCR reaction.
4. A PCR reaction mixture was made up in 40 pi with 5 pi lOx Taq buffer (Perkin
Elmer), 2 mM Magnesium chloride (Perkin Elmer), 200 pM each dNTP
(Pharmacia) and 1 unit AmpliTaq polymerase (Perkin Elmer). Reactions were set
up on boiled cell extracts and incorporated a negative control as well as the
appropriate positive and internal controls (provided with the primer kit).
5. The PCR amplification was carried out on a Elybaid Omnigene PCR thermal cycler
using the following program:
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SEGMENT CYCLES TEMPERATURE TIME
1 1 94 °C 5 minutes
55 °C 1.45 minutes
2 3 72 °C 3 minutes
94 °C 45 seconds
55 °C 1.45 minutes
3 40 72 °C 3 minutes
94 °C 45 seconds
55 °C 45 seconds
4 1 72 °C 10 minutes
27 °C 10 minutes
6. The PCR products were resolved by electrophoresis through a 3% agarose gel
as described in section 3.4. Mycoplasma contamination was indicated by the
presence of appropriately sized bands.
2.1.8 Electroporation of ES Cells
Transfection of ES cells with DNA was achieved by use of the electroporation
technique (Chu et al. 1987). Many transfection methods are available, but for these
experiments electroporation was the method of choice as it is quick, simple,
consistent, and in our hands usually transformed cells with a single copy of DNA.
A high voltage electrical pulse is applied to cells which allows DNA to enter via pores
in the cell membrane. The conditions for optimal transfection efficiency typically
result in 50% cell death. The parameters influencing transfection efficiency and cell
death are voltage, ionic concentration, DNA concentration and cell density. The
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transformation efficiency is low and to compensate for this the transforming DNA
carries a selectable marker gene.
The conditions employed in this work were as follows:
1. Recently thawed ES cells were grown up (usually on PEFS) until 80% confluency
in a 75 cm2 tissue culture flask was achieved.
2. Cells were trypsinised and counted in the usual fashion, spun down and
resuspended in PBS to give a cell density of 1.2 x 10 cells/ml.
3. A volume of 0.8 ml of the cell suspension was mixed with 100 pi of linearised
vector, transferred to an electroporation cuvette (BioRad) and left to stand for 10
minutes.
4. The cuvette was placed into the cuvette holder and inserted into the
electroporation chamber of the electroporation machine (BioRad Genepulser).
The settings were adjusted to 800 V, 500 pF capacitance, and the electric pulse
delivered. If operating correctly, a time constant of 0.1 - 0.2 was observed.
5. Cells were left to stand for 10 minutes, diluted into 10 ml of GMEM and seeded
into ten 100 mm gelatinised dishes containing 20 ml GMEM. The plates were
incubated as usual.
6. The medium was changed and the appropriate drug selection imposed 24 hours
after electroporation.
7. Every second day the medium and selection drug were changed until colonies were
visible and ready for picking.
2.1.9 Drug Selection
2.1.9.1 Positive selection markers.
As mentioned previously, electroporation was the chosen method of transfection for
ES cells but gives a relatively low transfection efficiency. Therefore, positive
selection markers were used to isolate the minority of transfected cells from the
majority of non-transfected cells.
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The positive selection markers used in this work were Neomycin phosphotransferase
which was selected for using the aminoglycoside G418 (Gibco, also known as
Geneticin), and Hygromycin B phosphotransferase which was selected for using the
aminoglycoside Hygromycin B (Calbiochem). Both are dominant selectable markers
of bacterial origin and encode resistance to these aminoglycosides through their
inactivation by phosphorylation. In non-resistant cells, G418 binds to the 16s rRNA
and Hygromycin B binds to the 30s rRNA, interfering with and inhibiting translation
and hence protein synthesis (Davies et al. 1993).
2.1.9.2 Negative selection markers.
Negative selection markers were used to eliminate transfected cells expressing a
negative selection gene carried by a vector, from a mixed population of expressing
and non-expressing cells. Throughout these experiments, the negative selection
marker employed was the Herpes Simplex virus Thymidine Kinase (hsvtk) gene. This
is a dominant selectable marker and was selected against using Gancyclovir (Syntex)
but l(l-2-deoxy-2-fluoro-P-D-arabinofuransyl)-5-iodouracil (FIAU) can also be used.
In both cases, a toxic base analogue is metabolised by hsvtk (but not the endogenous
mammalian tk gene), which has fatal consequences for the cell. Due to the toxic
nature of the hsvtk gene product, neighbouring, non-expressing cells can be also killed
by the 'bystander effect' when the toxic product is passed from expressing cells. This
3 2
effect was minimised by plating the cells at a low density (usually 2 x 1(1 cells/cm )
for Gancyclovir (Ganc) selection.
2.1.9.3 Determination of effective drug selection concentration.
It is important to determine the effective drug concentration for each individual cell
line so that the minimum effective dose can be used, and its influence on viability and
pluripotency of the cells can be checked.
The minimum effective dose was determined as follows:
1. ES cells were plated into 10 wells of a 24 well plate at a density of 1 x 104/well.
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2. Twenty four hours after plating, a dilution series based upon reported working
concentrations of the selection drug was added to the wells. The cells were
incubated as normal.
3. The medium and the selection drug were replaced every two days, and the cells
cultured until differences between dilutions were observed (at least one week).
For positive selection, the working concentration was taken as the lowest
concentration giving death of 100% of wild-type cells. For negative selection, the
working concentration was taken as the lowest concentration giving death of 100% of
cells transfected (and expressing) the hsvtk gene, which had no deleterious effect upon
wild-type cells.
For the cell lines employed in these experiments, these concentrations were as
follows:
• 200 flg/ml G418 *
• 150 (ig/ml Hygromycin B
• 2.5 pM Gancyclovir
• It was necessary to test each new batch of G418 as there can be considerable batch
variation.
2.1.10 Clone Picking And Expansion
Once clones were obtained, they had to be picked and maintained as separate cell
lines. Each clone was picked, and grown up to generate cells for DNA analysis and
also for frozen stocks which could be recovered upon identification of clones with the
desired genotype. This was carried out as follows:
1. Medium was aspirated from a plate containing clones which was then washed with
10 ml of PBS. The PBS was aspirated and replaced with a further 5 ml of PBS.
2. Colonies to be picked were encircled on the underside of the dish using a fine
tipped marker pen and the total number of clones per plate noted.
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3. Clones were observed under low power using an inverted microscope placed inside
a laminar flow cabinet.
4. Each clone was picked off using a sterile, fine-tipped pastette (Alpha Laboratories
Ltd) and placed into an individual well of a 96 well bacteriological plate containing
approximately 150 (il of Trypsin-EDTA. This was incubated for 5 minutes at
room temperature.
5. After incubation, the clone was pipetted up and down to facilitate trypsinisation,
and incubated again for a further 5 minutes.
6. Once single cell suspensions had been achieved, the clones were seeded into 1-2
wells of a 96 well plate and grown up without selection (in most cases on a feeder
layer of PEES).
7. When confluent, clones were trypsinised and seeded into fresh wells for expansion.
8. At the earliest opportunity, at least one confluent well of a 96 well plate was frozen
away at -180 °C in liquid nitrogen storage.
9. Cells were expanded into one well of a 24 well plate (and occasionally into a 25
cm2 flask) on gelatin to be grown up for the extraction of DNA.
10. Once confluent, the cells were harvested for DNA preparation and analysis
(chapter 3).
2.1.11 Long-term Storage of ES Cells
For long-term storage, aliquots of each cell line and clone were kept at -180°C in a
liquid nitrogen tank. With this method of storage, ES cells can be maintained in a
viable state for many years.
2.1.11.1 Freezing ES cells.
To successfully freeze ES cells, the cells must be frozen slowly. This was performed
as follows:
1. Cells were trypsinised when just confluent.
2. After spinning down, cells were resuspended in 1 ml of freezing mix consisting
of foetal calf serum and 10% Dimethyl Sulphoxide (DMSO, supplied by BDH).
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3. The cell suspension was placed into a 1 ml cryotube (Nunc) which was labelled
with the relevant information, and placed into a polystyrene freezing box.
4. The box was left at -70 °C overnight, and the cryotube transferred to a liquid
nitrogen tank. The liquid nitrogen level in the tank was checked and regularly
maintained.
1.1.11.2 Thawing ES cells.
To maximise cell recovery from liquid nitrogen storage, ES cells must be thawed
quickly. This was achieved as follows:
1. The appropriate cryotube was removed from liquid nitrogen storage and placed
directly into a beaker of water warmed to 37 °C.
2. As soon as the cell suspension had thawed and ice crystals were no longer
visible, the cryotube was swabbed with 70% ethanol and the cell suspension
removed.
3. Cells were added dropwise to 10 ml of GMEM and spun down to separate the
cells from the freezing mix.
4. Following resuspension in GMEM, the cells were seeded into an appropriate
tissue culture vessel and grown on (section 2.1.5).
2.2 NON-ES CELL CULTURE
2.2.1 Cell Line
For the purpose of this study, Cos-7 cells were used to express a vector encoding
recombinant LIF (section 2.1.3). These fibroblast-like cells are African Green
Monkey kidney cells which have been transformed with an origin-defective mutant
SV40 virus. Wild-type T antigen is produced by these cells making them a suitable
host for transfection with vectors which require its expression. Cos-7 cells were
obtained originally from American Type Culture Collection (ATCC).
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2.2.2 Culture Media And Solutions
Cos-7 cells were grown in Dulbecco's modification of Eagle's medium (DMEM)
supplied in powder form by Flow laboratories and made up in-house. This was
supplemented with 10% heat inactivated foetal calf serum (Gibco-BRL), and the
antibiotics Penicillin and Streptomycin (Gibco-BRL) at 100 units/ml and 100 pg/ml
respectively. The PBS and Trypsin-EDTA used were as described in section 2.1.2.
2.2.3 Maintenance of Cos-7 Cells.
As for ES cells, all manipulations were carried out in a laminar flow cabinet. Cells
were routinely grown in Nunc tissue culture flasks and incubated at 37 °C in an
atmosphere of 10% carbon dioxide. Cultures were grown until just confluent and
subcultured as follows:
1. Medium from a 25 cm2 flask was aspirated and the monolayer rinsed with 5 ml
PBS.
2. The PBS was aspirated, replaced with 1 ml Trypsin-EDTA and incubated for 5
minutes at 37 °C.
3. Gentle tapping was employed to dislodge the cells from the flask, which were
then resuspended in 10 ml of DMEM.
4. The cells were then reseeded at 1/10 of the current density and grown on at 37
°C in an atmosphere of 10 % C02.
2.2.4 Freezing And Long-term Storage of Cos-7 Cell.
Cos-7 cells like ES cells, were kept for long-term storage in a liquid nitrogen tank at -




MANIPULATION OF NUCLEIC ACIDS
MATERIALS AND METHODS
69
3.1 ISOLATION OF NUCLEIC ACIDS FROM
MAMMALIAN CELLS
3.1.1 Isolation of DNA From Mammalian Cells.
3.1.1.1. DNA isolation using phenol-chloroform extraction.
This method of DNA isolation was employed in the early stages of the project. Care
must be taken with this method to minimise any shearing of the DNA. All solutions
were therefore mixed by gentle inversion and DNA fractions transferred using
widebore pipette tips. Subsequent work utilised the quicker and less hazardous Quick
lysis method.
1. Cells were harvested as described in 2.1.5 and the cell pellet of a 25 cm2 flask
resuspended in 1 ml of lysis buffer containing 150 mM Sodium Chloride, 100
mM EDTA, 100 mM Tris-HCl (pH 8.0) and 0.5% Sodium dodecyl sulphate
(SDS).
2. RNA was removed by adding 10 pig RNase A (Sigma) per ml of cell suspension
and incubating at 37°C for one hour.
3. Proteinase K (Boehringer Mannheim) was added to give 100 (ig/ml and the cell
lysate incubated at 50°C for three hours.
4. After incubation, an equal volume of water-saturated Phenol (Boehringer
Mannheim) was added and the solutions mixed by gentle inversion until an
emulsion was obtained.
5. The two phases of the emulsion were separated by centrifugation at 3000 lpm
(Sorvall Coolspin) for ten minutes.
6. The aqueous (top) phase was removed using a wide bore pipette tip and placed
into a clean tube.
7. This aqueous phase was extracted twice more, once with 0.5 volume phenol +
0.5 volume chloroform, and then with an equal volume of a 24:1 mixture of
chloroform-isoamylalcohol.
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8. After the last extraction, the aqueous phase was placed into a clean tube and
precipitated with 0.5 volume 7.5 M Ammonium acetate and three volumes of
100% Ethanol.
9. Precipitated DNA was hooked out using a sterile glass rod and rinsed in 70%
Ethanol.
10. The DNA was briefly air dried (approximately two minutes) and then placed into
500 |il TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.4) and left to dissolve
overnight at 4°C.
3.1.1.2 DNA isolation from mammalian cells using quick lysis technique.
This technique is described by Laird et al. (1991) and was chosen as the preferred
method of DNA isolation because it was simple, quick, high yielding, and involved
minimal shearing forces on the DNA. In addition, this method did not require the use
of Phenol, and produced DNA which was of sufficient quality to be consistently
digested by restriction enzymes.
1. Cells were harvested as described in 2.1.5 and spun down. The pellet was
resuspended in 5 ml of quick lysis buffer (for a 25 cm2 flask), which contains 100
mM Tris-HCl pH 8.5, 5 mM EDTA, 0.2% (w/v) SDS, 200 mM Sodium chloride
and 100 (ig Proteinase K (Boehringer Mannheim).
2. The cell lysate was incubated at 37°C overnight and the DNA precipitated with
an equal volume of isopropanol.
3. Using a glass rod, the DNA precipitate was hooked out and washed briefly in
70% ethanol.
4. After air drying for two minutes, the DNA was placed into 500 |il TE buffer and
left at 4°C overnight to dissolve.
5. To ensure that the DNA was completely dissolved, the solution was incubated at
50°C for two hours.
71
3.1.2 Quantification Of DNA.
The concentration of DNA was estimated by reading its optical density (OD) at 260
nm. A 1/100 dilution was usually made in distilled water and read against a blank of
distilled water. After correction for dilution, an OD of 1.0 is equivalent to 50|ig/ml of
double stranded DNA.
3.2 BACTERIAL CELL CULTURE
All targeting vectors and the mammalian expression vector pC10-6R (for LIF
production) were constructed in bacterial plasmids which, upon transformation into a
suitable host strain, could be replicated along with the host DNA thereby amplifying
the plasmid.
3.2.1 Bacterial Host Strains.
JM83 F-,araA(lac-proAB),rspL,(Strr),(())80dA(lacz)M15) (Viera and Messing 1982).
This strain was used for propagation the plasmid pC10-6R.
XLl-Blue A(mcrA)182, A(mcrCB-hsdSMR-mrr)172, endAl, supE44, thi-1, recA,
gyrA96, relAl, lac, X-, [F\ proAB, lacqZA M15, TnlO, (tetr)] (Bullock et al. 1987).
This strain was used for propagation of the 'Hit and Run' targeting vectors.
3.2.2 Media and Additives
Terrific broth (TB)
12 g Bacto-tryptone (Difco)
24 g Yeast extract (Difco)
4 g Glycerol (Sigma)
Distilled water to 900 ml.
After autoclaving, 100 ml of sterile phosphate solution (0.1 M Potassium dihydrogen
phosphate and 0.72 M diPotassium hydrogen phosphate) was added.
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L-Broth Agar
2.46 g Magnesium sulphate
10 g Tryptone
5 g Yeast extract
10 g Sodium chloride
15 g agar (Oxoid Ltd)
Distilled water to 1 litre.
All medium was sterilised by autoclaving at 121°C for 20 minutes.
Ampicillin
The antibiotic ampicillin was added to medium to select for transformed bacteria
which express an ampicillin resistance gene carried by the plasmid. A stock solution
of ampicillin (Sigma) was made up in distilled water at a concentration of 50 mg/ml.
This was filter sterilised and stored at -20°C until required, when it was added to
medium to give a final concentration of 50 fig/ml.
3.2.3 Preparation Of Competent Ceils For Heat Shock Transformation.
This is the method developed by Hanahan (1983) and yields bacteria which are
competent for transformation at high efficiency by heat shock.
1. A fresh, single colony of JM83 was used to inoculate a 5 ml overnight culture of
L-Broth which was shaken at 37°C.
2. The next day, 2 ml of the overnight culture was used to inoculate 100 ml of
prewarmed L-broth, and incubated with shaking at 37°C until an OD550 nrn of 0.6
was achieved.
3. At this point, the culture was transferred to a pre-chilled, sterile flask and
incubated on ice for 10 minutes.
4. The culture was split between two sterile 50 ml Falcon tubes, and spun down at
3000 rpm (Sorvall RC-5B, DuPont Instruments) at 4°C for 5 minutes.
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5. The media was carefully removed and the pellet resuspended in 20 ml of ice-cold
transformation buffer (30 mM Potassium acetate, 100 mM Rubidium chloride, 10
mM Calcium chloride, 50 mM Manganese chloride, 15% Glycerol (v/v), pH 5.8).
6. The cell suspension was cooled on ice again for 10 minutes and then spun down
and pelleted again.
7. After removal of the supernatant, the cell pellet was suspended to a final volume
of 2 ml in a buffer containing 10 mM PIPES, 75 mM Calcium chloride, 10 mM
Rubidium chloride, 15% Glycerol (v/v), pH 7.0.
8. The cell suspension was cooled on ice for 15 minutes and then aliquoted (50 pi)
into precooled tubes and snap-frozen in a dry ice-ethanol bath.
3.2.4 Heat Shock Transformation Of Bacterial Cells.
1. The plasmid to be transformed was diluted to 50 ng in 5 pi in sterile, distilled
water.
2. Competent JM83 cells were thawed on ice and 50 ng (5 pi) of the plasmid to be
transformed was added and mixed with the cells.
3. After chilling on ice for 30 minutes, the cells were heat shocked by placing them in
a waterbath at 42°C for exactly 90 seconds and then returning them back onto ice
for 2 minutes.
4. L-Broth was added to make the cell suspension up to 1 ml, which was then
incubated on a shaker at 37°C for one hour.
5. After one hour, the antibiotic resistance genes earned by the plasmid should be
expressed in transformed cells These were selected by plating 100 pi of the cell
culture onto L-agar plates containing ampicillin.
6. Transformed cells were visible as colonies after overnight incubation at 37°C.
3.2.5 Small Scale Plasmid Preparation.
This is a quick method of isolating small amounts of crudely purified plasmid DNA
from transformed cells, and was an adaptation of the method described by Birnboim
and Doly (1979).
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1. An overnight culture of cells was set up in 10 ml of Terrific broth.
2. A small amount of the culture (approximately 1.5 ml) was removed and spun
down at 12 000 g in a microcentrifuge.
3. The supernatant was removed and the pellet resuspended in 100 pi of a solution
of 50 mM Glucose, 25 mM Tris-HCl (pH 8.0), 50 mM EDTA, 10 mg/ml
Lysozyme (Sigma).
4. After standing at room temperature for 10 minutes, 200 (_tl of a solution of 1%
(w/v) SDS and 0.2 M Sodium hydroxide was added to the cell lysate. The
solutions were gently mixed and left on ice for 5 minutes.
5. Then, 150 pi of Potassium acetate was added and the mix left for a further 5
minutes on ice.
6. The cell lysate was spun down at 12 000 g in a microcentrifuge and 400 pi of the
supernatant removed to a clean tube.
7. To precipitate the DNA, 240 pi (0.6 volumes) of isopropanol was added, and
the supernatant left at room temperature for 5 minutes.
8. The DNA was spun down at 12 000 g and the supernatant removed.
9. The pellet was washed with 70% ethanol, dried under vacuum for 5 minutes, and
then resuspended in 30 pi of TE buffer.
3.2.6 Large Scale Plasmid DNA Preparation.
This method of plasmid DNA preparation was used to produce large quantities of
high quality plasmid DNA suitable for use in the transfection of mammalian cells, and
is as described in Sambrook et al. (1989).
1. A 500 ml overnight culture in Terrific Broth was spun down at 6000 rpm (Sorvall
RC-5B, DuPont Instruments) for 5 minutes.
2. The supernatant was removed and the pellet resuspended in 20 ml of a solution
containing 50 mM Glucose, 25 mM Tris-HCl, 50 mM EDTA, and 10 mg/ml
Lysozyme (Sigma).
75
3. After standing at room temperature for 5 minutes, 40 ml of a solution of 1% (w/v)
SDS and 0.2M Sodium hydroxide was added, and the lysate left on ice for 10
minutes.
4. A volume of 30 ml of pre-cooled Potassium acetate was added, and the lysate
mixed gently by inversion. This was incubated on ice for a further 20 minutes.
5. Cell debris was pelleted by centrifugation at 12 000 rpm (Sorvall RC-5B, DuPont
Instruments), 4° C for 30 minutes.
6. The resulting supernatant was filtered through muslin into a clean vessel and mixed
with 0.6 volumes of isopropanol.
7. After standing at room temperature for 5 minutes, the DNA was spun down at 10
000 lpm (Sorvall RC-5B, DuPont Insttuments) at room temperature, for 30
minutes in a prewarmed rotor.
8. After discarding the supernatant, the pellet washed in 70% ethanol and air dried.
9. When dry, the pellet was dissolved in 7.7 ml of TE buffer to which 400 pi of 10
mg/ml Ethidium bromide and 9.2 g of Caesium chloride was then added.
10.The resultant solution was divided between two quickseal ultracentrifuge tubes
(Beckmann). These were balanced to within 0.01 g of each other, heat-sealed, and
centrifuged in a fixed-angle rotor ultracentrifuge (Beckmann TL-100) at 100 000
lpm for 16-18 hours at 20 °C.
11.Circular plasmid DNA was visible as a tight band approximately half way up the
centrifuge tube, and was extracted using a sterile 0.8 gauge hypodermic needle
(Becton Dickinson) attached to a syringe.
12.Removal of the Ethidium bromide from the DNA solution was achieved by
repeated extractions with water-saturated butan-l-ol until the organic phase
became colourless.
13.The DNA was then precipitated from this solution with 2.5 volumes of 70%
ethanol and either hooked out on a glass rod, or spun down by cenlrifuging at 10
000 lpm (Sorvall RC-5B, DuPont Instruments) for 10 minutes.
14.After washing briefly in 70% ethanol, the DNA was dried under vacuum and
resuspended in 200 pi of TE buffer.
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3.3 ANALYSIS OF DNA BY RESTRICTION ENZYME
DIGESTION
Digestion of DNA by restriction enzymes was carried out under the conditions
recommended by the manufacturer (usually Boehringer Mannheim) using the
appropriate buffer (supplied by manufacturer). When two enzymes were to be used,
the digests were earned out simultaneously if the buffer was compatible with both.
Otherwise, digestion with the enzyme requiring the lower salt concentration was
carried out first and then the salt concentration was altered to that suitable for the
second enzyme by addition of Sodium chloride. Restriction digests were terminated
by heat inactivation at 80° C for 10 minutes, or if to be run out on an agarose gel, by
the addition of 1/10 volume of stop mix (100 mM EDTA pH 8.0, 20% (w/v) Ficoll
(Pharmacia), and Orange G (Sigma).
3.3.1 Plasmid DNA Digest.
Typically, 1 (ig of plasmid DNA was digested with one unit of restriction enzyme in a
total volume of 20 p.1. Incubation was at the recommended temperature (usually 37°
C), for 1-2 hours.
3.3.2 Genomic DNA Digest.
For digests of genomic DNA, 6-8 |ig of DNA was digested with 20 units of
restriction enzyme in a total volume of 40 (_ll. Bovine serum albumin (BSA), supplied
by Boehringer Mannheim, was added to give a concentration of 0.1 mg/ml if the DNA
had been prepared by the 'Quick lysis' method. If a high salt buffer was used,
Spermidine (Sigma) was added to a concentration of 5 mM. Incubation was
overnight at a temperature recommended for the enzyme.
3.4 GEL ELECTROPHORESIS OF NUCLEIC ACIDS
Fragments of DNA and RNA were size separated through horizontal agarose gels by
electrophoresis.
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3.4.1 Solutions And Buffers.
10 X TBE
890 mM Tris-HCl
20 mM EDTA pH 8.0
890 mM Boric acid pH 8.3
20 X TAE
0.8 M Tris-HCl
20 mM EDTA pH 8.0
0.4 M Acetic acid
10 XDNA loading buffer ('Stop mix')
20 % (w/v) Ficoll (Pharmacia)
100 mM EDTA
Orange G (Sigma) to colour.
3.4.2 Agarose Gel Electrophoresis Of DNA.
Separation of DNA molecules according to size was achieved by electrophoresis
through an agarose gel of the appropriate density. Density was varied by altering the
percentage of agarose (Type II medium EEO, Sigma) in the gel.
Restricted genomic DNA was run slowly at 20 Volts overnight in a 0.8-1.0 % gel
made up in 1 X TAE buffer. Continuous circulation of buffer was maintained by use
of a peristaltic pump. Smaller DNA fragments, such as plasmid DNA or PCR
products were run in 1-2 % agarose gels, and fragments smaller than 400 bp were
resolved either by running in a 4 % Nusieve (FMC Bioproducts) gel, or a gel
containing 3 % Nusieve and 1 % agarose These were run out more quickly than
genomic DNA, usually between 60-100 Volts for up to one hour. For these gels, 1 X
TBE buffer was used. Ethidium bromide was added to all buffers at a concentration
78
of 1 fig/ml. Stop mix of 1/10 sample volume was added to all samples prior to
loading onto the gel.
Molecular weight markers were run alongside DNA samples to facilitate band sizing.
When separating fragments of 1-10 kb, Hind III digested lambda DNA (BRL) was
used, for small fragments under 1 kb e.g. PCR products, Hae III digested (j)X DNA
(BRL) was used.
Electrophoresed DNA was visualised on a UV transilluminator (UVP Products Ltd)
at 305 nm, and photographed using a video copy processor (Mitsubishi).
3.4.3 Preparative DNA Electrophoresis.
Specific DNA fragments to be used as probes for radiolabelling were isolated using
gel electrophoresis followed by processing with one of the two following methods:
3.4.3.1 DNA probe preparation using 'Geneclean'.
A restricted DNA sample was electrophoresed through an agarose gel of the
appropriate density in 1 X TBE buffer. The band to be used as a probe was carefully
excised from the gel and extracted from the gel slice using the 'Geneclean' reagents
(BIO 101) and protocol. The DNA was diluted in sterile water to give a
concentration of 30 - 50 ng/pl
3.4.3.2 Preparation ofDNA probe using low melting point agarose.
The restricted DNA to be used as a probe was run out in a low melting point agarose
gel (Ultrapure LMP agarose, BRL) and excised as a gel slice. The DNA was not
isolated from this slice, but instead the slice was weighed and diluted with sterile
water in a ratio of 3 ml/g of gel, so that 11 |il of diluted gel slice contained 25-50 ng
of DNA.
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3.5 TRANSFER OF NUCLEIC ACID TO MEMBRANES
3.5.1 Southern Transfer Of DNA.
The transfer of DNA form agarose gel to nylon membranes was achieved using an
adaptation of the capillary blotting method of Southern (1975).
1. Following electrophoresis, gels were placed upon a UV transilluminator, aligned
with a ruler (to facilitate future fragment sizing), and photographed.
2. DNA within the gel was denatured by gentle agitation of the gel in a solution of 0.5
M Sodium hydroxide and 1.5 M Sodium chloride, for 45 minutes.
3. The gel was then neutralised by further agitation in a solution of 1 M Tris-HCl and
2 M Sodium chloride, pH 5.5, for 45 minutes.
4. A large strip of 3 MM (Whatman) filter paper was soaked in 20 X SSC (3 M
Sodium chloride, 0.3 M TriSodium citrate, pH 7.4) and placed on a narrow board.
5. A wick was generated by placing the board over a reservoir of 20 X SSC and
placing the ends of the filter paper into the reservoir.
6. The gel was laid onto this wick and exposed regions of the wick were then covered
with Saran wrap (Dow Chemical Company).
7. A piece of nylon membrane (Hybond-N, Amersham) was cut to the exact size of
the gel and placed onto it. In order to eliminate any air bubbles which would
interfere with the transfer of DNA, a 10 ml glass pipette was rolled gently over the
hybond.
8. The hybond was then covered with a piece of 3 MM filter paper (also cut to size),
which had been prewetted in 2 X SSC.
9. A further two pieces of 3 MM filter paper (not prewetted this time) were added
followed by a stack of absorbent paper towels to a height of 12 cm and a glass
plate. A weight of approximately 1 kg was applied to the top.
10.The blot was left to transfer for a suitable amount of time, which, for genomic
blots, was no less than four hours and usually overnight.
11.When transfer had occurred, the blot was dismantled and the membrane washed
briefly in 2 X SSC to remove agarose fragments.
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12.The DNA was bound to the membrane, first by UV-mediated crosslinking by
exposure to 1200 (iJ UV irradiation in a Stratalinker (Stratagene), followed by
baking at 80°C for 30 minutes.
3.6 RADIOLABELLING OF DNA
3.6.1 Random Primed Labelling of DNA.
This method of random primed DNA labelling is based upon that of Feinberg and
Vogelstein (1983), in which a mixture of all possible hexanucleotides are hybridised to
the DNA to be labelled. A complementary strand is synthesised using the 3'OH
termini of the random hexanucleotide primer and labelling grade Klenow enzyme.
Radiolabelled [a-32P] dCTP is incorporated into the newly synthesised DNA as the
only source of dCTP, producing an equal degree of labelling along the entire length of
input DNA which is not influenced by the length of DNA to be labelled.
1. The DNA to be labelled was diluted with sterile distilled water to give 25-50 ng of
DNA in a volume of 11 |il.
2. This was denatured by heating at 100°C for 10 minutes, and then placed
immediately onto ice unless the probe originated from a gel slice, in which case it
was cooled to 37°C.
3. Reagents from a Boehringer Mannheim random prime labelling kit were added as
follows:
2 (il 10 X reaction buffer
1 |ll each of dATP, dGTP, dTTP, (0.5 mM)
2 Units of Klenow enzyme
30 |iCi [a-32P] dCTP (Amersham)
4. The reaction mix was incubated at 37 °C for 45 minutes after which time the level
of radiolabel incorporation was measured by Trichloroacetic acid precipitation
(Sambrook et al. 1989). A sufficiently high level of incorporation was deemed to
be 40 % of the radiolabel.
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5. Unincorporated nucleotides were removed by running the probe through a Nick
column (Pharmacia) and eluting in a volume of 400 pi of TE buffer.
6. To minimise non-specific binding of the probe, 500 pg sonicated Salmon sperm
DNA (Sigma) was added to the probe DNA, which was then denatured by heating
at 100 °C for 10 minutes.
7. The probe was then added to the hybridisation mix.
3.6.2 Pre-annealing of Repetitive Sequences.
The repetitive elements contained within probes were annealed after labelling to
prevent the repeats taking part in the hybridisation reaction. The procedure employed
was adapted from Sealey et al. (1985).
1. Labelling was carried out as described in section 3.6.1 but the probe was not run
through a Nick column.
2. Instead, 1 mg of sonicated human DNA was added to the probe along with 500 pg
of sonicated Salmon sperm DNA, and denatured by heating at 100 °C for 10
minutes.
3. To allow annealing of the repetitive sequences, the DNA was incubated at 68 °C
for 30-45 minutes.
4. After incubation, the probe was added to the hybridisation mix.
3.6.3 End Labelling Of DNA Oligonucleotides
Oligonucleotides were labelled by the transfer of the 32P-labelled y-phosphate from [y-
32P] ATP by the action of the enzyme T4 polynucleotide kinase (T4 PNK), onto the
terminal 5'-OH group. A reaction mix in a 20 pi volume was set up as follows:
30 ng Oligonucleotide
1 X Polynucleotide Kinase (PNK) buffer (5 mM Tris-HCl pH 8.0, 1
mM Magnesium chloride, 0.5 mM Dithiothreitol).
10 Units Polynucleotide Kinase (Boehringer Mannheim)
50 pCi [y-32P]ATP (Amersham)
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The reaction was incubated at 37 °C for 30 minutes and then added to the
hybridisation mix.
3.7 NUCLEIC ACID HYBRIDISATION
3.7.1 Hybridisation Solutions.
Hybond hybridisation mix.
6 X SSC (20 X SSC is 3 M Sodium chloride and 0.3 M TriSodium citrate, pH 7.4)
10 % (w/v) Dextran sulphate
0.1 % (w/v) Sodium pyrophosphate (Sigma)
0.5 % (w/v) SDS
4 X Denhardts solution (100 X Denhardts contains 2% (w/v) BSA (Sigma), 2 %
(w/v) Polyvinylpyrrolidone, 2 % Ficoll (Pharmacia), 1 mM EDTA)
Oligonucleotide hybridisation mix.
5 X SSC
0.05 % (w/v) BSA
0.05 % (w/v) Ficoll
0.1 % (w/v) SDS
0.05% (w/v) Polyvinylpyrrolidone
0.1% (w/v) Sodium Pyrophosphate
3.7.2 Prehybridisation And Hybridisation Protocols.
Prehybridisation of filters in hybridisation mix containing denatured, sonicated Salmon
sperm DNA was earned out before addition of the probe to block any non-specific
binding sites.
1. Filters were placed between two gauze sheets (which are used to prevent drying
out of the filter during hybridisation) and air bubbles were eliminated by
submerging and rolling these up under a solution of 2 X SSC.
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2. The filter-gauze roll was placed into a Hybaid hybridisation bottle and unrolled in a
solution of 2 X SSC.
3. This was poured off and replaced with the appropriate prewarmed hybridisation
mix, (Hybond hybridisation mix for random primed-labelled probes, or
Oligonucleotide hybridisation mix for end-labelled probes). A volume of 10 ml
was used for small hybridisation bottles, and 20 ml for large bottles.
4. To this, 500 |ig of denatured, sonicated Salmon sperm DNA was added, the bottle
sealed and placed into the rotating spindle of a Hybaid hybridisation oven.
5. Prehybridisation was carried out for at least one hour at 5 °C below the TM of the
oligonucleotide (see section 3.9.1) for end labelled oligonucleotides, or at 68 °C
for random prime-labelled probes.
6. Following prehybridisation, the probe was added and hybridised to the filter
overnight at the same temperature used for the prehybridisation.
3.7.3 Post-hybridisation Washing Protocols.
Following overnight hybridisation, the filters were washed to remove background
(non specific) hybridisation of the probe. The initial wash solution contained 2 X
SSC, 0.1 % (w/v) SDS and 0.1 % (w/v) Sodium pyrophosphate, heated to the
hybridisation temperature. Filters were washed at 68°C with gentle agitation for
twenty minutes after which time the background radioactivity was monitored. If the
background count was still high, washes of increasing stringency (decreasing SSC
concentration) were employed. The most stringent wash employed was 0.1 X SSC.
3.7.4 Removal OfHybridisation Signal.
Removal of the hybridisation was necessary for the reprobing or storage of filters, and
was achieved by one of the following two methods. For successful removal of
probes, it is important never to let the filter dry out.
3.7.4.1 Removal of hybridisation signal by the alkaline stripping method.
Removal of hybridisation signal was achieved by incubating the filter at 45°C for 30
minutes in a solution of 0.4 M Sodium hydroxide with gentle agitation. This solution
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was then replaced with a solution of 0.1 X SSC, 0.1% (w/v) SDS and 0.2 M Tris-
HC1, pH 7.5, and incubated for a further 30 minutes.
3.7.4.2 Removal ofhybridisation signal by the boiling method.
With this method, removal of signal was achieved by adding the filter to a boiling
solution of 0.1% (w/v) SDS and allowing it to cool to room temperature.
Complete removal of hybridisation signal was verified by use of one of the methods
for hybridisation signal detection described in section 3.8.
3.8 DETECTION OF HYBRIDISATION
3.8.1 Autoradiography.
Hybridised filters were wrapped in Saran wrap to prevent drying out and exposed to
Kodak X-OMAT film in light-proof cassettes with intensifying screens. Filters were
exposed to film at a temperature of -70 °C for periods of 30 minutes to 3 weeks,
depending upon signal strength. The film was developed using a Fuji RG II automatic
X-ray film processor.
3.8.2 Phosphorimaging.
A more rapid visualisation of hybridisation signal was achieved by use of a
phosphorimage system. The hybridised filters were wrapped in Saran wrap, placed
into a phosphorimage cassette (Molecular Dynamics) and exposed to the phosphor
screen at room temperature for a period of between 30 minutes and 36 hours,
depending upon signal strength. After an appropriate exposure time, the
phosphorimage screens were scanned on a Phosphorlmager (Molecular Dynamics),
where a laser beam converts the radioactive signal into a digital image. The amount
of radioactivity was represented by a proportional variation in pixel values, and the
image was displayed on a grey scale. Good visualisation of the image was achieved
by adjustment of the upper and lower limits of the grey scale, and the image was
printed out on a grey scale laser printer.
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3.9 AMPLIFICATION OF DNA BY THE POLYMERASE
CHAIN REACTION (PCR)
The Polymerase chain reaction (PCR) is an enzymatic amplification technique which
permits the cyclic amplification of a specific DNA sequence (Saiki et al. 1985, Mullis
and Faloona, 1987). Sequence specificity is provided by a pair of oligonucleotide
primers which direct amplification and are complimentary in sequence to the 5' ends
of the sequence to be amplified. The primers anneal to the template DNA under
conditions permitting only exact complimentary annealing, and prime the extension of
complimentary DNA by the enzyme DNA polymerase.
The PCR reaction is a series of cycles consisting of three steps each involving an
incubation at different temperatures for set periods of time. The first step is a high
temperature incubation causing denaturation of the template DNA, which is necessary
for its amplification. This is followed by rapid cooling to a temperature which
promotes precise annealing of the oligonucleotide primers. A period at 72°C follows,
this is the optimum temperature for extension of DNA by the thermostable DNA
polymerase.
3.9.1 PCR Of Genomic DNA.
3.9.1.1 PCR setup.
A PCR reaction was set up in a 50 |il volume as follows:
100 ng template DNA
5 |il 10 X PCR buffer II (Perkin Elmer)
3 |il (25 mM) Magnesium chloride (Perkin Elmer)
1 |_Ll each primer (250 ng/|il)
10 mM each dNTP (Pharmacia)
1 unit thermostable AmpliTaq DNA polymerase (Perkin Elmer)
The reaction mix was overlaid with mineral oil (Sigma) to prevent evaporation, and
placed onto a Hybaid Omnigene thermal cycler. The temperature and length of each
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step was varied according to the primer pair and the length of the fragment to be
amplified.
Each PCR reaction always included an initial cycle with a long denaturation step at a
higher temperature, usually 94 °C for 3 minutes. This was followed by a set of cycles,
the number of which was dependent on the efficiency of the amplification (usually 30).
This set consisted of a denaturation step (usually 92 °C for 30 seconds), followed by
an annealing step. The annealing temperature was assessed for each primer pair and
was taken as 5 °C lower than the melting temperature (TM) of the primers. The TM
was determined by the equation TM (at 1 M Na+ = 4(G+C) + 2(A+T). Annealing was
generally earned out for one minute and was followed by extension at 72 °C for
approximately one minute/kb to be amplified. The final cycle incorporated an
increased extension step, usually of 7 minutes.
The products of a PCR reaction were visualised by running 10 |il on an ethidium























































































Embryonal stem cells, when returned to the environment from which they were
originally isolated, can behave like normal cells of the blastocyst inner cell mass, and
contribute to all of the tissues of the resulting animals. To retain this ability, ES cells
must be maintained in a pluripotent state (section 2.1).
In this study, we attempted to make chimaeras from targeted cell lines by the
coculture/aggregation method (Nagy and Rossant 1993). This technique involves the
coculture of ES cells and morulae resulting in the internalisation of the ES cells into
the developing embryo. The morulae are cultured overnight to the blastocyst stage
and implanted into a pseudopregnant foster mother, where they go on to form viable
progeny which should include a contribution from the introduced ES cells. This
method is thought to be a quicker and simpler than the alternative, technically
demanding, method of microinjection (Gordon et al. 1980). The microinjection
technique usually requires many hours of practice before the necessary level of manual
dexterity is achieved, and in contrast to the aggregation technique, utilises elaborate
and expensive equipment (Wood et al. 1993). The aggregation technique does
however, have disadvantages associated with it. The zona pellucida is removed prior
to aggregation, requiring that the morula and ES cells be cultured overnight until a
blastocyst is formed. Both ES cells and the morulae have differing nutritive
requirements at this stage, consequently the culture media employed for the overnight
incubation represents a compromise between the two requirements and is optimal for
neither cell type.
The day to day husbandry of the mice involved in this study as well as administration
of the hormones required for the superovulation regime, was carried out by staff of
the Biomedical Research Facility.
4.2 Preparation of ES Cells For Chimaera Production.
ES cells for chimaera production were maintained under optimal conditions as far as
possible. Cells were passaged at least once after thawing as described in section 2.1.
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On the day of aggregation, a subconfluent culture of exponentially dividing cells was
washed with 5 ml of PBS and incubated with 1 ml of half-strength trypsin-EDTA. As
soon as the cells formed loose clumps, 10 ml of GMEM was added to inactivate the
trypsin. The cell suspension was left in the flask at 37 °C and used for aggregation
within one hour.
4.3 Mouse Strains.
A Fi hybrid mouse strain from a C57BL/6 X CBA cross (C57BL/6 being the female)
was used to generate morulae for chimaera production. These mice display hybrid
vigour, are a compatible host for 129/Ola ES cells, and carry pigmentation and other
marker alleles which differ sufficiently from those carried by the ES cells to facilitate
early detection of chimaeras. The strain used for foster mothers and vasectomised
stud males was the Swiss albino mouse strain. An albino strain was used for this
purpose so that in the eventuality of any embryos being generated by the foster
mothers (e.g. if the vasectomised stud male produces sperm, or a non-vasectomised
stud male is used in error), the offspring would be easily detected as non-pigmented
albinos within a pigmented litter.
4.4 Superovulation of Females For Embryo Collection.
In order to collect a large number of morulae from a single mouse, female mice were
induced to superovulate by administration of Pregnant Mares Serum Gonadotrophin
(PMSG, Intervet). This stimulates follicles in the ovary to mature and was given as an
intra-peritoneal (i.p.) injection of 5 i.u. (international units). This was followed 48
hours later by i.p. injection of 5 i.u. of Human Chorionic Gonadotrophin (HCG),
which overrides the mouse's own luteinising hormone and stimulates the mature
follicles to ovulate. The females were set up for mating with stud males 2-6 hours
after HCG injection and were checked for vaginal plugs the following morning. The
presence of a vaginal plug was taken as evidence of mating.
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4.5 Preparation of Pseudopregnant Foster Mothers.
Pseudopregnant foster mothers at an appropriate stage of pregnancy were required to
provide a uterine environment which was receptive to embryo implantation and
development. Foster mothers whose pseudopregnancies were at a stage compatible
with that of the transferred blastocysts, were prepared by mating female mice in
oestrus (identified by appearance of vaginal epithelium) to vasectomised, sterile males.
The stimulus ofmating causes the female to display the hormonal profile of a pregnant
female, and subsequent embryo transfer at the appropriate time provides a signal for
further maintenance of pregnancy. Blastocysts, at 3.5 d. p. c., were transferred into
pseudopregnant females at 2.5 d. p. c. of pseudopregnancy. This discrepancy is to
allow the blastocysts to resynchronise with the uterus and recover from a period of
culture in vitro.
4.6 Medium and Solutions.
M16 Medium
This is a modified Krebs-Ringer bicarbonate salt solution as described by Whittingham
(1971). It was prepared in-house in 100 ml quantities from the individual components
listed below, Filter sterilised through a 0.2 |im filter (Gelman), and stored at 4 °C for
up to one month. Morulae and ES cells were cultured in microdrops (25-50 ql) of
this medium under a layer of filtered, light paraffin oil (BDH), at a temperature of 37
°C in an atmosphere of 5% C02. The microdrops were prepared in tissue culture
plates and equilibrated in a C02 incubator for at least 30 minutes prior to use.
0.553 g Sodium chloride
0.036 g Potassium chloride
0.025 g Calcium chloride dihydrate
0.016 g Potassium dihydrogen phosphate
0.029 g Magnesium sulphate hexahydrate
0.210 g Sodium bicarbonate (Sigma)
0.32 ml (60% (w/w) syrup) Sodium lactate (Sigma)
0.004 g Sodium pyruvate (Sigma)
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0.1 g Glucose
0.4 g BSA (Sigma)
0.006 g Penicillin G Potassium salt (Sigma)
0.005 g Streptomycin sulphate (Sigma)
0.001 g Phenol red
All made up to 100 ml with ultrapure distilled water.
M2 Medium
This medium is similar to M16 medium but has some of the bicarbonate replaced by
HEPES buffer. It too was prepared in house in 100 ml quantities from individual
components listed below, and filter sterilised through a 0.2 pm filter (Gelman). This
medium was stored at 4 °C for up to one month. All work involving the handling of
morulae outside of the incubator was carried out in M2 medium.
0.553 g Sodium chloride
0.036 g Potassium chloride
0.025 g Calcium chloride
0.016 g Potassium dihydrogen phosphate
0.029 g Magnesium sulphate
0.035 g Sodium bicarbonate
0.497 g HEPES
0.32 ml Sodium lactate (60% syrup)
0.004 g Sodium pyruvate
0.1 g Glucose
0.4 g BSA
0.006 g Penicillin G
0.005 g Streptomycin sulphate
0.001 g Phenol red
Made up to 100 ml with ultrapure distilled water.
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4.7 Morula Collection
Eight cell stage embryos for aggregation were recovered from superovulaled females
as follows:
1. Superovulated females were sacrificed at 2.5 d. p. c.
2. The oviducts and upper part of the uterus were dissected out, any body fat
trimmed away, and placed into a drop of M2 medium.
3. Morulae were washed out from the oviducts by flushing through approximately 0.5
ml M2 medium with the aid of a 30 gauge needle, or released by tearing open the
oviducts using fine forceps.
4. A mouth controlled pipette attached to a drawn out glass Pasteur pipette was used
to collect all the liberated morulae and transfer them to microdrops of M2 medium.
4.8 Aggregation Formation.
Embryo-ES cells aggregates were prepared with the aid of Phytohaemagglutinin
(Sigma) which helps stick the ES cells to the embryo. Clumps of ES cells were stuck
to single morulae or sandwiched between a pair of embryos. There seems to be some
debate as to whether a higher rate of chimaera production is obtained from aggregates
constructed with a single embryo, or with a pair of embryos, and for this reason we
constructed both. Bradley (1987) suggests that a single embryo might not be able to
properly regulate a group of ES cells, whereas a combination of two embryos might
overcome this problem. However, Nagy (1994) proposes that a higher percentage of
germ line transmission might be achieved from chimaeras resulting from aggregations
of single embryos with ES cells. He argues that in 50 % of single embryo
aggregations the favourable combination of XX (female) morula and XY (male) ES
cells can occur, compared to only 25 % of two embryo sandwich aggregations. This
combination is desirable as the resulting chimaera will be phenotypically male with the
XX primordial germ cells derived from the host embryo unable to form gametes.
Therefore germline contribution of the ES cells is favoured.
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Embryo and ES cell aggregates were constructed as follows:
1. Removal of the zona pellucida (a necessary prerequisite for aggregation with ES
cells) was achieved by transferring the embryos into a 0.5 % solution of Pronase
(Sigma) in M2 medium for approximately five minutes.
2. Once the zona pellucida had disappeared, the embryos were passed through two
microdrops of M2 medium to wash off excessive pronase, and transferred in
batches of approximately 10, to a microdrop of 0.2 (ig/ml Phytohaemagglutinin
(Sigma) in M2 medium.
3. A small amount of ES cell aggregates were transferred into the same microdrop,
and aggregates prepared by sticking together clumps of ES cells containing 5-10
cells to single morula, or by sandwiching them between two morulae.
4. Aggregates were washed through two drops of M2 medium to remove traces of
the Phytohaemagglutinin, and placed into individual drops of M16 medium.
5. After overnight incubation, the majority of aggregates had formed blastocysts and
were ready for implantation.
4.9 Transfer ofManipulated Embryos To Pseudopregnant Host Females.
Manipulated embryos were transferred into pseudopregnant females whose stage of
pregnancy was one day behind that of the embryos. At this stage of pregnancy the
blastocysts would normally be found in the uterus and therefore this is where the
manipulated embryos were returned. The uterine environment of the pseudopregnant
females should be receptive to implantation of these embryos and expedite their
development into viable offspring. This surgical procedure was usually carried out on
the afternoon of the day following morula aggregation, and was performed on the
open bench under general anaesthesia as follows:
1. Blastocysts to be transferred were collected together into a microdrop of M2
medium.
2. The transfer pipette (a drawn out Pasteur pipette attached to a mouth pipette) was
prepared by taking up liquid paraffin to the length of the drawn out section,
followed by a small amount of air (to create an air bubble), a small amount of M2
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medium, and another air bubble. The embryos to be transferred were taken up
next, in as small an amount of medium as possible, followed by another air bubble
and a small amount of medium. Paraffin oil provided a means of slowing down the
movement of liquids when expelled from the pipette, as too forceful a transfer
could result in the embryos being washed straight through the uterus and out of the
cervix. The air bubbles were incorporated as a visual marker to indicate when the
medium containing the embryos had passed into the uterus.
3. Swiss albino foster mothers were anaesthetised by administration of an i.p.
injection of a solution containing 0.75 ml Hypnorm analgesic (Roche), 0.5 ml
Hypnovel anaesthetic (Roche), 4.5 ml sterile distilled water.
4. Once consciousness was lost (usually after five minutes), the mouse was placed
face down onto absorbent paper towel and its back was sprayed with absolute
ethanol to sterilise this area.
5. A dorsolateral incision was made through the skin and the ovarian fat pad located
through this incision.
6. Another, smaller incision was made through the peritoneum directly above the fat
pad.
7. The ovarian fat pad was grasped with blunt forceps and gently eased out through
the incisions bringing with it the ovary, oviducts and upper part of the uterus.
8. The mouse was then placed onto the stage of a stereo dissecting microscope which
was focused on the exposed uterine horn.
9. A hole was made into the uterine horn by insertion of a 25 gauge hypodermic
needle (Becton Dickinson), into which the end of the transfer pipette was inserted.
The embryos were gently expelled into the uterus from the transfer pipette.
10.After easing the uterus, ovary and fat pad back into the body cavity using blunt
forceps, the peritoneum was closed with a single silk suture, and the skin wall by
two or three Michel wound clips.
11.The female was kept warm until full consciousness was attained, when she was
placed into a clean cage along with other foster mothers.
12.Three days prior to birth, pregnant females were separated into individual cages.
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13.A litter of pups resulting from embryo transfer was usually bom seventeen to
eighteen days following the procedure.
4.10 Analysis of Progeny From Embryo Transfer.
The contribution of the ES cells to the offspring resulting from morula aggregation
could be assessed visually by use of pigmentation markers. The chinchilla (cch) allele
earned by the ES cells affects melanocytes which determine coat colour pigmentation.
Any contribution to the melanocytes of the offspring from the ES cells will be
manifested as hair with reduced pigmentation (yellow pigment affected more than
black pigment) when compared to the agouti coat colour contributed by the Ft
C57BL/6 X CBA morulae. The pink eye dilution allele carried the ES cells also
manifests itself visually. This allele again affects melanocytes, causing some degree of
non-pigmentation (pink) in the eyes, and has the effect of reducing coat pigmentation
but affects black pigmentation more than yellow. Therefore, the combined effect of
these marker alleles is to allow visual detection of ES cell contribution by loss of
pigmentation in the eye and reduced pigmentation of the coat hairs.
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CHAPTER 5




Many strategies have been devised to introduce subtle, precise mutations into ES
cells. These are described in detail in section 1.2. This thesis describes the use of one
of these methods, the 'hit and run' technique (also known as 'in out' targeting), to
introduce mutations into Cftr in mouse ES cells.
5.1.1 Strategy.
The 'hit and run' technique is a two step procedure requiring two separate
homologous recombination events (section 1.2.4.2 and figure 5.1). Initially, a gene
targeting experiment is conducted involving large scale clone picking and screening
for cells in which the targeting vector has integrated into the target site, the 'hit'
event. Following their identification, a negative selection is applied to correctly
targeted clones to pick out those cells which have subsequently lost the targeted
vector, through the desired intrachromosomal recombination 'run' event. Clones
surviving the second round of selection are again picked, grown up and analysed.
These two rounds of selection and clone picking, each requiring analysis, are very
labour-intensive and time consuming. Growing up each clone to produce sufficient
cells for DNA analysis, and generating frozen stocks, significantly increases the
passage number and therefore the opportunity for a deterioration of the condition of
the cells, whether through microbial contamination, development of karyotypic
abnormalities, or loss of germ line competence.
Through consideration of these aspects, we reasoned that this two step analysis was
not strictly necessary. It was argued that only correctly targeted clones will have a
duplication of the target DNA and will be capable of losing the integrated vector
through intrachromosomal recombination within the duplicated region. Therefore, it
would not be necessary to screen the clones surviving the first (positive) selection,
which represent targeted and randomly integrated transfected cells. By putting these
cells straight onto the second selection, all randomly targeted clones should die as
they would still retain the tk gene, and only targeted cells which have lost tk gene
99
expression due to excision of the vector, (the 'run' event), should survive. Some cells
will inevitably survive Gancyclovir selection through inactivation rather than actual
loss of the tk gene, but these events should be extremely rare, making these cells a
small minority. Therefore, it should be feasible to pick and screen clones only after
the second round of selection.
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Figure 5.1 'Hit and Run' gene targeting strategy.
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5.2 HIT AND RUN TARGETING VECTORS
Vectors employed for the introduction of subtle mutations through the 'hit and run'
pathway are a modified version of an insertion vector (section 1.2.4.1). As for
insertion vectors, a positive selection gene (e.g. Neomycin or Hygromycin) is
necessary for the selection of transfected cells, but for 'hit and run', a negative
selection gene (e.g. tk) for selection of 'run' events is also required. The vector
carries the homologous genomic targeting sequences employed in insertion vectors,
but for this purpose, the mutation to be introduced is also present in these targeting
sequences.
5.2.1 Vector Construction
The vectors used in this study were constructed by Dr Paul Dickinson, and were
based upon the vector pIV3.5H used by Dorin et al. (1992) to disrupt Cftr in ES
cells. This vector was modified as follows (Fig. 5.2):
(I) The Neomycin selection cassette was replaced with a Hygromycin-
hsvtk fusion gene from the plasmid tgCMV/HgTK (a kind gift from Dr
Steven Lupton). This selection cassette produces a fusion protein with
the ability to confer both resistance to Hygromycin selection and
sensitivity to Gancyclovir selection (Lupton et al. 1991). Expressing both
positive and negative selection from a single promoter offers the
advantage that any gene inactivation/suppression mechanism should act
equally upon both selections. This is important when employing a
negative selection screen which selects for loss of gene expression. With
this fusion gene, any such inactivated cells should not be Hygromycin
resistant and therefore would not survive the positive selection round.
(II) The genomic sequences carried by the vector pIV3.5H were extended
by the addition of 0.8 kb of genomic sequence, bringing the overall length
of genomic homology to 4.3 kb. This additional genomic sequence
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included a mutant exon 10, in which a CF-associated mutation had been
introduced by use of PCR mediated mutagenesis (Cormack 1994).
Prior to transfection, it is necessary to linearise insertion vectors within the region of
homology generating a double strand break which stimulates single, reciprocal
recombination with the chromosomal target. Unfortunately, the Asp 718 restriction
site which had been used previously for linearisation of the insertion vector pIV3.5H
in high frequency targeting of Cftr, was no longer unique, as modification of pIV3.5H
had resulted in the introduction of further Asp 718 restriction sites. Restriction
analysis of the genomic sequences was therefore necessary to identify another unique
restriction site which was suitable for linearisation of the vector. One such site was
identified, an Hpa I restriction site, which was situated 1.2 kb from the 5' end of the
genomic targeting sequences (Fig. 5.2), and gave a more even distribution of genomic
sequences on either side of the double stranded break than the Asp 718 site, (1.2 kb 5'
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5.3 HIT AND RUN TARGETING
5.3.1 Experiment HR1
5.3.1.1 Method
The ES cell line E14 was grown up on a PEF feeder layer (section 2.1), and 1()7 cells
of a passage 23 culture were transfected by electroporation with 100 (ig of Hpa I-
linearised vector pHTHRAF508. Following transfection, the cells were seeded into
ten 100 mm gelatinised tissue culture plates (106 cells/plate), and incubated overnight.
Twenty four hours post-transfection, Hygromycin selection was imposed and
maintained until colonies were visible. Eight days after transfection, plates containing
Hygromycin resistant colonies were trypsinised and seeded onto PEF feeder layers in
fresh plates. Gancyclovir selection was imposed twenty four hours later and
maintained until clones were visible. Once visible, the clones were picked and grown
up to generate cells for frozen stocks and DNA analysis.
5.3.1.2 Results and analysis.
Clone numbers.
Twenty eight Gancyclovir resistant clones were obtained by this 'hit and run'
targeting experiment, and the numbers are detailed in table 5.1. A targeting frequency
of 1 in 50 was achieved by Dorin ef al. (1992) when targeting this locus with a similar
vector. Assuming the same targeting frequency for this experiment, approximately
four targeted clones would be expected in the two hundred Hygromycin resistant
clones obtained from the first round of selection. With only twenty Hygromycin
resistant clones per plate, it would be anticipated that only four out of the ten plates
would contain a targeted clone and therefore give clones which survive Gancyclovir
selection. As seen below, six plates contained Gancyclovir resistant clones and four
did not, which is still within the order of what was expected and implies that at least
six independent and correctly targeted clones were obtained after Hygromycin
selection. All the Hygromycin resistant clones present on plates 7, 8, 9, and 10
probably represent randomly targeted clones which were not able to excise the
plasmid through intrachromosomal recombination, and so consequently died when
Gancyclovir was imposed.
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Table 5.1 Numbers of clones obtained at each stage of experiment HR1.
PLATE No. No. HYGr CLONES No. GANCr CLONES
1 5
2 AVERAGE OF 20 2








Analysis ofGancyclovir resistant clones.
If successful, this experiment should introduce a three base pair deletion, as the only
alteration to Cftr in the ES cell clones. Detection of such a small change in gene
structure requires a sufficiently sensitive technique, and for this experiment it was
envisaged that this mutation could be detected by the use of allele-specific PCR
(Okayama et al. 1989).
Primers were designed which, when used in different combinations, could distinguish
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Figure 5.3 The possible genotypes of clones from 'Hit and Run' targeting.
The solid black line represents Cftr genomic sequences, the black rectangle exon 10,
and the position of a CF-associated mutation is marked by A. Unknown genomic
sequences are indicated by a dotted line. Plasmid sequences are shown as a diagonally
hatched region, and the Hyg/TK fusion gene by vertical hatching. The direction of
transcription is indicated by a bent arrow. Restriction sites are Asp 718 (A), Eco RI
(E), Hpa I (Hp), Hind III (H), and Xba I (X). The annealing sites of PCR
oligonucleotides and the direction of priming are indicated by arrows. (A) The
structure of pHTHRA 'Hit and Run' targeting vector. (B) The predicted mutant
genomic structure around exon 10 of Cftr following homologous recombination with
vector pHTHRA. A 'hit' event. (C) Random, non-homologous integration of vector
pHTHRA with unknown flanking genomic sequences. (D) Genomic structure around
exon 10 of wildtype Cftr allele. (E) The desired mutant allele of a 'run' event,
differing from the wildtype allele only by the presence of a mutation (A) in exon 10.
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A PCR reaction was conducted on HR1 clone DNA, utilising the primer M10AF
which is specific for the AF508 mutation, and primer MI 10 which primes from a 3'
region external to the targeting region. This combination is therefore diagnostic for a
'run' event which has retained the AF508 mutation. No PCR products were obtained
from this reaction, but as there was no positive control template DNA available, this
in itself is inconclusive. The possibility that the absence of product is due to failure of
the PCR reaction rather than absence of the correct template cannot be ruled out.
A second PCR reaction was conducted, this time employing the primers M10AI and
MI10 which amplify across exon 10 out into genomic DNA flanking the 3' side of the
vector. This reaction would amplify DNA from a 'run' event which has retained or
lost the mutation, and the 3' duplicated region (predicted to be wildtype) from a 'hit'
event, but should not amplify DNA from a randomly targeted clone. The wildtype
allele on the non-targeted chromosome will also be amplified in all genotypes. PCR
products of the correct size were obtained for all clones and were run out on a 2%
agarose gel, blotted, and then analysed by allele specific hybridisation (section 3.6).
The filter containing the PCR products was probed with the oligonucleotide MlOAF,
which should hybridise to amplified exon 10 DNA containing the AF508 mutation.
This probe however, exhibited some non-specific hybridisation as shown by the signal
obtained in the lane containing non-transfected E14 DNA (figure 5.4). After
employing the stringent washing conditions of 2 X SSC for fifteen minutes at 75°C,
this aberrant signal was still visible in the E14 lane, but was significantly stronger in
the positive control lane containing amplified vector DNA bearing the AF508
mutation (PCR products from M10AF and reverse primers). After accounting for the
intensity of Ethidium bromide staining, the signal in the lanes of HR1 clones was
similar to that of the E14 negative control and less intense than the positive control.
Despite the non-specific hybridisation exhibited, this result suggests that the AF508
mutation was not present in the products of this PCR reaction and that the amplified
DNA represents a wildtype allele. This could mean that the clones are all from a 'run'
event which has reverted to wildtype (or wildtype cells which have come through the
selections), but as at least one wildtype allele will be amplified in all genotypes, does
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not exclude the possibility that the clones still contain the vector. The mutant exon 10
of an integrated vector would not be amplified in this PCR reaction.
123456789 1011121314151617
Figure 5.4 Hybridisation of AF508 allele-specific oligonucleotide (MlOAF) to
PCR-amplified Cftr exon 10 DNA of HR1 clones.
Genomic DNA was amplified using primers M10AI and MI10, blotted and probed
with the AF508 allele-specific oligonucleotide M10AF.
Lane 1 is a negative control, non-transfected E14 DNA, and lanes 2-16 HR1 clones.
Lane 17 is a positive control of pHTHRAF508 vector DNA amplified with primers
M10AF and reverse primers generating a AF508 mutation containing product.
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In order to investigate whether the targeting vector was still present in these clones, a
PCR reaction was carried out using the primers MlOAF and Reverse. These amplify
from the AF508 mutation across into plasmid sequences carried by the vector, and so
are specific for integrated vector DNA but does not distinguish between correctly
targeted and randomly targeted vector DNA. Products of the expected size were
generated by this PCR reaction (figure 5.5) suggesting that both the mutation and the
vector are present in the clones. A faint band can be seen in the negative control
which was set up in the absence of a DNA template, and probably represents
contamination of the reaction with vector DNA. However, the bands given by the
HR1 clones (apart from lanes 6 and 7), are much stronger than this contaminant band
and are unlikely to have arisen through vector contamination.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
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Figure 5.5 Amplification of vector sequences in HR1 clone DNA.
An Ethidium bromide stained 1% agarose gel showing HR1 clone DNA amplified in a
PCR reaction with primers MlOAF and reverse primers.
Lanes 1 and 11 are PhiX174 Hae III size markers. Lanes 2 and 3 are negative
controls of amplification without DNA template, or with a non-transfected DNA
template respectively. Amplified DNA from HR1 clones is present in lanes 4-10 and
12-15. Lane 16 is the positive control containing amplified DNA from a cell line




This 'straight through' 'hit and run' strategy seems to be at least partly successful as
Gancyclovir resistant clones were obtained, and appear to be a result of initial
transfection with the targeting vector. However, it would seem that all of the clones
obtained in this experiment were 'false positives' in that they had survived
Gancyclovir selection despite containing the vector. This is probably due to
inactivation of the tk gene in these clones which could be caused by point mutation or
the influence of flanking DNA in randomly integrated clones. The desired excision of
the vector following integration in the 'hit' stage had not occurred.
Analysis of these clones was not straightforward and a much simpler and reliable
method would be needed, especially in view of the large number of transgenic mice
which would be generated and require analysis if this targeting was successful.
Therefore it was decided to make use of codon 'wobble' and alter the nucleotide
sequence of the vector for future experiments so that a novel restriction site is created
by the mutation, whilst the amino acid sequence remains unchanged.
5.3.2 Experiment HR2
Another 'straight through' 'hit and run' experiment was conducted along the same
lines as experiment HR1. This time a targeting vector was used bearing another CF
associated mutation, the AI506/7 mutation, which creates an Ssp I restriction site to
facilitate clone analysis. It had been decided at this point that 'hit and run' targeting
for this thesis should concentrate upon introducing the AI506/7 mutation into ES
cells, and that targeting of the AF508 mutation would be carried out in parallel by
others in our group. This was due to the desirability of a mouse model carrying the
most common CF mutation, the AF508 mutation, and the pressure to produce this
mouse model quickly. The characterisation of a AF508 mouse would need to be
conducted speedily and would not allow time for the acquisition of the necessary level
of skill in the appropriate techniques. However, although a AI506/7 mouse would be
of considerable and complimentary interest, its creation would not attract the same
degree of urgency and would therefore be better suited to a project for a PhD thesis.
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The AI506/7 mutation represents a deletion of an Isoleucine amino acid at either
codon 506 or 507 (both are Isoleucines., Kerem et al. 1990). This mutation accounts
for approximately 0.2% of CF mutations, making it around the fourteenth most
common CF-causing mutation (The Cystic Fibrosis Genetic Analysis Consortium
1994). The proximity of this single amino acid deletion at codon 506 or 507, to the
major CF-associated mutation AF508 (also a single amino acid deletion) at codon
508, makes a comparison between the two mutations worthwhile. In common with
AF508 CFTR, the mutant protein arising from the AI506/7 mutation has also been
shown to be subject to biosynthetic arrest, becoming mislocalised within the cell
(Cheng et al. 1990). Due to its low frequency, very few AI506/7 homozygous
patients have been reported, however this mutation has been designated a 'severe'
allele based upon the observation that it confers a pancreatic insufficient phenotype
in AI506/7/AF508 compound heterozygotes (Kerem et al. 1990., Kristidis et al.
1992).
The AI506/7 mutation was engineered into the targeting vector in such a way that it
created a diagnostic restriction site (figure 5.6). This was achieved by making use of
codon 'wobble', a phenomenon which allows multiple codons to specify the same




Nucleotide sequence 5' AAT ATC ATC TTT GGT 3'
Amino acid sequence N N I I F G C
B Mutant AI506/7 sequences
Nucleotide sequence 5' AAT ATC TTT GGT 3'
Amino acid sequence N N I F G C
C Ssp I restriction enzyme recognition sequence
5' AATATT 3
D Vector sequences <1
Nucleotide sequence 5' AAT ATT TTT GGT 3'
Amino acid sequence N N I F G C
Figure 5.6 Alteration of vector AI506/7 sequences to introduce a diagnostic
restriction site.
(A) Represents wildtype nucleotide and amino acid sequences at codons 505 to 509,
and (B) the mutant sequence of the AI506/7 mutation in which an Isoleucine has been
deleted at codon 506. (C) Shows the recognition sequence of the restriction enzyme
Ssp I, and (D) the altered mutant nucleotide sequence which creates the Ssp I site
whilst leaving the amino acid sequence unchanged. The nucleotide bases are
represented as (A) adenine, (T) Thymine, (G) Guanine, and (C) Cytosine. The amino
acids are denoted as (N) Asparagine, (I) Isoleucine, (F) Phenylalanine, and (G)
Glycine. The site of cutting within this sequence is indicated by the arrow.
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5.3.2.1 Method
A passage nineteen culture of El4 ES cells were grown up on a PEF feeder layer, and
107 cells transfected with 100 |ig of Hpa /-linearised vector pHTHRAI. The cells
were plated out as before (see HR1) and Hygromycin selection imposed after twenty
four hours.
It was thought that in the previous experiment, the time between Hygromycin and
Gancyclovir selection, (twenty four hours), may not have been sufficient to allow
excision of the vector (the 'run' event), to occur. In the original paper by Hasty et al.
(1991) the highest rate of vector excision achieved was 4 X 1 0"3 cells. Some of the
small Hygromycin resistant clones may not contain as many as 103 cells and
occurrence of this excision event would therefore be unlikely. To determine if this has
some effect on the number of Gancyclovir clones obtained, five of the plates
containing Hygromycin resistant clones (series A), were trypsinised into fresh gelatin
coated plates seven days after Hygromycin selection and maintained without selection
for two days to allow cell numbers to increase before Gancyclovir selection was
imposed. The other five plates (series B), were maintained on Hygromycin selection
for ten days, and then trypsinised into fresh gelatinised plates where Gancyclovir
selection was imposed immediately. For this experiment, Gancyclovir selection was
carried out in the absence of PEF feeder layers to eliminate the possibility of their
presence playing some part in allowing cells containing the vector to survive
Gancyclovir selection. Ten days after Gancyclovir selection was imposed, resistant
clones were picked and seeded into a 96 well plate. Unfortunately, the medium used
to feed these cells must have been contaminated and after an overnight incubation, all
clones were contaminated and discarded.
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5.3.2.2 Results
Despite losing all of the clones through contamination, some useful data was obtained
from this experiment concerning the numbers of clones surviving each selection (table
5.2).
Apart from plate A3, there seems to be no significant difference between the number
of Gancyclovir resistant clones obtained in series A than with series B plates. The
two days of selection-free culture of series A allowed the cell numbers to increase
before Gancyclovir selection was imposed, and should have increased the opportunity
for a 'run' event to occur. The large number of Gancyclovir resistant clones present
on plate A3 may be significant. Perhaps these clones represent the number of cells
which arise from one or more true 'run' events, whereas the smaller number of clones
present on other plates represent a small number of cells which are able to survive
Gancyclovir selection through other, less frequent, means of loss of gene expression.
Table 5.2. Numbers of clones obtained at each stage of experiment HR2.













It is difficult to draw any conclusions from this experiment as none of the clones was
available for DNA analysis. The numbers of Gancyclovir resistant clones obtained
was promising, and it would have been interesting to establish if the large numbers of
clones on plate A3 had survived Gancyclovir selection through a different mechanism
to those clones present on other plates.
5.4 DISCUSSION
From these experiments it was difficult to establish whether this targeting strategy was
successful. Although this 'straight through' strategy is time and labour saving, it had
the disadvantage that only the end result was analysed and no information was
obtained regarding events preceding this last step. It could be argued that Cftr is not
being targeted at all during the first step, and that all of the Hygromycin resistant
clones represent random targeting events which are only able to survive Gancyclovir
selection by inactivation of the tk gene, rather than through excision of the vector.
The more time consuming method of picking and analysing the Hygromycin resistant
clones after the transfection would provide information on the targeting efficiency at




TARGETING THE Cftr LOCUS
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6.1 INTRODUCTION
On the basis of previous experiments described in chapter 5, it was decided to
conduct the 'hit and run' strategy in two separate stages, analysing the clones
resulting from each step. This should provide information not available from previous
experiments as to whether Cftr is being correctly targeted, the manner in which the
vector is integrating, and the frequency at which this targeting occurs. It would also
enable targeted clones to be thoroughly examined before proceeding onto the second
stage, and therefore maximises the chance of achieving the desired result.
The first step in this procedure involved targeting the Cftr locus with the 'hit and run'
vector, pHTHRAI (described in section 5.2). In contrast to previous experiments, the
clones resulting from this initial step were picked individually and screened for those
in which the vector had integrated through homologous recombination into the target
site.
6.2 HR3 TARGETING EXPERIMENT
6.2.1 Method.
A passage 19 culture of E14 ES cells was grown up and 107 cells transfected by
electroporation with 100 |lg of the 'hit and run' targeting vector pHTHRAI, as
described in section 2.5. Hygromycin selection was carried out as before, and once
visible, clones were picked and grown up for frozen stocks and analysis.
6.2.2 Results.
6.2.2.1 Clone numbers.
The numbers of Hygromycin resistant clones obtained from this transfection are
shown in table 6.1. The transfection efficiency of this experiment was 1 X 10~3. No
clones were obtained from the non-transfected control plates, indicating that the
selection was working efficiently. A total of ninety six clones were picked and grown
up, sixty six of which were taken through to DNA analysis.
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Table 6.1 Numbers of Hygromycin resistant clones obtained in HR3 targeting
experiment.














6.2.2.2 Screening for 'Hit' clones.
Hygromycin resistant clones from experiment HR3 were screened by Southern blot
analysis to identify clones in which the vector had integrated into the target site.
Genomic DNA was extracted from the clones, subjected to double digestion with the
enzymes Xba I and Sal I, and hybridised to the 0.6EH genomic probe. This probe
consists of a 0.6 kb Eco RI-Hind III genomic fragment from a region of Cftr which
lies 3' to the target site and which would be external to a correctly integrated vector
(figure 6.1). An Xba I fragment which encompasses the target site hybridises with the
0.6EH probe to give a band of approximately 6 kb for the wildtype allele.
Homologous recombination of the targeting vector into this target site would increase
the size of this Xba I fragment by that of the targeting vector (approximately 10.5 kb)
to 16.5 kb. The integrated vector introduces a Sal I site into this Xba I fragment, and
correctly targeted clones will therefore generate two fragments, one of which
hybridises to the 0.6EH probe to give a band of 8 kb. In this assay, homologous
recombinants are identified by presence of a 8 kb mutant band appearing above the 6





















Figure6.1Restrictionmapofxon10tar etsi . ThesolidblacklinerepresentsthCftrgenomicsequenc ,thb ackrectanglexo10,dtpositifhAI506/7muta on
ismarkedbyAI.Plasmidsequencesrshownsdiagon lhatc edregio ,ndthHygromycin-tfcfusigbvertical hatching.TherestrictionsitesrA p718(A),EcoRIEHindIII(H),papS l(S),pa dXbaX).T siteofhybridisationeachprob ,andthediagn ticfragmen swhicht ydetin ic t dbeneathacll le.




Figure 6.2 Screening for targeted 'hit' clones.
Southern blot analysis of HR3 clone DNA Xba I-Sal I digests probed with the 0.6EH
probe. Lane one is the non-transfected control and displays the 6 kb band of the
wildtype allele, indicated by the arrow. Lanes 2 to 10 contain HR3 clone DNA. The
presence of the upper 8 kb band in lane three (denoted by *) in addition to the 6 kb
wildtype band, is indicative of a correct targeting event. The position of the closest
lambda Hind 111 marker bands are indicated to the right of the blot.
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Screening of HR3 clones in this manner detected three correctly targeted 'hit' clones
designated 3.7, 3.10, and 7.8 (figure 6.3). A total of 66 Hygromycin resistant clones
were analysed, giving a targeting frequency of 1 homologous recombinant in every 22
transfected clones for this experiment (4.6%). The equal dosage of bands indicates
the expected ratio of one wildtype to one mutant allele, but does not exclude the
possibility of multiple copy integration, as this probe would only pick up the most 3'
copy ofmultiple, tandemly integrated vectors.
Figure 6.3 Southern blot of three HR3 targeted 'hit' clones.
This figure shows the Southern blot result of the three targeted HR3 clones identified
by probing Xba I-Sal I digests with the 0.6EH probe. Lanes 1 to 3 are the targeted
clones which exhibit the 8 kb band of the targeted allele in addition to the 6 kb band
of the wildtype allele. Lane 4 is the non-transfected control displaying only the 6 kb
wildtype band.
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6.2.2.3 Confirmation of 'Hit' clones.
Confirmation that these 'hit' clones were the result of the predicted integration of a
single copy of the targeting vector into the targeted site was obtained by further
Southern blot analysis.
The filter of HR3 'hits' digested with Xba I and Sal I (figure 6.3) was reprobed with
the 1.3XH probe. This is a 1.3 kb Xba I-Hind III genomic fragment, this time from a
region of Cftr 5' to the target site which is predicted to be external to a correctly
targeted vector (figure 6.1). This hybridised to a band of the predicted size of 6 kb
for the wildtype allele, and 8.5 kb for the mutant allele, which represents the second
of the fragments generated by the unique Sal I site introduced by the vector into the
Xba I fragment encompassing the target site (figure 6.4). This confirms correct
targeting and the integrity of the 5' region of the target site.
Figure 6.4 Confirmation of HR3 'hit' clones.
The Southern blot of HR3 Xba I-Sal I digests reprobed with the 1.3XH probe. As
before, lanes 1 to 3 are the targeted clones which display the 8.5 kb band of the
mutant allele, in addition to the 6 kb band of the wildtype allele. Lane 4 is the non-






6.2.2.4 Screening of 'Hit' clones for presence ofmutation.
The presence of the AI506/7 mutation in these 'hit' clones was ascertained by probing
Ssp I-Eco RI genomic digests with the 0.8HE probe. This probe is a 0.8 kb Hind III-
Eco RI genomic fragment which is present in the genomic targeting sequences earned
by the vector (figure 6.1). Hybridisation with this probe detected the expected 2.2 kb
fragment of both the wildtype allele of the non-targeted chromosome, and the non-
mutant, endogenous allele of the targeted chromosome, as well as the smaller 0.8 kb
band created by cutting at the unique Ssp I site produced by the mutation (figure 6.5).
Screening of the clones by this method indicated that one of the clones, 7.8 had lost
the mutation, whilst clones 3.7 and 3.10 had retained the mutation. The dosage of the
mutant band versus the wildtype bands suggests that only a single copy of the vector
has integrated. The wildtype band is expected to be twice as intense as the mutant
band, representing the two wildtype alleles versus the one mutant allele. In this case
the mutant allele is actually less than half the intensity of the wildtype, but as this is a
small fragment (approximately 800 bp), it may be explained by inefficient DNA
transfer. The absence of any unexpected bands on this blot confirms that there are no
other copies of the vector integrated elsewhere in the genome of these clones, as the
probe was internal to the targeting vector and would have visualised any other copies
of the vector.
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Figure 6.5 Screening HR3 'hit' clones for the presence of the AI506/7 mutation.
The lane labelled E14 contains DNA from the non-transfected control, and exhibits
the 2.2 kb band of the wildtype allele alone. The following 3 lanes contain DNA from
HR3 'hit' clones, with the name of each clone indicated above the appropriate lane.
These all display the 2.2 kb band generated by both the wildtype allele and the non-
mutant exon 10 of the targeted allele. In addition, clones 3.7 and 3.10 exhibit the 0.8
kb band generated by cutting at the novel restriction site introduced by the AI506/7
mutation. Vector DNA alone is present in the lane labelled vector, and confirms that
the 0.8 kb band is indeed generated from vector sequences.
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6.2.2.5 Karyotype analysis of targeted clones.
The karyotype of the three 'hit' clones was checked to ensure that further experiments
were only conducted with clones of a good karyotype which should be capable of
producing germline chimaeras. Chromosome counts (section 2.1.6) revealed that
clones 3.7 and 3.10 had only 2/10 and 1/10 mitotic spreads with the correct
chromosome number respectively. Clone 7.8 was slightly better, with 4/10 spreads
with the correct chromosomal number, which might be good enough to warrant
continuing into the next phase.
6.2,3 Conclusions.
This experiment was successful in targeting Cftr at a high frequency of 4.6%,
generating three targeted 'hit' clones. Two of these 'hit' clones, 3.7 and 3.10, arose
on the same plate (plate three), and so it is possible that they are clonal, both arising
from the same targeting event. This would decrease the estimated targeting efficiency
to 3%, which would still be considered a high targeting frequency for this locus.
However, a greater number of clones originating from plate three were analysed than
from any other plate. Therefore, the multiple targeting events identified on this plate
are probably a reflection of this. All three of these clones appear to be the result of
insertion of the targeting vector into the target site in the predicted manner. The
AI506/7 mutation was retained in clones 3.7 and 3.10, but the average chromosome
number of cells from these clones was too abnormal to warrant continuing with these
clones. In contrast, clone 7.8 had a karyotype which was just passable, but this clone
had lost the AI506/7 mutation. Naturally, only 'hit' clones which have retained the
mutation can be used for the next stage, where excision of the vector along with the
endogenous wildtype copy generates cells in which the mutation is retained as the
only alteration to Cftr. Conducting a 'run' experiment with clone 7.8 would mean
that the only genotype possible on excision of the vector would be a reversion to
wildtype. A good karyotype is required in order to generate germ line chimaeras from
such mutant cells.
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In summary, although this experiment was successful in targeting Cftr, none of the
'hit' clones generated were suitable for taking forward into the second, 'run' step.
6.3 HR5 TARGETING EXPERIMENT
The targeting experiment HR3 generated three 'hit' clones, none of which were
suitable for conducting the 'run' step due to loss of mutation and poor karyotypes.
This targeting was repeated again, but in view of the poor karyotypes obtained
previously, a new ES cell line (CGR8) which had a stable karyotype and good record
of germ line competency was used.
6.3.1 Method.
A passage thirteen culture of CGR8 ES cells was grown up on a PEF feeder layer,
and 8 X 106 cells were transfected as before (section 2.1.8). Hygromycin resistant
clones were selected, picked and prepared for analysis as before.
6.3.2 Results.
6.3.2.1 Clone numbers.
The number of Hygromycin resistant clones obtained is shown in table 6.2. The
transfection efficiency of this experiment, 2.8 X 10"3, is slightly higher than that
obtained with HR3. This is known to be dependent upon many factors which vary
between experiments, and might be a reflection of the different cell lines used. A
greater number of clones were obtained overall in this experiment and more were
taken through to the analysis stage than in HR3.
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Table 6.2 Numbers of Hygromycin resistant clones obtained in HR5 targeting
experiment.












6.3.2.2 Screening for 'hit' clones.
The Hygromycin resistant clones from experiment HR5 were screened by Southern
blot analysis as before, by probing Xba I-Sal I double genomic digests with the
0.6EH probe (6.2.2.2). This resulted in the identification of fifteen 'hit' clones
(figures 6.6 and table 6.3), giving a targeting frequency of 13.6% which is higher than
that of the previous experiment. However, one of the 'hit' clones represented by lane
3 of figure 6.6, gave an additional band along with those expected for a targeted 'hit'
clone. This band was absent in a subsequent Southern blot utilising a probe internal
to the targeting vector (figure 6.8), and therefore cannot be attributed to additional
copies of the targeting vector. As this band hybridises to the 0.6EH genomic probe, it
might have arisen through a rearrangement of the target site and therefore was not
used for future experiments. All other 'hit' clones gave bands of the expected size
which confirmed the integrity of the 3' genomic sequences. The equal intensity of
these bands confirmed the expected dosage of one mutant to one wildtype allele.
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Figure 6.6 Southern blot of HR5 targeted 'hit' clones.
Southern blot showing the bands displayed by the targeted 'hit' clones identified by
screening HR5 clones by probing Xba I-Sal I digests with the 0.6EH probe. Lane 1 is
the non-transfected control which exhibits the 6 kb of the wildtype allele alone. Lanes
2 to 13 are the targeted 'hit' clones identified by the presence of the 8 kb band in
addition to the wildtype band. Lane 14 is a randomly targeted clone which displays
only the wildtype band with this target site-specific probe.
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6.3.2.3 Confirmation of 'hit' clones.
The structure of the 5' region of the targeted site in 'hit' clones was confirmed as in
HR3 (6.2.2.3) by reprobing the filter of Xba I-Sal I digests (figure 6.6) with the 5'
1.3XH probe (figure 6.7). Bands of the expected size of 6 kb for the wild type allele,
and 8.5 kb for the mutant allele were obtained, confirming the integrity of the 5' site.
Figure 6.7 Confirmation of targeted clones by reprobing with a 5' probe.
The Southern blot displayed in figure 6.6 was reprobed with the 1.3XH 5' probe. As
before, Lane 1 is the non-transfected control which exhibits the 6 kb of the wildtype
allele alone. Lanes 2 to 13 are the targeted 'hit' clones identified by the presence of
the 8.5 kb band in addition to the wildtype band.
6.3.2.4 Screeningfor presence ofthe mutation.
The presence of the mutation was ascertained as before (6.2.2.4) by probing a Ssp I-
Eco RI Southern blot with the 0.8HE probe which hybridises to genomic sequences
carried by the vector (figure 6.8). This identified 12 (80%) 'hit' clones which had
retained the mutation, and 3 (20%) clones which lost the mutation (detailed in table
6.3). The absence of any other bands hybridising to this internal probe indicates that
there are no other copies of the vector integrated elsewhere in the genome.
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Figure 6.8 Screening HR5 'hit' clones for the presence of the AI506/7 mutation.
The lane labelled CGR8 contains DNA from the non-transfected control, and exhibits
the 2.2 kb band of the wildtype allele alone. The following 12 lanes contain DNA
from HR5 'hit' clones, with the name of each clone indicated above the appropriate
lane. These all display the 2.2 kb band generated by both the wildtype allele and the
non-mutant exon 10 of the targeted allele. In addition, some clones exhibit the 0.8 kb
band generated by cutting at the novel restriction site introduced by the AI506/7
mutation. The lane labelled 8.5 is a non-targeted clone. Vector DNA alone is present
in the lane labelled vector, and confirms that the 0.8 kb band is indeed generated from
vector sequences.
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6.3.2.5 Chromosome analysis ofHR5 'hit' clones.
The chromosome count of some of the 'hit' clones was analysed and found to be
consistently good, with between 90-100% of mitotic spreads having the normal
number of 40 chromosomes. This was good enough to warrant continuing with these
clones as they should be capable of generating germline chimaeras.
Table 6.3 Presence of AI506/7 mutation and chromosome counts of HR5 'hit'
clones.





1 1.10 YES 100
2 2.13 YES 90
3 3.11 YES 100
4 4.3 YES ND
4.8 NO ND
5 0
6 6.22 YES ND








8 8.5 YES ND




Successful targeting of Cftr was again achieved, this time using the CGR8 cell line. A
slightly higher transfection efficiency of 2.8 X Iff3, and a much higher targeting
frequency of 13.6% was obtained with this experiment than with HR3. This
generated 15 'hit' clones, all but one of which appear to be the result of integration of
a single vector molecule into the target site through the predicted homologous
recombination mechanism. Multiple 'hit' clones were obtained from the same plates
in some cases, suggesting the possibility that they arose from the same targeting
event. However, due to the large numbers of clones analysed from some plates it is
feasible that multiple but separate targeting events could have arisen on the same
plate. The fact that in each case, one of the 'hit' clones arising on such a plate had
lost the mutation, whilst other 'hit' clones had retained it, suggests that at least two
independent events must have occurred on each plate. The AI506/7 mutation had
been lost from 20% of these 'hit' clones leaving 12 'hit' clones suitable for taking
forward to the 'run' stage. Chromosome analysis was carried out on some of these
'hit' clones, and revealed a normal or near normal chromosome number in all of those
analysed.
6.3.4 Generating Transgenic Mice From Targeted 'Hit' Clones.
Targeted 'hit' clones from the HR5 targeting experiment were used in an attempt to
generate chimaeras by techniques described in chapter 4, which could then be bred to
generate mice which were homozygous for the disruption of Cftr. The production of
these mice would be of interest for the following reasons:
(I) Before embarking upon the lengthy procedure of the 'run' stage of this strategy, it
would be advantageous to ascertain whether these 'hit' clones were capable of
contributing to the germ line of chimaeras and therefore transmitting a mutation. This
was important, as the ultimate aim of this project was to produce mice from ES cell
clones resulting from a 'run' event which have retained the mutation. Therefore it is
important to ensure that the 'hit' clones have retained this ability to contribute to the
germ line and generate chimaeric mice before they are taken through into the 'run'
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stage. A problem with germ line transmission may arise through the presence of the
hsvtk gene in the targeting vector of 'hit' clones, as it has been reported that hsvtk
gene expression can disrupt sperm development causing male transgenic mice to be
infertile (Braun et al. 1990). However, Ramirez-Solis et al. (1993) achieved germ
line transmission of 'hit' clones which contained hsvtk when targeting the Hoxb-4
locus, although this occurred at a lower frequency than with clones which did not
contain the hsvtk gene.
(II) In addition to checking the germline competency of the 'hit' clones, the
generation of mice with this targeted disruption and duplication of exon 10 would be
of interest in terms of phenotype displayed by mice homozygous for this mutation. A
mouse model has been generated for CF which has a targeted disruption and
duplication of a region around exon 3, giving a structure similar to that of a targeted
'hit' event (O'Neal et al. 1993). The phenotype of this mouse is severe, as no wild
type mRNA is generated, and the duplication of exon 3 causes a frameshift mutation
as the exon is 109 base pairs in length. Another CF mouse model created using
insertional mutagenesis (Dorin et al. 1992), also creates a duplication, this time part
of exon 10. The phenotype of this mouse model is much milder than for the exon 3
duplication, due to the generation of a low level of wildtype mRNA by alternative
splicing. This aberrant splicing pattern is caused by skipping of the mutant exon 10 by
the splicing mechanism, and is thought to be due to a bias against the large exon
formed by the inframe fusion of the partial exon 10 sequences to the plasmid
sequences. It is difficult to predict the phenotype which might be shown by mice
homozygous for the disruption and duplication of exon 10 generated by integration of
the 'hit and run' targeting vectors. In this case, the duplicated exons will not cause a
frame shift mutation and therefore mRNA and mutant protein should be generated.
There may be a selection against mRNA with a duplicated exon which might not then
be translated, resulting in a severe phenotype. It is also possible that due to the
relatively normal nature of the duplicated exons, these will splice into the mRNA and
be translated into protein. The presence of the AI506/7 might still be recognised by
the 'quality control' mechanisms of the endoplasmic reticulum, leading to its failure to
134
process properly, thereby becoming mislocalised in the cell as in the human CF
condition. Therefore, it would be interesting to see which of these possible scenarios
would be the consequence of a mouse which is homozygous for the 'hit' mutation.
The targeted 'hit' clones 1.10 and 7.15 were used in an attempt to generate transgenic
mice by the ES cell and morulae aggregation techniques described in chapter 4.
These techniques had not previously been used in this lab, and the setting up and
establishing of the required conditions have taken time. Although litters have been
born, they have all originated from the morulae alone, and no chimaeras have been
generated by this technique to date. This is probably a reflection of our lack of
expertise in this area rather than a failure of the ES cells to generate mice. A different
version of the aggregation chimaera technique is used successfully by Dr Andras
Nagy. This uses a darning needle of a specific type (Hungarian) to create small
depressions in a tissue culture dish, which forces the ES cells and the morulae into
close contact without the need for phytohaemagluttinin (Nagy and Rossant, 1993).
Our failure to generate chimaeras could be attributed to the excessive handling of the
ES cells and the exposure to Phytohaemagglutinin entailed by our protocol, which
might have a deleterious effect upon their pluripotency. These experiments are now
being continued by another member of the group, primarily using the AF508 'hit'
clones, but as yet, no mice have been generated.
6.4 DISCUSSION
This chapter has described the successful targeting of the murine Cftr gene with 'hit
and run' targeting vectors as the first step towards the introduction of subtle
mutations by the 'hit and run' targeting strategy. Clones have been generated which
have a duplication of a region of exon 10 due to integration of a 'hit and run' targeting
vector through homologous recombination. A large number of these targeted clones
have retained the mutation carried by the vector and are suitable for taking through to
the next 'run' stage where a negative selection against the vector will be imposed to




Two different ES cell lines were used for these targeting experiments, each derived
from the same 129 strain of mouse. Both cell lines gave a relatively similar
transfection efficiency of between 1-2 X 10~3, but differed in the frequency at which
Cftr was targeted. A targeting frequency of 4.6% was achieved with the E14 cell line,
whereas a higher frequency of 13.6% was obtained using CGR8 ES cells. This is in
contrast to the targeting frequencies obtained for different cultures of the same two
cell lines, when targeting Cftr with a similar 'hit and run' vector (this time carrying the
AF508 mutation) in our lab under similar conditions (Dickinson et al. 1993). In these
experiments the more consistent targeting frequency of 8.5% and 10.9% were
obtained for E14 and CGR8 cell lines respectively. The difference in targeting
efficiency for the targeting experiments described in this chapter cannot be attributed
to differences in transfection efficiency, as these were similar for both cell lines. The
main difference between these experiments and those with the AF508 vector, is in the
positive selection that was used. The experiments detailed here utilised Hygromycin
as the positive selection, whereas the vector carrying the AF508 mutation used G418.
The effectiveness of the Hygromycin positive selection is unlikely to vary in different
cell lines, and any differences would be reflected in the transfection efficiencies.
Differences in targeting efficiencies between identical experiments have also been
reported by Ramirez-Solis et al. (1993), when targeting the Hoxb-A locus, and by
Koller et al. (1991) when targeting exon 10 of Cftr and another locus (hprt) in
parallel. Koller et al. reported some correlation between increasing culture passage
number and increased targeting efficiency. In this instance, it was the E14 cell line
used here which had a higher passage number rather than the CGR8 cell line which
gave the higher targeting frequency. However, the passage number of a cell line is
only an empirical measure of its expansion and cannot be directly compared between
cell lines. It is possible that cells are more receptive to targeting at different times,
and the disparity in targeting efficiencies is more a reflection of this than of any true
differences between the cell lines. It should be considered that the 'hit' clones
obtained from targeting the E14 cell line had an abnormal karyotype which may be
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representative of the culture used for the transfection. Therefore, this abnormal
karyotype could be responsible for the depressed targeting efficiency in some way,
especially as the E14 'hit' clones obtained at a much higher targeting frequency using
the AF508 targeting vector did not have such an aberrant karyotype.
6.4.2 Targeting Frequencies.
The data generated by these targeting experiments, when combined with that of
similar targeting experiments carried out in our lab by Fiona Kilanowski and Julia
Dorin, has allowed some important observations to be made regarding the efficiency
of targeting at this locus with insertion vectors (table 6.4, and Dickinson et al., 1993).
6.4.2.1 Insertion versus replacement targeting vectors.
The targeting of genomic regions around exon 10 of Cftr has also been accomplished
in other labs, (Koller et al. (1991)., Snouwaert et al. (1992)., Ratcliff et al. (1992).,
van Doorninck et al. (1993)., and Deng et al. (1994) ). The type of vector used and
the targeting frequency reported varies considerably (figure 6.5). A high proportion
of these targeting experiments have utilised replacement (Q.) type targeting vectors
(described in section 1.2.4.1), and achieved largely very low targeting frequencies
ranging from 0.04% (Koller et al. 1991), to 1.4% (Deng et al. 1994). This contrasts
with the significantly higher targeting frequencies of 3.8-13.6% achieved in this and
other labs using insertional (O) type targeting vectors. Despite the greater lengths of
genomic homology incorporated into the replacement vectors, which are known to
increase targeting efficiency (discussed later), the replacement vectors still targeted
Cftr much less efficiently. The reported targeting frequencies for replacement vectors
at this locus also varied enormously (by three orders of magnitude), whilst insertion
vectors from two different labs target to an efficiency of within 10% of each other.
i
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Increased targeting frequencies for insertion vectors when compared to replacement
vectors have also been reported by another group when targeting a different
mammalian locus. Hasty et al. (1991) conducted a comprehensive comparison of the
efficiency at which similar- insertion and replacement vectors targeted the hprt locus in
ES cells. They consistently obtained a nine fold increase in targeting frequency when
insertion vectors were used. This effect is disputed by Deng and Capecchi (1992),
who conducted a similar comparison at a different region of the hprt locus. They
found no difference in targeting efficiency between the two vector types when using
isogenic targeting sequences in the vectors. However, when the genomic
homologous sequences of the vectors were from a non-isogenic source, the targeting
efficiency of the replacement vector was dramatically reduced. They suggest that
replacement vectors are more sensitive to the presence of heterological sequences due
the different mechanism of integration (described in detail in section 1.2.4.1). In order
for a replacement vector to integrate into the genome through homologous
recombination, a crossover event must occur on both arms of the vector (Hasty et al.
1991., Hasty et al. 1992., Deng and Capecchi, 1992., Hastings et al. 1993). If
heterologous sequences are present on one arm of the vector, the efficiency of the
crossover on that arm will be reduced, thereby reducing the efficiency of
recombination for the entire vector. In contrast, insertion vectors only require a single
crossover to occur in any region of the homology for efficient insertion of the whole
vector into the endogenous sequences, and consequently will be less sensitive to the
presence of any heterologies in the targeting sequences. Therefore, it could be argued
that the decreased targeting efficiencies of replacement vectors observed by Hasty et
al. are a consequence of their use of nonisogenic DNA in the targeting vectors.
Thomas and Capecchi (1987), reported no significant difference when also targeting
the hprt locus with both vector types. However, the insertion vector used in these
targeting experiments had an unusual feature, as the Neomycin selection gene was
present in the 3' arm of the targeting vector and so interrupted the length of
homology. The amount of continuous homologous sequences is known to affect the
targeting efficiency (discussed later), and could be responsible for suppressing the
targeting efficiency of the insertional vector. The targeting frequencies of both vector
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types have also been compared in the yeast Saccharomyces cerevisiae (Hastings et al.
1993). A two to three fold increase in targeting frequency was observed with
insertion vectors in these experiments, and therefore is consistent with the same
effect observed when targeting the Cftr locus in murine ES cells.
The proposed higher targeting efficiency of insertional vectors is thought to be a
result of the mechanism of homologous recombination. As mentioned above (and
described in detail in section 1.2.4.1), integration of an insertion vector is thought to
occur through a single crossover point, whereas a replacement vector requires a
crossover event to occur on both arms of the vector. The formation and stabilisation
of two such recombination events may be less efficient than that of a single event,
which would be reflected in the targeting efficiencies of the two vectors.
The higher efficiency targeting we and others have achieved at the Cftr locus using
insertion (O) type targeting vectors is in agreement with that observed by one group
at another locus and also in targeting experiments in yeast, but differs from the
observations of some other labs. The 'double strand break repair' model for
integration of DNA through homologous recombination (Orr-Weaver et al. 1981,
Szostak et al. 1983) however proposes a different mechanism of integration for the
two vector types, which leads to the prediction that the more simple insertion events
are likely to be more efficient and consequently occur at a higher frequency.
6.4.2.2 Effect of homology carried by targeting vectors on targeting efficiency.
The targeting experiments carried out in our lab (table 6.4) have provided some
important insights into the effect of the homologous sequences earned by the vector
upon the targeting frequency at the Cftr locus. As all of the vectors used represent
modifications of the pIV3.5H targeting vector, meaningful comparisons can be made
between the effects of these modifications upon targeting frequency.
A simple increase in the length of homology to the target site of vector
pHRNTAF508 from 3.5 kb to 4.3 kb, resulted in an increase in targeting efficiency
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from 2.2% to 3.8%. Although this is clearly not significant, some effect of increased
homology resulting in a higher targeting frequency is expected. Rubnitz and
Subramani (1984)., Thomas and Capecchi (1987)., Hasty et al. (1991)., Deng and
Capecchi (1992)., and Berinstein et al. (1992), have all reported this phenomenon
which has also been observed when targeting genes of the yeast genome (Rothstein
1991). Targeting frequency appears to have a strong dependence upon the length of
homology between vector and target sequences. An increase in length of homology
from 1.3 to 6.8 kb has been found to result in greater than a two hundred fold
increase in the targeting efficiency of both insertion and replacement vectors (Hasty et
al. 1991). Deng and Capecchi (1992) reported that a length of more than 14 kb of
homology is needed before this effect diminishes. Although targeting vectors of
different origin cannot be directly compared, it is interesting to note that out of all the
replacement vectors used to target Cftr (table 6.5), the replacement vector which gave
the highest targeting frequency also incorporated the greatest length of homologous
sequences.
The distribution of the homologous sequences might also affect the efficiency of
homologous recombination, as we observed an increase in targeting efficiencies when
the site of the double strand break was moved by utilising a different restriction
enzyme. Linearisation of the vector pHRNTAF508 at the Asp 718 restriction site
generated 0.4 kb of homology 5', and 3.9 kb of homology 3', which resulted in a
targeting frequency of 3.8%. Utilisation of the Hpa I restriction site gave a more
even distribution of homology with 1.2 kb 5', and 3.1 kb 3', and increased the
targeting frequency significantly from 3.8% to 8.5%. This effect could be attributable
to a more even distribution of homology either side of the double strand break, or the
creation ofmore 'recombinogenic' free ends. Both Hasty et al. (1991) and Berinstein
et al. (1992) found that targeting efficiencies were determined by the total length of
homology of vector sequences to the target site, rather than distribution of genomic
sequences. A complete failure to target Cftr was reported by van Doorninck et al.
when a Nhe I site was used to linearise the insertion vector, however, the same vector
gave a targeting frequency of 9% when cut with Nsi I. The effect of the different
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restriction sites on the distribution of homology was not given, but van Doorninck et
al. suggested that this is due to a property of the sequences around the site of
linearisation. Therefore the increased frequency observed when the targeting vector
was linearised with Hpa I is probably a property of the double strand break created by
the restriction site.
6.4.2.3 Comparison of 'hit and run' vectors.
The 'hit and run' targeting vector pHRNTAF508 differs from the vector used in the
targeting experiments described in this thesis, only by the mutation carried and the
selection genes used. Vector pHRNTAF508 carries a gene for resistance to the
positive selection G418, whereas pHTHRAI carries the gene for Hygromycin
resistance. Despite this, the targeting frequencies obtained with these vectors are
remarkably similar, except for the targeting experiment HR3 in which the targeting
frequency appears to have been depressed, perhaps due to the abnormal chromosome
number. Therefore, the positive selection regime used does not appear to affect the
targeting frequencies achieved.
6.4.2.4 Source ofDNA.
One factor which is known to have a significant effect on targeting frequency is the
source of genomic DNA. If the homologous sequences present on the vector are not
isogenic with the ES cells, that is to say from the same mouse strain, the small
sequence heterologies present have been found to have a profound negative effect
upon targeting efficiencies (te Riele et al. 1992, van Deursen and Wieringa 1992,
Deng and Capecchi 1992, Wurst et al. 1994). The magnitude of this effect varies
from locus to locus. This was not an issue with our targeting vectors as isogenic
DNA was used throughout, however, this factor does appear to affect targeting
frequency at the Cftx locus as demonstrated by the failure of van Doorninck et al.
(1993) and O'Neal et al. (1993) to target this locus when using a non-isogenic
targeting construct.
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6.4.3 Structure of Insertion Events.
All but one of the targeted 'hit' clones obtained in the targeting experiments described
in this thesis were the result of a simple integration of a single vector into the target
site in the predicted manner. This is in line with the common observation that
integration of a vector into a target site through homologous recombination is rarely
accompanied by insertion of another copy elsewhere in the genome. This
phenomenon was described by Reid et al. (1991) when attempting to cotransfect two
unrelated insertion vectors into ES cells as a method of enriching for a non-selectable
homologous recombination event. They found that although non-targeted
cotransformations occurred frequently, the homologous recombination of a vector
with the target site was rarely (in only 4% of cases) accompanied by integration of a
second DNA molecule. In addition, DNA that had integrated through homologous
recombination was usually present as a single copy, whereas DNA which had
integrated through non homologous means was frequently present as concatemers at
multiple sites throughout the genome. The integration of a single copy of DNA in the
predicted manner is a frequent observation of targeting with insertion vectors, and
contrasts with the aberrant integration patterns reported for replacement vectors
(Hasty et al. 1992., Thomas et al. 1992., Hasty et al. 1992., Davis et al. 1992., Zhang
et al. 1994). Integration of replacement vectors often occurs through mechanisms
such as insertion, and is thought to be due in some cases to the recircularisation of the
vector, or the formation of vector concatemers prior to integration. The apparent low
occurrence of such a phenomenon with insertion vectors is thought again to be a
reflection of the different methods of integration for the two vector types. Integration
of an insertion vector is thought to occur through invasion of one of the free ends of
the double strand break into the homologous region of the target site, as predicted by
the double strand gap repair hypothesis (Szostak et al. 1983), described in section
1.2.4. This displaces a strand of DNA which is then available for strand invasion by
the other free end. Both ends of the double strand break become rapidly associated
with the target site DNA and are not available for recircularisation or concatemer
formation. Integration of replacement vectors however is thought to occur via a
double crossover event, which is thought to be less efficient than for an insertion
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event, leaving the free ends of the double strand break exposed for longer periods to
the ligation activities of the cell.
6.4.4 Loss Of Mutations During Integration.
The loss of the AI506/7 mutation in 33% of the targeted HR3 'hit' clones and 20 % of
HR5 'hit' clones is a phenomenon which has been widely reported (Valancius and
Smithies 1991a., Valancius and Smithies 1991b., Hasty et al. 1991., Hasty et al.
1992., Deng and Capecchi 1992., O'Neal et al. 1993., Rubinstein et al. 1993.,
Ramirez-Solis et al. 1993., Wu et al. 1994). The frequency of loss of a mutation has
been reported to be related to its proximity to the double strand break used to
linearise targeting vectors (Valancius and Smithies 1991., Deng and Capecchi 1993),
an observation that has also been made in yeast targeting experiments (Orr-Weaver et
al. 1988., Rothstein 1991). Targeting experiments conducted in our lab using a very
similar 'hit and run' targeting vector to introduce the AF508 mutation, experienced a
similar frequency of mutation loss of 33%. As the position of the AF508 mutation
from the double strand break differed by only 3 base pairs from the position of the
AI506/7 mutation, the comparable frequency of mutation loss is therefore consistent
with this proposed relationship of frequency of mutation loss to distance from the
double strand break. When targeting the same region of Cftr with a vector in which
the AF508 mutation was located only 620 base pairs away from the double strand
break, Van Doorninck et al. (1993) found that 84% of 'hit' clones had lost the
mutation. The observations at this locus are consistent with those observed by others
at different loci. Wu et al. (1994) report a loss of a mutation located 670 base pairs
from a double strand break in 59% of clones when targeting the Collagen type I gene
in ES cells. The frequency of mutation loss was investigated by Deng and Capecchi
(1993) at the hprt locus by placing the mutation at varying distances from the double
strand break. When this distance was only 0.7 kb, the mutation was lost in 74% of
targeted clones, whereas a distance of 4.2 kb resulted in mutation loss in only 5% of
clones. The loss of the AI506/7 mutation in 20-33% of the 'hit' clones when situated
2 kb from the double strand break is consistent with the rate of mutation loss
compared to proximity to the double strand break relationship observed at other loci.
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This loss of heterologous sequences appears to be largely a feature of homologous
recombination of insertion vectors, and has been reported to occur extremely rarely in
cells targeted with replacement vectors (Deng and Capecchi 1993). It has been
suggested that this is a reflection of the different integration pathways utilised by
insertion and replacement vectors during homologous recombination (Hasty et al.
1992). Insertion vectors are thought to integrate via the double strand gap repair
pathway (Orr-Weaver et al. 1981., Szostak et al. 1983., Hasty et al. 1992., Deng and
Capecchi 1993). During the integration process, the free ends of the double strand
break are thought to be degraded by the action of an exonuclease and the double
strand gap enlarged before being repaired using the target site as the template
(Valancius and Smithies, 1991, Hasty et al. 1992, Deng and Capecchi 1993, Kumar
and Simons 1993) Targeting experiments incorporating double strand gaps rather
than breaks have been reported to efficiently and precisely target a locus, with the
missing homology from the double strand gap being 'filled in' during integration of
the vector (Valancius and Smithies 1991). This phenomenon has been exploited by
Smithies and Kim (1994) to create functional duplications of the Angiotensin gene, by
targeting the gene with an insertion vector bearing homology to the most 5' and 3'
regions. The 8 kb gap in the genes homology was repaired during the integration of
the vector to create a complete tandem duplication of the gene. Heterologous
sequences present at the site of the double strand break are invariably lost during
homologous recombination, consistent with the occurrence of exolytic enlargement of
the double strand break prior to integration (Hasty et al. 1992, Kumar and Simons
1993). The correlation of mutation loss with proximity to the double strand break is
therefore likely to be a reflection of the degree of exonuclease gap enlargement
required for removal of the mutation.
The observation of mutation loss and the proposed mechanism has consequences
upon the design of a 'hit and run' targeting vector. To minimise mutation loss through
exonuclease gap enlargement, the mutation should be positioned away from the site
used to linearise the vector. However, to maximise the region through which
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recombination can occur in the 'run' stage to excise the wild type copy, the mutation
should be placed at a distance from the plasmid sequences. Therefore a compromise
must be reached between the distance from the double strand break which should
result in retention of the mutation at a reasonable frequency, and the homology
available for recombination between the mutation and the plasmid sequences (Hasty
and Bradley, 1993). In hindsight, although the configuration of the 'hit and run'
targeting vector pHTHRAI used in these targeting experiments resulted in a
sufficiently high frequency of mutation retention, the length of homology available for
intrachromosomal recombination during the 'run' stage favours loss of the mutation.
Some groups have reported that the position of a mutation in a targeted 'hit' event
can occur in an orientation other than that predicted (Hasty et al. 1991, O'Neal et al.
1993, Wu et al. 1994). In a small proportion of clones, the mutation has been found
to be present in the opposite duplicate to that intended, and is thought to be a
consequence of migration of the Holliday junction across the mutation site to resolve
on the other side during the recombination process. Alternatively, the mutation has
also been found to be present in both duplicated sequences at an equally low
frequency and is also thought to be due to migration of a Holliday junction, but in this
case preceded by mismatch heteroduplex repair in favour of the mutant sequences
(Hasty and Bradley 1993). The generation of such a clone with the mutation present
in both duplicated regions would be advantageous for use in the 'run' stage, as
excision of the vector should always result in the retention of the mutation in a 'run'
clone. Unfortunately, none of the 'hit' clones generated in these targeting
experiments had two copies of the mutant allele (as determined by Southern blot
analysis, (figures 6.5 and 6.7) and so did not have this advantage.
The observations made during the targeting of the Cftr locus are therefore in general
agreement with those made by others when targeting the same and different loci. The
data generated supports the theory that insertion vectors target more reliably and at a
higher frequency than replacement vectors. The targeted 'hit' clones generated by
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SELECTION FOR THE 'RUN' EVENT
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7.1 INTRODUCTION
The previous chapter described the generation of 'hit' clones in which the 'hit and
run' targeting vector pHTHRAI506/7 had integrated into the target site of Cftr
through homologous recombination. This created a duplication of the target site
with, in the majority of 'hit' clones, the AI506/7 mutation present in one of the
duplicates (figure 7.1). Twelve such 'hit' clones possessed the AI506/7 mutation,
and were suitable for use in the 'run' stage.
The second step of the 'hit and run' targeting strategy, the 'run' step, entailed the
imposition of a negative selection onto targeted 'hit' clones to select against the
integrated vector. It was envisaged that a certain proportion of cells would excise the
integrated vector through intrachromosomal recombination within the duplicated
sequences, and survive the negative selection regime due to the concurrent loss of the
Hygromycin-r& fusion gene along with the vector sequences. Depending upon the
actual position of the crossover, the excision recombination event could have one of
two consequences: (a) recombination anywhere within the endogenous 3' duplicated
region would result in loss of the integrated vector and a reversion back to a wildtype
(non-targeted) status, (b) recombination within the 5' duplicated sequences would
excise the endogenous wildtype exon 10 along with the vector, leaving the mutant
exon in its place. The AI506/7 mutation in the mutant exon would then be present as
the only alteration to the target site.
7.2 RUN2 'RUN' EXPERIMENT
7.2.1 Method
The 'hit' clone 1.10 was expanded on a PEF feeder layer and 9.2 X 107 cells used for
selecting 'run' events. These cells were seeded at different densities, and in the
presence or absence of feeder layers, to determine the influence of these different
conditions upon the effectiveness of the selection and perhaps frequency of the 'run'
event. These conditions are detailed in table 7.1.
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Table 7.1 The conditions used for seeding cells for RUN2.
TOTAL No. SEEDING
CELLS DENSITY TOTAL No. PEF FEEDER
(x 106) (No. cell/plate x 106) PLATES LAYER ?
12 2 6 YES
40 2 20 NO
40 4 10 NO
92 — 36 —
Twenty four hours after the cells were plated out, Gancyclovir negative selection was
imposed. The minimum concentration of Gancyclovir required to kill cells
expressing the Hygromycin-r& fusion gene had been previously established on a
targeted 'hit' clone by the method described in section 2.1.9. In order to determine
whether this concentration of 2.5 pM, or a slightly higher concentration would be
more effective, the selection was imposed on half of the plates at a concentration of
2.5 pM, and the other half at 3.5 pM. The Gancyclovir-containing medium was
replaced every two days. Once visible, clones were picked and grown up to generate
cells for frozen stocks and DNA analysis.
7.2.2 Results
7.2.2.1 Clone numbers.
After six days of Gancyclovir selection, clones were visible and ready for picking
from those plates in which the cells had been plated at a density of 2 X 106 cells per
plate in the absence of a PEF feeder layer. Cells which had been plated at the higher
density of 4 X 106, also in the absence of PEFS, became confluent before the
selection took effect. A much longer period was required before these cells began to
die in Gancyclovir, and when this did occur, a very small number of Gancyclovir
resistant clones were obtained from only one of the ten plates. The plates in which
the cells had been plated onto a PEF feeder layer also became confluent before the
selection was effective, but these plates generated a very large number of
Gancyclovir resistant clones.
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The total number of clones present on each plate, and the number of clones picked
from each are detailed in table 7.2, and summarised in table 7.3. A total of 330
Gancyclovir resistant clones were picked from the clones arising in this experiment.
Although a much higher number of clones arose on those plates in which cells had
been selected upon a PEF feeder layer, fewer clones were picked from these plates as
the high clone density meant it was difficult to distinguish and pick individual clones.
Very few clones arose on the plates where cells had been plated at the higher density
of 4 X 106 cells per plate, whereas plates seeded at the lower density of 2 X 106 cells
per plate under identical conditions generated a substantial number of Gancyclovir
resistant clones. A difference was observed between the frequency of Gancyclovir
resistant clones obtained with the two different concentrations used, with the higher
concentration generating a smaller number of clones.
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Table 7.2 The numbers of clones arising in experiment RUN2.
SEEDING PEF CONC. TOTAL No.
DENSITY FEEDER GANC No. CLONES
(No. cells/plate x 106) LAYER
?
OiM) CLONES PICKED
2 NO 2.5 33 20
2 NO 2.5 28 28
2 NO 2.5 26 16
2 NO 2.5 52 32
2 NO 2.5 21 16
2 NO 2.5 28 6
2 NO 2.5 33 11
2 NO 2.5 19 8
2 NO 2.5 NC 0
2 NO 2.5 NC 0
TOTAL — — — 240 137
2 NO 3.5 35 26
2 NO 3.5 29 15
2 NO 3.5 35 26
2 NO 3.5 17 10
2 NO 3.5 19 12
2 NO 3.5 25 8
2 NO 3.5 NC 0
2 NO 3.5 NC 0
2 NO 3.5 NC 0
2 NO 3.5 NC 0
TOTAL — — — 160 97
4 NO 2.5 0 0
4 NO 2.5 0 0
4 NO 2.5 0 0
4 NO 2.5 0 0
4 NO 2.5 0 0
TOTAL — — — 0 0
4 NO 3.5 12 8
4 NO 3.5 0 0
4 NO 3.5 0 0
4 NO 3.5 0 0
4 NO 3.5 0 0
TOTAL — — — 12 8
2 YES 2.5 -1000 24
2 YES 2.5 -1000 23
2 YES 2.5 -1000 0
TOTAL — — — -3000 47
2 YES 3.5 -500 24
2 YES 3.5 -500 17
2 YES 3.5 -500 0
TOTAL — — — -1500 41
NC. Not counted
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Table 7.3 A summary of the number of Gancyclovir resistant clones arising in
experiment RUN2.
SEEDING PEF CONC. FREQUENCY No.
DENSITY FEEDER GANC GANCr CLONES
(No. cells/plate x 106) LAYER ? (|J-M) CLONES (x 10 5) PICKED
2 NO 2.5 1.5 137
2 NO 3.5 1.3 97
4 NO 2.5 0 0
4 NO 3.5 0.06 8
2 YES 2.5 50 47
2 YES 3.5 25 41
7.2.2.2 Screening HR5 RUN2 clones for loss of the 'hit and run' targeting vector.
Unfortunately a large number of the clones which had been picked became
contaminated before DNA and frozen stocks were generated, and so were unavailable
for analysis. From the 330 clones picked, only 89 made it through to the analysis
stage.
The DNA from the 'run' clones was analysed by Southern blot. Initially, the same
combination of Xba l-Sal I double digests probed with the 0.6EH probe used to
identify 'hit' clones in which the vector had integrated into the target site (section
6.2.2.2), was used to screen 'run' clones for those in which the vector had excised.
However, the pattern of bands obtained with these digests was confusing, as the Sal I
restriction enzyme appeared to have not cut the DNA to completion. Despite taking
measures to improve the degree of cutting with this enzyme, such as using a new
batch of enzyme, and cleaning up the DNA by Ammonium acetate-Ethanol
precipitation, the partially digested bands were still obtained. However, the Xba I
restriction enzyme had cut to completion, indicating that the quality of the DNA
could not be too low.
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In order to determine if the vector was still present in these clones, another diagnostic
Southern blot was conducted, this time on DNA digested with the restriction enzyme
Bgl I. These digests were blotted and probed with the same 0.6EH probe used for the
Xba I-Sal I digests. In this instance, the probe will hybridise to two bands in
wildtype clones, and three in 'hit' clones, due to the presence of a Bgl I site in the
genomic fragment used as the probe (figure 7.1). In wildtype clones a 23 kb
fragment representing the Bgl I fragment 5' to the site in the probe, and a 9 kb
fragment representing the 3' Bgl I fragment, will hybridise to this probe. In 'hit'
clones the 23 kb fragment detected by this probe is reduced to 3.8 kb by cutting at the
additional Bgl / sites present in the vector. Therefore, 'hit' clones are identified by
the presence of a 3.8 kb mutant band in addition to the two wildtype bands, and this
mutant band would be absent in 'run' clones which had excised the vector.
Furthermore, in 'hit' clones, the 9 kb band should be twice the intensity of the other
wildtype band and the 3.8 kb mutant band as there should be twice the number of
copies present. The 23 kb band and the 3.8 kb mutant band should be of equal
dosage as there should be only one copy of each present. Due to its large size
however, the 23 kb wild type band often does not transfer as efficiently as the smaller




















Figure7.1Thestructu eandre ictionmapoftarg edandwildtypealleles. ThesolidblacklinerepresentsCftrgenomicsequences,thblackrectanglexo10,andthposi iotAI506/7mut t oisma kedby A.Plasmidsequencesarshowncrosshat dregio ,andthHygromycin-t/cfusioebve ti lhatch n .Restric iitB l
I(Bg),EcoRIE),Hind111(H),Sal(Sa dXbaI(X).Thesitofhybridisa ionfthe0.6 Hprobindicatedonb ttwildtypand mutantallele.
When analysed by this digest and probe combination, 100% of the RUN2 clones
were identical to the HR5 1.10 'hit' clone which had not undergone Gancyclovir
selection, as they displayed the 3.8 kb mutant band as well as the wildtype bands
(figure 7.2). There was no obvious size difference between the mutant band of the
non-selected 'hit' clone and that of the 'run' clones, suggesting that there were no
large deletions or rearrangements which could account for inactivation of tk gene.
1 23456789 10 11 12 13 14 15 16 17 18 19
kb
WT- - - — «»«M ~ ~ ** *- - 23
WT- *- m m """ m m ** *
Mutant- ~ m ** w -3.8
L
Figure 7.2 Southern blot analysis of RUN2 Gancyclovir resistant clones.
A Southern blot of Bgl I digests was probed with the 0.6EH genomic probe. Lane 1
shows the two wildtype bands of 23 kb and 9 kb, obtained with DNA from non-
transfected CGR8 ES cells. (The bands are less distinct in this lane due to reduced
DNA loading). Lane 2 represents DNA from the 'hit' clone 1.10 which had not been
exposed to Gancyclovir selection, and displays the 3.8 kb band of the mutant targeted
allele in addition to the two wildtype bands. Lanes 3 to 19 show bands which were
typical of all RUN2 clones, and identical to those of the non-selected 'hit' clone,
except for lane 17 which does not contain any DNA.
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7.2.2.3 Screening RUN2 clones for Hygromycin resistance.
All of the 'run' clones had appeared to survive Gancyclovir selection despite
containing the integrated vector. In order to determine if the Hygromycin-//c fusion
gene was still functional, the positive Hygromycin selection used to obtain the 'hit'
clones, was imposed upon some of the 'run' clones.
Twenty six 'run' clones were grown in medium containing Hygromycin at the same
concentration used to select the 'hit' event. Immediately after imposition of
Hygromycin selection, the cultures of 'run' clones appeared to die back, as was the
case with non-transfected, wild type CGR8 cells used as a control. However, in
contrast to wild type cells, after two weeks of selection the cultures from the 'run'
clones had grown back to give healthy looking, fully Hygromycin resistant cultures.
The 'hit' clone 1.10, from which these 'run' clones were derived, did not exhibit any
cell death in Hygromycin selection and appeared to be completely Hygromycin
resistant.
7.2.3 Conclusions
This experiment was not successful in generating true 'run' clones in which the
vector had excised, as all of the Gancyclovir resistant clones obtained still appeared
to contain the intact 'hit and run' targeting vector. Useful information however, was
obtained regarding the effectiveness of Gancyclovir selection under different culture
conditions. Despite the failure to obtain clones in which the vector had excised, this
selection was apparently effective, as cell death occurred on all plates, and in most
cases generated Gancyclovir resistant clones. The different conditions in which the
cells were seeded appeared to affect the number of Gancyclovir resistant clones
obtained.
Growing the cells on PEF feeder layers generated far more resistant clones than on
the equivalent non-feeder layer plates. The mechanism of Gancyclovir resistance
however, did not appear to differ between clones arising in the presence or absence of
a PEF feeder layer, and therefore the higher number of clones generated was probably
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a reflection of the higher plating efficiency displayed by CGR8 ES cells when grown
on a PEF feeder layer.
The density at which the cells were seeded also affected the frequency at which
resistant clones were obtained, with the higher seeding density of 4 X 106 cells per
plate appearing to give a lower frequency of Gancyclovir resistant clones. This
negative effect of higher seeding densities is probably due to the 'bystander' or
'cross-feeding' effect (Hooper, 1987.; Hasty and Bradley, 1993). This is a problem
known to occur with negative selection regimes like the tUGancyclovir or hprt
system, in which a non-toxic selection agent is metabolised to a cytotoxic analogue
by cells expressing the negative selection gene. The propensity of ES cells to
aggregate, and high seeding densities, facilitate cross feeding between cells. Under
these conditions, a cell expressing tk which will die in Gancyclovir selection, can
pass the cytotoxic base analogue to a non-expressing cell, causing it to also die in the
selection even though it is not expressing the tk gene. This phenomenon has even
been exploited in gene therapy studies where administration of Gancyclovir to rats
with experimentally induced cerebral gliomas resulted in complete regression of
tumours which had as few as 20% of cells transfected with the hsvtk gene (Culver et
al. 1992). The potential for this effect to occur during selection for a 'run' event is
great, as the majority of cells will be expressing tk and a non-expressing cell is likely
to be surrounded by a large number of potentially lethal expressing cells. This effect
can be overcome by seeding cells at low densities so that the contact between tk
expressing and non-expressing cells is minimised. From our results it appears that a
seeding density of 2 X 106 cells per 100 mm plate is sufficiently low to allow the
survival of non-expressing cells, whereas the density of 4 X 106 is too high. The
failure of the majority of plates seeded at this higher density to generate Gancyclovir
resistant clones is therefore likely to be a result of the 'bystander effect'. In light of
this, seeding densities for all future 'run' experiments were no higher than 2 X 106
cells per plate.
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The concentration at which the Gancyclovir selection was imposed also seems to
affect the number of resistant clones obtained, with more arising from selection at the
lower concentration of 2.5 pJVL It is difficult to ascertain the effectiveness of either
concentration, as none of the Gancyclovir resistant clones were 'true runs' (i.e. they
still contained the tk gene), and the mechanism by which they survived the selection
is unknown. It is possible that the tk gene had been inactivated by some mechanism
and that the Gancyclovir selection was selecting clones which did not express the tk
gene. There does not appear to be any differences between the 'false positive'
Gancyclovir resistant clones obtained at each concentration, and therefore both
concentrations appear to have selected for the same event. If this is the case, and the
clones obtained do not express tk, the lower numbers of resistant clones obtained at
the higher concentration of Gancyclovir could be a reflection of a non-specific
toxicity of Gancyclovir which might be seen at high concentrations. Based upon this
information, the lower concentration of 2.5 |iM Gancyclovir was used in all future
experiments.
The demonstration by Southern blot analysis that the 'hit and run' targeting vector
was still present in the 'run' clones showed that they had survived the negative
selection by an unexpected mechanism. The absence of any detectable difference in
the structure of the targeted allele of these 'run' clones when compared to that of the
'hit' suggests that they still contain the intact, integrated 'hit and run' targeting vector.
It was envisaged that recombination within the duplicated sequences would result in
excision of the vector and loss of the tk gene, thereby rendering the cells resistant to
Gancyclovir selection. Instead, some other mechanism resulting in loss of tk gene
expression appeared to be at work which did not alter the gene structure discernibly.
Similar experiments targeting different loci have reported a range of frequencies for
the vector excision event. Hasty et al. (1991) reported a frequency of 3.8 X 10"3 cells
at the hprt locus, and a lower frequency of 4.3 X 10"6 cells at the Hox 2.6 locus. An
n
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even lower frequency of 8 X 10" cells was observed by Valancius and Smithies
(1991) at the hprt locus, implying that the frequency of an excision event is highly
variable both between and within genes, and could be specific to the recombinogenic
160
nature of a particular region. Therefore it is difficult to predict the frequency at
which this excision event might occur within the duplicated regions of the 'hit'
clones in these experiments.
An investigation into the Hygromycin resistance of these clones also gave some
unexpected results. As both Hygromycin resistance and Gancyclovir sensitivity are
encoded by the same fusion gene, any mechanism which inactivates the expression of
the tk gene would be expected to also inactivate expression of the whole fusion gene,
thereby also rendering the clones Hygromycin sensitive. The Gancyclovir resistance
of the 'run' clones which contain the intact 'hit and run' targeting vector suggests that
the tk gene must have been inactivated in some way. When this was tested by putting
the 'run' clones back onto Hygromycin selection, the clones initially appeared to be
Hygromycin sensitive and began to die, but then grew back again. This suggests that
either Hygromycin selection was also inactivated in the clones, but they eventually
were able to overcome this inactivation by some means, or that a small proportion of
the cells were Hygromycin resistant, and it was these that increased in numbers over
time. In either case, the mechanism by which these 'run' clones were able to survive
Gancyclovir selection was not known.
The results from this experiment are in contrast to those obtained in similar
experiments conducted in parallel in our lab. Selection for 'run' events on targeted
'hit' clones containing the AF508 mutation which were comparable to those 'hits'
used in these experiments, found that the majority of Gancyclovir resistant clones
obtained after selection appear to be true 'run' events in which the vector has
excised. In all cases, excision of the vector resulted in reversion back to wildtype
status. A few 'false positives' were seen in these experiments where clones
surviving the selection had not excised the vector, but in contrast to this experiment,
these were by far the minority of Gancyclovir resistant clones obtained. The
discrepancy between the two experiments was difficult to reconcile considering the
similarity of the two 'hit and run' targeting vectors.
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7.3 RUN3 'RUN' EXPERIMENT
The previous 'run' experiment was unsuccessful in generating any clones which had
excised the 'hit and run' targeting vector. This experiment was repeated again with
the same 'hit' clone, but was conducted in a slightly different manner.
7.3.1 Method
Cells from a passage 26 culture of the 'hit' clone 1.10 were used to select for a 'run'
event. These cells were seeded at two different densities, 1 X 105, and 1 X 106 cells
per 100 mm tissue culture plate. Lower seeding densities were used than in the
previous experiment, in an attempt to minimise the loss of non-expressing cells
through the 'cross-feeding' effect. All cells for selection of the 'run' event were
grown upon PEF feeder layers during selection as this was found to increase the
number of Gancyclovir resistant clones obtained in the previous experiment.
In order to obtain some estimate of the rate of vector excision, the Gancyclovir
selection was added to a set of plates seeded at both densities, at daily intervals after
seeding. Therefore, on the day of plating, Gancyclovir was added to a set of plates
containing cells at both seeding densities which were labelled 'day 0'. Twenty four
hours after plating out, selection was added to an identical set of plates labelled 'day
1', and so on until seven days after plating, selection was added to the last set of
plates labelled 'day 7'. This regime was to be repeated with cells which had been
grown on Hygromycin selection prior to Gancyclovir selection, and results from the
two experiments compared.
Control plates were also included to determine that the Gancyclovir selection was
working efficiently and killing those cells which were expressing the Hygromycin-tk
fusion gene. For this, cells were plated at one of the densities used for selecting the
'run' event (1 X 105 cells per 100 mm plate), and maintained in Hygromycin
selection to ensure that the fusion gene was being expressed, as demonstrated by their
resistance to Hygromycin. Gancyclovir selection was then added to one plate per day
sequentially, as with those plates for selection of the 'run' event. Clones expressing
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the fusion gene should not be able to survive both Hygromycin selection and
Gancyclovir selection when imposed simultaneously, and consequently the
Hygromycin resistant cells should die on addition of Gancyclovir. Any cells able to
specifically inactivate the tk gene expression of the fusion gene (e.g. by a point
mutation in tk) should be detected on the control plates. As PEFS are not resistant to
Hygromycin, these cells were selected in the absence of PEF feeder layers, unlike
selection for the 'run' event.
Gancyclovir was used at the concentration of 2.5 |iM. The medium and appropriate
selection was replaced every three days, and once visible, the clones were picked and
grown for frozen stocks and DNA analysis.
7.3.2 Results
7.3.2.1 Clone numbers.
Clones were visible on average eight days after addition of Gancyclovir selection.
The plates in which Gancyclovir was added at the later days after plating were
confluent by the time the selection was imposed. The numbers of clones obtained on
each plate are detailed in table 7.4. No clones were visible on the control plates,
indicating that the selection was working efficiently, and that cells expressing the
fusion gene did not survive the Gancyclovir selection. A greater number of clones
were obtained at the higher seeding density under all conditions in this experiment,
unlike experiment RUN2 (section 7.2). The number of Gancyclovir resistant clones
did increase with delayed Gancyclovir addition, although after day 2 it was difficult
to distinguish individual clones and so it was not possible to determine clone
numbers and establish if this effect continued throughout the time course. For this
reason the number of clones arising on each plate are only detailed up to day 3 in
table 7.4.
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Table 7.4 The number of Gancyclovir resistant clones obtained in experiment
RUN3.
TIME OF GANC SEEDING TOTAL
PLATE No. ADDITION DENSITY NUMBER OF
(Days after plating) (No. cells/plate x 106) CLONES
1 0 0.1 80
2 0 0.1 120
TOTAL — — 200
3 0 1.0 400
4 0 1.0 360
TOTAL — — 760
5 1 0.1 224
6 1 0.1 184
TOTAL — — 408
7 1 1.0 1000
8 1 1.0 1400
TOTAL — — 2400
9 2 0.1 544
10 2 0.1 352
TOTAL — — 896
11 2 1.0 TMTC
12 2 1.0 TMTC
TOTAL — — TMTC
13 3 0.1 TMTC
14 3 0.1 TMTC
TOTAL — — TMTC
15 3 1.0 TMTC
16 3 1.0 TMTC
TOTAL — — TMTC
TMTC. Too many clones to count. Individual clones not distinguishable.
7.3.2.2 Screening HR5 RUN3 clones for vector excision.
A total of 112 RUN3 clones were picked and grown up for DNA analysis. Microbial
contamination was a problem again however, and only 8 clones were available for
analysis. These eight clones were analysed by the same method used to identify
targeted 'hit' clones, in which a Southern blot of Xba I-Sal I double digests was
probed with the 0.6EH genomic probe (6.2.2.2). This detects a wildtype band of 6
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kb, and a band of 8 kb which represents the integrated vector. A true 'run' event, in
which the vector had excised, would be identified by the absence of the 8 kb mutant
band with only the wild type band present.
Screening the RUN3 clones in this manner gave a pattern and size of the bands which
were identical to those of the 'hit' from which they were derived, indicating that




Figure 7.3 Screening RUN3 clones for the presence of the 'hit and run'
targeting vector.
A southern blot of Xba I-Sal I double digests was probed with the 0.6EH genomic
probe. Lane 1 shows the 6 kb wildtype band obtained with non-transfected CGR8
ES cells, and lane 2 the additional 8 kb band of the mutant allele created in 'hit'
clones by integration of the targeting vector. Lanes 3 to 10 show the bands obtained




This experiment was again unsuccessful in generating true 'run' clones which had
excised the 'hit and run' targeting vector to become Gancyclovir resistant. The
Gancyclovir selection was efficient at killing all cells expressing the Hygromycin-t&
fusion gene, as demonstrated by the death of all Hygromycin resistant cells present
on control plates when Gancyclovir selection was also imposed. Therefore the 'run'
clones obtained in this experiment must be Gancyclovir resistant, and have survived
Gancyclovir selection through some mechanism of loss of tk gene expression.
In contrast to the previous experiment, a higher number of Gancyclovir resistant
clones were obtained from the plates in which the cells were plated at a higher
density. However, the ten fold difference in the number of cells plated resulted in
less than a ten fold difference in the number of clones obtained. The higher number
of Gancyclovir resistant clones obtained at the higher plating density implies that at
these densities, 'cross feeding' was not occurring. This is in contrast to the
substantially lower numbers of Gancyclovir resistant clones obtained at the higher
plating density in the previous experiment. Therefore it appears that the plating
densities utilised in this experiment are sufficiently low to eliminate cross-feeding,
thereby allowing the survival of cells which were not expressing tk gene. The
generation of clones from plates which became confluent prior to addition of
Gancyclovir however, does not fit with the 'cross feeding' theory. The majority of
clones on these plates should be expressing the tk gene, and therefore the close cell
contact when confluent should result in extensive cross feeding, and hence cell death.
It is possible that in this situation, the period of cell growth which occurred prior to
addition of Gancyclovir enabled the non-expressing cells to increase in numbers to
such an extent that a dense colony was formed in which the majority of cells were
protected from the toxic products of neighbouring cells. This would overcome the
'crossfeeding' effect experienced by cells when selection is imposed soon after
seeding when the cells are at or near the vulnerable single cell stage of growth.
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The number of Gancyclovir resistant clones did increase with the delay between
plating and addition of the selection, however this could be a reflection of the
increase in number of cells not expressing tk which were already present in the
population of cells used to set up the 'run' selection. This possibility could be
eliminated by growing the 'hit' clone in Hygromycin selection immediately prior to
the Gancyclovir selection to ensure that all cells were initially expressing the
Hygromycin-t/: fusion gene. Any Gancyclovir resistant clones arising in the
following 'run' selection should then be the result of recent loss of tk gene expression
events, and an estimation of frequency could be determined.
The Gancyclovir resistant RUN3 clones which did survive to the analysis stage were
found to still contain the integrated 'hit and run' targeting vector. As in RUN2, there
did not appear to be any difference between the pattern and size of the bands obtained
for the non-selected 'hit' clone and the RUN3 clones implying that there were no
gross deletions or rearrangements present in the integrated vector. Therefore it
appears that these clones have lost sensitivity to Gancyclovir by some mechanism
which produces no obvious changes to the fusion gene detectable by the Southern
blot analysis. As none of the cells were preselected for expression of the fusion gene
prior to the Gancyclovir selection, it was not possible to determine whether this
inactivation of tk occurred during the Gancyclovir selection, or if these cells were
already present in the population of the 'hit' clone culture used to set up this
experiment.
7.4 RUN4 'RUN' EXPERIMENT
A further 'run' experiment was set up this time using cells which had been
preselected in Hygromycin selection. This experiment was set up in the same format
as RUN3 so that the results could be compared and the effect of Hygromycin
preselection determined. This should ensure that the starting population of cells were
all expressing the fusion gene before the Gancyclovir selection was imposed, and
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should eliminate any cells from the population which had already lost sensitivity to
Gancyclovir by any mechanism.
7.4.1 Method
Cells from the same 1.10 'hit' clone cell culture used to set up RUN3 were grown
under Hygromycin selection for 10 days, during which they reached a passage
number of 28. The cells were seeded at the same two densities of 1 X 105, and 1 X
106 cells per 100 mm plate used in experiment RUN3, again upon PEF feeder layers.
Gancyclovir selection was added sequentially to eight sets of plates on a daily basis
as for RUN3, but in this experiment the period between plating and imposition of
Gancyclovir selection also represented the period between Hygromycin selection and
Gancyclovir selection. Therefore, cells which were seeded in the 'day 0' plates were
switched from Hygromycin selection to Gancyclovir selection on the same day.
Duplicate plates were seeded at each density for each day of Gancyclovir addition up
until 'day 3', after which only one plate at each density was provided. Identical
control plates to those of RUN3 were set up in which cells seeded at the density of 1
X 10s cells per 100 mm plate were maintained in Hygromycin selection in the
absence of a PEF feeder layer, and Gancyclovir selection was added at daily
intervals.
All plates were fed every three days with the appropriate medium and selection, and
once visible, clones were counted, picked, and grown up for analysis.
7.4.2 Results
7.4.2.1 Clone numbers.
Gancyclovir resistant clones were obtained on average, eight days after Gancyclovir
selection was imposed. As before, plates in which there was the longer delay before
plating and addition of Gancyclovir selection, became confluent before the selection
was imposed. No clones were visible on any of the control plates indicating that the
Gancyclovir selection was working efficiently and killing all cells expressing the
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Hygromycin-f/: fusion gene. The numbers of clones obtained are detailed in table
7.5.
As in the previous experiment (section 7.3), the number of Gancyclovir resistant
clones increased with the increased time between plating and imposition of the
selection. However in this experiment, far fewer clones were obtained from the
plates receiving the earlier additions of Gancyclovir than in RUN3, although by the
end of the time course the numbers had reached comparable levels. At the earliest
time points, there was very little difference between the number of clones obtained
from plates seeded at the same density, although later on in the experiment the
numbers of clones arising on plates seeded at the higher density became greater, and
these plates reached a density that rendered them uncountable one day ahead of the
plates seeded at the lower density.
Table 7.5 The numbers of Gancyclovir resistant clones obtained in experiment
RUN4.
TIME OF GANC SEEDING MEAN NUMBER OF
ADDITION DENSITY CLONES PER

















TMTC. Too many clones to count. Individual clones not distinguishable.
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7.4.2.2 Screening RUN4 clones for vector excision.
A total of 78 RUN4 clones were picked and taken through to the analysis stage where
they were screened for the presence of the 'hit and run' targeting vector by probing a
Southern blot of Bgl I digests with the 0.6EH genomic probe (as described in
7.2.2.2). As in previous 'run' experiments this detected the 3.8 kb mutant band
characteristic of the integrated hit and run targeting vector in all of the clones
analysed, suggesting that the vector had not excised (figure 7.4).




Mutant- I m -3.8
Figure 7.4 Screening RUN4 clones for excision of the 'hit and run' targeting
vector.
A Southern blot of Bgl I digests probed with the 0.6EH genomic probe. Lane 1
shows the 23 kb and 9 kb wildtype bands of the non-transfected control, and lane 2
the additional 3.8 kb band of the mutant allele created in 'hit' clones by integration of
the targeting vector. Lanes 3 to 13 show the bands obtained from all RUN4 clones
which are identical to that of the 'hit' clone from which they were derived.
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7.4.3 Conclusions
This 'run' experiment was consistent with previous experiments in its failure to
generate 'run' clones in which the vector had excised, instead generating Gancyclovir
resistant 'run' clones which were indistinguishable at the Southern blot level from
the 'hit' clones from which they were derived. However the Hygromycin pre-
treatment of the cells prior to their use in the 'run' stage, and the comparison with the
similar RUN3 experiment which did not utilise this pre-treatment yielded some
interesting data.
Preselection of 'hit' cells with Hygromycin prior to use for the 'run' selection should
eliminate any cells which do not contain or express the fusion gene at a sufficient
level to confer resistance to Hygromycin. Due to the nature of the Hygromycin-tk
fusion gene, any mechanism which acts on the promoter to suppress Hygromycin
expression should have the same effect upon tk expression, and therefore this
preselection step should eliminate cells already present in the population which are
Gancyclovir resistant through loss of the fusion gene expression. However, any cells
which have specifically inactivated the tk part of the fusion protein e.g. a point
mutation, without loss of Hygromycin resistance would not be eliminated by this
preselection step. However, such cells would be identified on the control plates.
A comparison of the numbers of Gancyclovir resistant clones obtained in identical
'run' experiments utilising cells from the same 'hit' clone cell culture but which
differed in their exposure to Hygromycin provided interesting data regarding the
frequency of loss of Gancyclovir sensitivity (figure 7.5). The difference between the
numbers of Gancyclovir resistant clones present at day 0 indicates that there was a
significant number of Gancyclovir resistant clones already present in the 'hit' culture
at the start of the experiment. The very low numbers of resistant clones obtained
from the same culture which had been exposed to Hygromycin prior to Gancyclovir
selection indicated that these clones were eliminated from the population by
Hygromycin pre-treatment. This implies that the Gancyclovir resistance of these
cells is likely to be due to an absence or dysfunction of the Hygromycin-t& fusion
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gene product which also rendered them sensitive to Hygromycin. Therefore, many of
the Gancyclovir resistant clones obtained from 'run' experiments in which the 'hit'
clone had not been preselected with Hygromycin immediately prior to Gancyclovir
selection are probably the progeny of previous events which have resulted in loss of
Gancyclovir sensitivity. Loss of Gancyclovir sensitivity however, appears to be a
relatively common event. Although Hygromycin pre-treatment appeared to eliminate
virtually all Gancyclovir resistant cells from the starting population, their numbers
rapidly increased with time until they reached a number which was comparable with
those obtained from the culture which had not been exposed to Hygromycin.
Therefore the Gancyclovir selection imposed to select for a 'run' event in which tk
expression was lost through excision of the targeting vector, instead appeared to be
selecting for a different mechanism of loss of tk gene activity which occurred in these
'hit' clones at a frequency of approximately 1 X 10"5 to 1 X 10"6 cells.
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Figure 7.5 The number of Gancyclovir resistant clones obtained at two
different plating densities in 'run' experiments RUN3 and RUN4.
A cut off level of 500 was taken as the level at which clone numbers were declared
too many to count.
The legend label 0.1 refers to the numbers of clones obtained in experiment RUN3
from cells plated at a density of 0.1 X 106 cells/100 mm plate, and 1.0 the numbers of
clones obtained in the same experiment from cells seeded at the higher density of 1.0
X 106 cells/100 mm plate. Clone numbers from cells preselected with Hygromycin
in experiment RUN4 are labelled as 0.1 HYG for cells plated at 0.1 X 106 cells/100
mm plate, and 1.0 HYG for cells plated at a density of 1.0 X 106 cells/100 mm plate.
The presence of the 'hit and run' targeting vector in the 'run' clones demonstrated that
although the pre-treatment with Hygromycin was effective in eliminating such clones
from the starting population, the frequency of loss of sensitivity to Gancyclovir was
such that by the end of the experiment a large number of such 'false positive' clones
were generated. The complete absence of any 'run' clones in which the vector had
excised indicated that whatever mechanism is responsible for the loss of tk gene
activity, it was occurring at a much higher frequency than the desired 'run' event.
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All experiments to date have utilised the same HR5 'hit' clone (1.10) to select for a
'run' event. The phenomenon in which 'run' clones derived from this 'hit' which are
Gancyclovir resistant yet still retain the 'hit and run' targeting vector may be unique
to this clone. Therefore this experiment should be repeated with another 'hit' clone
to investigate this possibility.
7.5 RUN6 RUN' EXPERIMENT
Selection for a 'run' event was conducted using a different 'hit' clone to the one used
in previous experiments to determine if the unpredicted results were unique to the
HR5 'hit' clone 1.10, or were a feature of all 'hit' clones.
7.5.1 Method
The 'hit' clone HR5 3.11 was grown on Hygromycin selection for seven days by
which time it had reached a passage number of twenty two. Cells were seeded at a
density of 1 X 105 cells per 100 mm plate onto PEF feeder layers, on sixteen plates in
total. Gancyclovir was added to duplicate plates at daily intervals as before (RUN3
and RUN4), from day 0 to day 7. Control plates were included of 1 X 105 cells per
100 mm plate on Hygromycin selection, in the absence of PEF feeder layers as before
(RUN3 and RUN4). Gancyclovir selection was added to the control plates at daily
intervals as for selection for the 'run' event. The selection containing medium was
replaced every two days, and once visible, clones were picked and grown for DNA
analysis and frozen stocks.
7.5.2 Results
7.5.2.1 Clone numbers.
Gancyclovir resistant clones were visible on average, eight days after Gancyclovir
selection was imposed. No clones were visible on the control plates, indicating that
the Gancyclovir selection was working efficiently. As in previous experiments, those
plates which received the later additions of Gancyclovir became confluent before this
selection was imposed. The number of clones obtained are detailed in table 7.6. A
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substantial number of clones was obtained on the day 0 plates, and the numbers of
Gancyclovir resistant clones increased with increasing time between plating and
addition of Gancyclovir selection, as in previous experiments.
Table 7.6 The number of Gancyclovir resistant clones obtained from
experiment RUN6.
TIME OF GANC
ADDITION TOTAL No. No. CLONES










TMTC: Too many clones to count.
7.5.2.2 Screening RUN6 clones for excision of the hit and run' targeting vector.
A total of 24 RUN6 clones were taken through to the analysis stage where they were
screened for the presence of the 'hit and run' targeting vector by probing a Southern
blot of Xba I-Sal I double digests with the 0.6EH probe, a combination of digest and
probe which had been used previously to detect targeted 'hit' clones (6.2.2.2). This
revealed the same partially cut bands as those obtained when screening RUN2 clones
by the same procedure (figure 7.6). These bands are indicative of the enzyme Sal I
not cutting at the site present in the 'hit and run' targeting vector. However, the
presence of the 16.5 kb Xba I fragment which represents the mutant allele of a
targeted 'hit' clone, indicates that the targeting had not excised in these cells.
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Figure 7.6 Screening RUN6 clones for the presence of the 'hit and run'
targeting vector.
A Southern blot of Xba I-Sal I double digests was probed with the 0.6EH genomic
probe. Lane 1 represents DNA from non-transfected CGR8 ES cells, and shows the
6 kb band of the wildtype allele. Lane 2 contains DNA from the 'hit' clone 1.10 and
displays the 8 kb band of the mutant allele as well as the 6 kb wildtype band. Lanes
3 to 14 show results typical of all of the RUN6 clones. As well as the 6 kb wildtype
band, 23 kb bands are present which represent the Xba I fragment of the target site
containing the integrated 'hit and run' targeting vector, and the 8 kb band created by
cutting the 23 kb Xba I fragment at the Sal I site present in the targeting vector. The




This experiment was unsuccessful in generating 'run' clones in which the 'hit and
run' targeting vector had excised. The absence of clones on the control plates
indicated that the Gancyclovir was working efficiently and killing those cells
expressing the fusion gene. The Hygromycin preselection of the 'hit' clone should
have ensured that all cells were expressing the Hygromycin-fft fusion gene at the start
of the experiment. Therefore it appears that during Gancyclovir selection for the
'run' event, loss of tk gene activity occurred, allowing cells with the targeting vector
to survive.
These results are in agreement with those obtained from previous experiments in
which Gancyclovir selection was imposed upon a different 'hit' clone. This suggests
that the phenomenon of clones surviving Gancyclovir selection with the
Hygromycin-r£ selection gene intact is not specific to one 'hit' clone.
A comparison of the numbers of Gancyclovir resistant clones obtained form 'hit'
clone 3.11 and those obtained in the comparable 'run' experiment (RUN4) from 'hit'
clone 1.10 are shown in figure 7.7. A higher number of Gancyclovir resistant clones
are obtained from 'hit' 3.11 at the beginning of the time course than from 'hit' 1.10.
Despite this, in both experiments the numbers clones rise slowly at approximately the
same rate over the first three days, until day 4 when there is a rapid increase in clone
numbers in both experiments. The higher number of clones obtained from day 0
plates in experiment RUN6 suggests that there were more Gancyclovir resistant
clones present in the starting population of the 'hit' clone. However, Hygromycin
selection should have removed all Gancyclovir resistant clones from the 'hit', and so
this higher number of Gancyclovir resistant clones could be a consequence of a
higher frequency of loss of tk activity in the 3.11 'hit' clone. The similar rates of
increase in numbers of Gancyclovir resistant clones obtained from both 'hit' clones,
suggests that a similar mechanism of Gancyclovir resistance is occurring in both 'hit'
clones.
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TIME OF GANCYCLOVIR ADDITION (days)
Figure 7.7 A comparison of the number of Gancyclovir resistant clones
obtained from two different 'hit' clones under identical conditions.
The label 'Hit' 1.10 in the legend refers to the number of Gancyclovir resistant clones
obtained from 'hit' clone 1.10 in experiment RUN4, and the label 'Hit' 3.11 refers to
the number obtained from 'hit' clone 3.11 in experiment RUN6.
The results from this experiment utilising the 'hit' clone 3.11, and comparison with
those utilising the 'hit' clone 1.10, demonstrate that the phenomenon of loss of
Hygromycin-tA: gene activity during Gancyclovir selection is common to both 'hit'
clones. These 'hit' clones are the result of separate targeting events, as they arose on
separate plates during a targeting experiment. Therefore, the properties they
displayed are likely to be characteristic of pHTHRAI506/7 'hit' clones in general, and
indicate that loss of the Hygromycin-tA; fusion gene activity during Gancyclovir
selection is likely to be a common occurrence.
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7.6 DISCUSSION
All 'run' experiments conducted so far had been completely unsuccessful in
generating even a single clone in which the vector had excised. The Gancyclovir
resistant clones arising from two different 'hit' clones appear to have retained the 'hit
and run' targeting vector and the Hygromycin-/fc fusion gene, and Southern blot
analysis did not identify any differences between the mutant allele of the 'run' clones
and that of the 'hit' from which they were derived. It appeared that some other
mechanism was responsible for the loss of tk gene activity in these 'run' clones,
which did not induce any obvious structural change to the mutant allele. These
results do not exclude the possibility that excision of the vector is occurring in some
cells, as this high level of 'false positive' Gancyclovir resistant clones could be
obscuring such an event if it were occurring at a low frequency.
The observation that clones can survive a negative selection with the negative
selection gene of a vector seemingly intact, has also been reported by others when
targeting different loci in ES cells. Wu et al. (1994), used the 'hit and run' targeting
strategy to introduce base substitutions into the murine type I collagen gene. They
found that 32% of 'run' clones which were resistant to FIAU (an alternative selection
against tk gene expression), had still retained the targeting vector. A similar figure of
38% was reported by Ramirez-Solis et al. (1993) when targeting the Hoxb-4 locus
with this technique, and the lower figure of 22% of cells surviving the negative
selection with the intact targeting vector was reported by Valancius and Smithies
(1991) when introducing mutations into the hprt gene using a version of the 'hit and
run' strategy which they called the 'In-Out' targeting procedure. Use of alternative
strategies for the introduction of subtle mutations into genes, which also utilised a
negative selection step have encountered this problem to varying degrees. Askew et
al. (1993) found that 92% of Gancyclovir resistant clones obtained from the second
step of a variation of the double replacement targeting strategy also contained the
intact replacement vector. Analysis of the tk gene within the replacement vector
detected no gross rearrangements. The introduction of a small deletion into the
murine type I collagen gene by Wu et al. (1994) this time using a double replacement
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strategy, also found that 40% of FIAU resistant cells contained the tk gene.
Therefore although the proportion of resistant clones varied, these observations of
clones surviving negative selections with the negative selection genes intact suggests
this phenomenon was not unique to the Cftr locus or this targeting vector. They also
show that loss of sensitivity to a negative selection was not a feature peculiar to the
use of Gancyclovir to select against tk gene expression as a negative selection system,
as some of these experiments utilised FIAU to select against Gancyclovir expression,
and others utilised selection for and against the hprt gene as their selection system.
This results however, are in contrast to comparable experiments carried out by others
in our own lab to introduce the AF508 mutation into Cftr using a similar (but not
identical) 'hit and run' targeting vector. In these experiments, negative selection
generated many clones in which the AF508 vector was absent, indicating that they
had excised the vector and reverted to a wildtype genotype. The main difference
between the AF508 'hit and run' targeting vector and the AI506/7 'hit and run'
targeting vector was that the positive and negative selections were expressed from
two genes under the control of two separate promoters. Also, the AF508 'hit and run'
targeting vector employed Neomycin as the positive selection rather than the
Hygromycin selection utilised by the AI506/7 'hit and run' targeting vector. The
difference in the nature of Gancyclovir resistant clones generated by the two vectors
might therefore be a result of the different selection cassettes, and this possibility
should be investigated before any further 'run' experiments were conducted.
The conclusions from these experiments can be summarised as follows:
1. Cells were surviving Gancyclovir selection with the Hygromycin-t£ fusion gene
intact.
2. Southern blot could not distinguish any differences between mutant allele of 'hit'
and that of 'run' clones.
3. The Hygromycin-t/c fusion gene of the 'hit' clone from which 'run' clones were
derived was functional.
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4. Gancyclovir selection was shown to be effective.
5. Loss of tk gene activity therefore occurred during 'run' stage.
6. Control plates indicated that loss of Gancyclovir sensitivity was a result of loss of
both Hygromycin and tk activity of fusion gene product.
These experiments and the observations of others, imply that some mechanism other
than vector excision was responsible for loss of tk gene activity during Gancyclovir
selection. The high frequency at which this inactivation occurred and the large
number of resistant clones generated could be masking any resistant clones which
arose through the desired mechanism of vector excision. Therefore it was important
before proceeding any further, to identify the mechanism by which cells containing




INVESTIGATION OF THE GANCYCLOVIR
RESISTANCE OF 'RUN' CLONES
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8.1 INTRODUCTION
Previous experiments in which Gancyclovir selection was imposed upon targeted
'hit' clones to select for excision of the 'hit and run' targeting vector had produced
clones which were Gancyclovir resistant without the vector excision event. All of the
clones examined had retained the targeting vector which implies that this high
background could be masking the presence of any clones which had lost tk
expression through the desired mechanism of vector excision.
Further analysis was carried out on Gancyclovir resistant clones arising from one of
these 'run' experiments to identify the mechanism by which the tk gene had become
inactivated so that possible ways of overcoming this might be developed.
8.2 INVESTIGATION OF THE SELECTION RESISTANT
PHENOTYPE OF RUN4 CLONES
In order to determine if both the Hygromycin and the tk components of the fusion
gene had been inactivated in the RUN4 clones, a number were tested for Hygromycin
and Gancyclovir resistance.
8.2.1 Method
Twenty five 'run' clones, plus the 'hit' clone from which they were derived, were
each seeded at a density of 4 X 104 cells into four wells of a twenty four well plate.
Twenty four hours after seeding, Hygromycin selection was imposed at the usual
concentration of 150 (ig/ml upon one of the four wells of each clone. Gancyclovir
selection was imposed onto another well, and Hygromycin and Gancyclovir selection
combined onto a third, leaving the fourth well of each clone as a non-selected




The resistance of each clone to either selection varied widely, with different
combinations of sensitivity and resistance observed (table 8.1). A large number of
clones were resistant to Hygromycin selection and sensitive to Gancyclovir selection,
a phenotype consistent with a functional Hygromycin-tk fusion gene. However, most
of these clones also produced a variable background of Gancyclovir resistant clones.
A few clones appeared to be sensitive to Hygromycin and resistant to Gancyclovir
selection, a phenotype consistent with inactivation of the selection fusion gene, and
also gave rise to a varying background, this time of Hygromycin resistant cells.
Some clones gave a phenotype which was completely at odds with the presence of
the integrated 'hit and run' vector, that is resistance to both selections.
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The presence of the 'hit and run' targeting vector with a functional Hygromycin-t&
fusion gene should confer Hygromycin resistance and Gancyclovir sensitivity on the
RUN 4 clones. This phenotype however, was only displayed by some of the clones.
If the fusion gene had become inactivated, the reverse phenotype of Hygromycin
sensitivity and Gancyclovir resistance should then be observed. Although these two
phenotypes were seen in a number of clones, they did not account for all of the
phenotypes observed. Some clones displayed the bizarre phenotype of resistance to
both selections (Hygromycin but not tk gene activity), which is at odds with
Hygromycin resistance and Gancyclovir sensitivity being conferred by the same
fusion protein. In addition, clones which appeared to be Gancyclovir sensitive also
displayed various levels of background resistance, as did Hygromycin sensitive
clones. It is also interesting to note that no clones were found to be sensitive to both
selections (i.e. exhibiting tk gene activity only).
The variety of phenotypes displayed by the 'run' clones were unexpected as it had
been assumed that they had all survived Gancyclovir selection through the same
mechanism of inactivation of the Hygromycin-t£ fusion gene. It was surprising that a
large number of clones were sensitive to Gancyclovir as these clones should not have
survived the 'run' Gancyclovir selection. This might suggest that the Gancyclovir
selection was not effective, however large scale cell death occurred when
Gancyclovir was imposed on the 'hit' clone during the 'run' step, giving rise to
clones rather than confluent plates. In addition, the absence of clones on the control
plates on which Hygromycin and Gancyclovir selection were imposed together
implied that the selection was working efficiently as clones would have arisen on
these plates if the Gancyclovir selection had not killed cells which were expressing
the fusion gene. This phenotype of Hygromycin resistance and Gancyclovir
sensitivity is what is expected for clones which still contain and express the intact 'hit
and run' targeting vector. Therefore, it is difficult to account for how these
Gancyclovir sensitive clones survived the Gancyclovir selection as they appear to be
expressing the selection fusion gene. The various levels of background Gancyclovir
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resistant cells obtained from the Gancyclovir sensitive clones however, suggests that
some cells in this clone population did not produce the Thymidine kinase fusion
protein.
The Hygromycin sensitive and Gancyclovir resistant phenotype displayed by some
clones was the phenotype which would be expected for cells in which the fusion gene
was not expressed or lost. The presence of the 'hit and run' targeting vector in these
clones indicated that in these cells, the selection fusion gene had become inactivated.
As cells were preselected for those which were expressing the fusion gene as
indicated by Hygromycin resistance prior to setting up the 'run', this inactivation of
the fusion gene must have occurred during selection for the 'run' event. The various
levels of Hygromycin resistant cells arising from these clones indicates that the
fusion gene was not inactivated in all of the cells from these clone populations.
The observation that some clones were resistant to both selections is inconsistent
with the expression of both selections from a single fusion gene. Resistance to
Hygromycin is observed in cells which are expressing the Hygromycin-tA: fusion
gene, and therefore these cells should also be sensitive to Gancyclovir. Any
mechanism which has inactivated the tk gene expression of these clones must have
not affected Hygromycin expression. Loss of tk gene activity alone by the
Hygromycin-tA fusion protein could arise as a result of small changes to the tk gene,
such as point mutations which would not disrupt its Hygromycin resistant properties.
Alternatively, the level of expression of the fusion gene could differentially affect the
Hygromycin resistance and tk sensitivity. A low level of expression of the fusion
gene might be sufficient to confer resistance to Hygromycin whereas a much higher
level of expression might be required to bestow sensitivity to Gancyclovir. However,
both of these mechanisms of selective tk gene inactivation can be discounted as they
would both give rise to clones on the control plates on which both Hygromycin and
Gancyclovir had been imposed simultaneously. The complete absence of any clones
in combined selection indicates that a single cell within a clone population was
capable of displaying either a discrete Hygromycin resistant and Gancyclovir
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sensitive, or a Hygromycin sensitive and Gancyclovir resistant phenotype only,
consistent with complete expression or inactivation of the Hygromycin-r& fusion
gene. This implies that the resistance to both selections displayed by some clones
must be attributable to a mixed population of expressing and non-expressing cells.
Hygromycin would select for those cells in the population which are expressing the
fusion gene, and Gancyclovir for those in which such expression is absent. The
background of resistant cells observed with Hygromycin sensitive clones could
therefore represent a minority of expressing cells in a mainly non-expressing
population, whereas the Gancyclovir resistant background of a Gancyclovir sensitive
clone might represent a minority of expressing cells in a clone population.
Therefore it appears that the 'run' clones were mixed populations with a variable
proportion of cells which did not express the Hygromycin-tfc fusion gene, as observed
by their selection resistant phenotype. A large number of 'run' clones exhibited a
Gancyclovir sensitive phenotype which was inconsistent with their original
generation from Gancyclovir selection of the 'hit' clone. The mechanism by which
the Hygromycin-rfc fusion gene had become inactivated was unknown.
8.3 FURTHER SOUTHERN BLOT ANALYSIS OF RUN4
CLONES.
The RUN4 clones which had been tested by addition of the different selection
regimes were analysed further by Southern blotting.
8.3.1 Method
A Southern blot utilising the digest and probe combination which had been used
previously to detect 'hit' clones (chapter 6) was conducted to determine if there were
any differences between the 'run' clones and the 'hit' from which they were derived,
which might account for their altered selection resistance. For this, RUN4 clone
DNA was digested with Xba I and Sal I, and probed with the 0.6EH probe.
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8.3.2 Results
This analysis yielded complex pattern of bands which appeared to represent a failure
of the restriction enzyme Sal I to cut the DNA at the site present in the 'hit and run'
targeting vector (figure 8.1). The degree of cutting of this enzyme appeared to vary
between the RUN4 clones, but consistently cut DNA from the non-selected 'hit'
clone to completion. On close examination, the degree of cutting at the Sal I site in
the targeting vector appeared to correlate with the selection resistant phenotype of the
RUN4 clones, and is presented in table 8.2.
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Figure 8.1 Further Southern blot analysis of 'RUN4' clones.
Clone DNA was digested with Xba I and Sal I restriction enzymes and probed with
the 0.6EH genomic probe. Lane 1 is the non-transfected control displaying the
wildtype 6 kb Xba I fragment generated at a wildtype locus (indicated by wt). Lane 2
is the 'hit' clone which has not been subject to Gancyclovir selection. This displays
the wildtype 6 kb band as well as the 8 kb mutant band generated when the 16.5 kb
Xba I fragment created by insertion of the targeting vector into the target site is cut at
the Sal I site present in the targeting vector (labelled X-S). Lanes 3 to 19 represent
RUN4 clone DNA which all display the 6 kb wildtype band. However the intensity
of the 8 kb mutant band (X-S) varies between each clone, with a predominance of the
16.5 kb band (X-X) representing the increased Xba I fragment created by insertion of
the wildtype allele which has not cut at the Sal I site present in the vector. For
identification on table 8.2, the RUN4 clones in each lane are as follows: Lane (3)
1.2, (4) 6.2, (5) 8.3, (6) 9.4, (7) 9.7, (8) 9.8, (9) 11.1,(10) 11.2,(11) 11.4,(12) 11.7,
(13) 12.1, (14) 12.6, (15) 13.5, (16) 13.7, (17) 14.4, (18) 14.7, (19) 16.2.
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Table 8.2 The selection resistant phenotype of RUN4 clones and their
correlation with the degree of cutting at the Sal I site of the 'hit and run'
targeting vector.
MUTANT DEGREE OF





GROUPI 18.3 Xba-Sal 100
Hygromycin resistant 12.6 Xba-Sal 100
Gancyclovir sensitive
No background resistance
GROUP II Hit 1.10 Xba-Sal 100
Hygromycin resistant 18.1 Xba-Sal 100
Gancyclovir sensitive 11.2 Xba-Xba + Xba-Sal 70
Few GancyclovirR colonies 8.3 Xba-Xba + Xba-Sal 50
9.7 Xba-Xba + Xba-Sal 50
9.8 Xba-Xba + Xba-Sal 50
10.1 Xba-Xba + Xba-Sal 50
13.5 Xba-Xba + Xba-Sal 50
16.2 Xba-Xba + Xba-Sal 50
12.1 Xba-Xba + Xba-Sal 20
21.1 Xba-Xba + Xba-Sal 20
GROUP III 11.4 Xba-Xba + faint Xba-Sal 10
Hygromycin resistant 11.7 Xba-Xba + faint Xba-Sal 10
Gancyclovir sensitive 14.4 Xba-Xba + faint Xba-Sal 10
High GancyclovirR 14.7 Xba-Xba + faint Xba-Sal 10
GROUP IV 1.2 Xba-Xba 0
Hygromycin resistant 9.4 Xba-Xba 0
Gancyclovir resistant 11.1 Xba-Xba 0
13.7 Xba-Xba 0
GROUP V
Hygromycin sensitive 11.8 Xba-Xba 0
Gancyclovir resistant
GROUP VI
Hygromycin sensitive 6.3 Xba-Xba 0
Gancyclovir resistant
Background HygromycinR
GROUP VII 7.1 Xba-Xba + faint Xba-Sal 10
Hygromycin sensitive 6.2 Xba-Xba + faint Xba-Sal 10
Gancyclovir resistant
High HygromycinR
Xba-Xba represents the 16.5 kb Xba I fragment generated when the Sal I site present
in the vector does not cut. Xba-Sal represents the 8 kb fragment generated by cutting
the 16.5 kb Xba-Xba fragment at the Sal I site introduced by the vector.
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8.3.3 Conclusions.
There is a strong correlation between the degree of cutting at the Sal I site in the 'hit
and run' targeting vector with the selection resistant phenotype of the RUN4 clones.
Clones whose phenotype suggested that the fusion gene had been inactivated,
exhibited bands on the Southern blot indicative of a complete failure of the
restriction enzyme Sal I to cut at the restriction site in the 'hit and run' targeting
vector. In contrast, clones whose phenotype appeared to indicate that the fusion gene
was active, gave bands indicative of Sal I digestion at the restriction site in the
vector, although the degree of cutting at this site decreased in clones with increasing
levels of background Gancyclovir resistance. Therefore whatever mechanism was
causing loss of the Hygromycin-^ fusion gene activity, also appeared to be
preventing the restriction enzyme Sal I from cutting at the site in the 'hit and run'
targeting vector.
The Sal I restriction site of the 'hit and run' targeting vector is situated at the 3' end of
the Hygromycin-tA: fusion gene, in the sequence specifying the tk gene and hence
Gancyclovir resistance. It is compelling that cells which have appeared to survive
Gancyclovir selection through inactivation of the tk gene, fail to cut at a Sal I
restriction site located in this gene. Analysis showed that this enzyme does however
cut to completion at the Sal I site present in the targeting vector of cells from the
targeted 'hit' clone which had not been subjected to Gancyclovir selection. This
suggests that the Sal I restriction site was intact in the 'hit' clones used for the 'run'
selection, and that whatever event was responsible for preventing the enzyme from
cutting at this site in the 'run' clones probably occurred during the 'run' stage. This
also implies that whatever mechanism was responsible for inactivation of the
Hygromycin-t/: fusion gene, also prevented the Sal I restriction enzyme from cutting
at the site in the selection gene.
The restriction enzyme Sal I is known to be sensitive to methylation of CpG
sequences, which it is unable to cut (Arrand et al. 1978). Methylation of CpG
sequences is also a recognised mechanism of gene inactivation which does not
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mutate the gene in any way (see discussion 8.6). Therefore it is possible that the
mechanism by which the RUN4 clones were able to survive Gancyclovir selection
was by methylation-induced suppression of the Hygromycin-t& gene expression. As
methylation does not cause any physical alteration or mutation to the DNA
sequences, methylation-induced gene suppression is a reversible effect. The
background Hygromycin or Gancyclovir resistance seen with most of the clones
could be due to a minority of cells in the population which have a different
methylation status, and hence different expression of the Hygromycin-f& fusion gene.
The degree of cutting at the Sal I site in the targeting vector could be a reflection of
the methylation status of the clone cell population, and also an indicator of fusion
gene expression. If this were the case, it would suggest that clones which exhibited
complete inhibition of cutting at the vector Sal I site, and which did not exhibit
fusion gene activity, were Gancyclovir resistant due to methylation-induced
suppression of the fusion gene expression. Conversely, clones which did express the
fusion gene and did cut to quite a high degree at the Sal I site, would not be
methylated. In addition, the background Gancyclovir resistant cells seen with
Gancyclovir sensitive clones could represent methylated cells in a largely non-
methylated population, and perhaps the original methylation status of the clone which
had allowed it to survive the Gancyclovir selection of the 'run' step. The
Hygromycin resistant background of the Hygromycin sensitive clones would in turn
represent a non-methylated sub-population of cells in a largely methylated
population. The clones which were resistant to both selections could therefore also
represent methylated and non-methylated subpopulations which were either
expressing or not expressing the fusion gene, and were therefore resistant to both
selections.
8.4 CORRELATION OF Sal I DIGESTION WITH
FUSION GENE EXPRESSION.
It has been proposed that clones which are Gancyclovir resistant despite containing
the 'hit and run' targeting vector, have inactivated the selection genes through
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methylation. These clones have also been suggested to be mixed populations with
varying levels of non-methylated expressing cells and methylated non-expressing
cells which was reflected by the degree of cutting of the restriction enzyme Sal I at
the site in the tk gene sequences of the fusion gene.
An experiment was conducted to ascertain whether the degree of cutting at the Sal I
restriction site in the 'hit and run' targeting vector did correlate with expression of the
fusion gene, as demonstrated by Hygromycin resistance and Gancyclovir sensitivity.
8.4.1 Method
RUN4 clones were seeded into two wells of a twenty four well plate as before
(8.2.1), and Hygromycin selection was imposed upon one well, and Gancyclovir
selection upon the other. Any cells which were resistant to the selection, including
those demonstrating just a low background resistance, were grown until confluent.
Once confluent, the cells were harvested and DNA extracted. A Southern blot was
then performed on Xba I-Sal I digested DNA, which was probed with the 0.6EH
probe as before (8.3.1).
8.4.2 Results
The bands obtained indicated that DNA from all of the clones which had been grown
on Hygromycin cut almost completely at the Sal I site in the targeting vector to
generate the expected 8 kb band (figure 8.2). However, cells from the same clones
which had been grown on Gancyclovir selection exhibited very little cutting at the
this site, resulting mainly in a 16.5 kb Xba I mutant band. This result was obtained
for all of the clones which were tested, regardless of the selection resistant phenotype




Cells which are expressing the fusion gene will be Hygromycin resistant and will be
selected for in Hygromycin selection whereas cells not expressing the fusion gene
will be selected for in Gancyclovir selection. Therefore, the observation that
selection of RUN4 clones in Hygromycin selection also induces cutting at the Sal I
site in the 'hit and run' targeting vector, whereas selection in Gancyclovir represses
cutting at this site in the same clone suggests there is a definite link between fusion
gene activity and cutting at the Sal I site of the targeting vector.
It is also interesting that the same effect was seen in all clones tested despite the
differing phenotypes displayed previously (table 8.1). When cells which gave rise to
the Gancyclovir background resistance of Gancyclovir sensitive clones were
analysed, they displayed an inhibition of Sal I digestion at the site in the vector.
Conversely, the cells which gave the Hygromycin resistant background of
Hygromycin sensitive clones showed almost complete cutting at the Sal I site.
Therefore it appears that the 'run' clones are mixed populations with respect to
activity of the fusion gene, and that different subpopulations of cells can be selected
for by Hygromycin or Gancyclovir selection. The differential cutting at the Sal I site
in the targeting vector of the same clone when grown on the two different selections
suggests that this difference in expression could be due to methylation-induced gene
suppression which has inactivated the fusion gene and also inhibited Sal I cutting in
this region.
8.5 AN INVESTIGATION INTO THE METHYLATION
STATUS OF THE RUN4 CLONES
The results from the previous experiments have shown that inactivation of the
Hygromycin-t/c fusion gene is linked to a failure of the Sal I restriction enzyme to cut
at a site in this gene. Sal I is an enzyme which is known to cut only non-methylated
DNA and it is therefore possible that methylation within the fusion gene is
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inactivating the gene expression. The methylation status of the RUN4 clones was
investigated by the use of other methylation sensitive enzymes.
8.5.1 Method
RUN4 clone DNA was digested separately with two different enzymes, Hpa II and
Msp I. These enzymes both cut at the same site however, Hpa II does not cut
methylated DNA. Therefore, any differences between the bands obtained from these
digests on a Southern blot, identifies regions in which Hpa II has not cut, indicating
that the DNA is methylated. In order to detect differences in methylation in different
regions of the targeted Cftr allele, the Southern blot of these digests was hybridised
with probes from different regions of the target site:
(I) A probe consisting of the whole of the Hygromycin-t& fusion gene was
used to identify methylated regions within the sequences encoding the
selection resistance.
(II) The filter of the Hpa II and Msp I digests was stripped and reprobed with
the 0.6EH genomic probe from 3' region external to the integrated targeting
vector. This should detect any methylation present in the 3' sequences
flanking the target site.
(III) The same filter was also probed with the 1.3XH probe. This should
identify any methylation differences in the region of Cftr which is 5' to the
integrated vector.
8.5.2 Results
A difference in the degree of cutting of the two enzymes was seen with all three




This probe detected three bands of 2.7, 0.3, and 0.1 kb from DNA which had been
digested with the Msp I restriction enzyme (figure 8.3). However the 2.7 kb band
was much fainter or absent from DNA digested with the methylation sensitive
enzyme Hpa II, and in addition larger bands of 5.3 and 9.8 kb were also visible. The
absence of any differences between the Hpa II and Msp I bands in the 'hit' clone
suggests that this methylation is unique to the fusion gene of the Gancyclovir selected
'run' clones. The specificity of the probe for the Hygromycin-tk fusion gene




(II) 3' 0.6EH Probe
The bands obtained with this probe also differed between the two digests, with a 1.6
kb band present in the Msp I digested DNA being absent from the same DNA
digested with Hpa II (figure 8.4). Instead, larger bands of 5.3 and 6.6 kb were visible
in the Hpa II digests. This indicates that the methylated DNA sequences of the
RUN4 clones were not confined to the Hygromycin-r& fusion gene, and that the
genomic region flanking the 3' end of the integrated 'hit and run' targeting vector was
also methylated. The 1.6 kb band was also absent in the 'hit' clone and the non-
transfected control, indicating that this region is also methylated in cells which have
not undergone Gancyclovir selection.
(III) 1.3XH Probe
This probe detected an 8 kb band in the Msp I digests which was absent in the Hpa II
digests indicating that the 5' region of Cftr was also methylated (figure 8.5). This
altered band pattern was again seen in the 'hit' clone as well as the non-transfected
control indicating that this region is normally methylated in cells which have not
been selected in Gancyclovir.
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Figure 8.4 Analysis of the methylation status of the 3' sequences flanking the
target site by Southern blot utilising methylation-sensitive restriction enzymes.
A Southern blot of DNA digested with restriction enzymes Hpa II or Msp I was
reprobed with the 0.6EH probe. All of the lanes denoted by H contain DNA which
has been digested with the restriction enzyme Hpa II, and the lanes labelled M, DNA
which had been digested with Msp I. The lanes labelled CGR8 contain DNA from a
non-transfected control, and those labelled 'hit' DNA from the 'hit' clone from
which the 'run' clones were derived. The remaining pairs of lanes contain DNA
from RUN4 clones.
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Figure 8.5 Analysis of the methylation status of the 5' sequences flanking the
integrated targeting vector of RUN4 clones by Southern blot utilising
methylation-sensitive restriction enzymes.
A Southern blot of DNA digested with restriction enzymes Hpa II or Msp I was
probed with the 1.3XH genomic probe. All of the lanes denoted by H contain DNA
which has been digested with the restriction enzyme Hpa II, and the lanes labelled M,
DNA which had been digested with Msp I. The lanes labelled CGR8 contain DNA
from a non-transfected control, and those labelled 'hit' DNA from the 'hit' clone
from which the 'run' clones were derived. The remaining pairs of lanes contain
DNA from RUN4 clones.
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8.5.3 Conclusions
These results suggest that the RUN4 clones do have an altered methylation status to
that of the 'hit' clone within the region of the Hygromycin-t& fusion gene. This
methylation was not confined to the Hygromycin-t/c fusion gene as methylated
sequences were also detected in the 5' and 3' sequences flanking the integrated 'hit
and run' targeting vector. The observation that these 5' and 3' regions were also
methylated in non-transfected control cells, indicates that this region of Cftr is
usually methylated. The methylation of this region of Cftr is not unique to ES cells,
as a Southern blot conducted by Dr Donald Davidson utilising the same digests and
probe combination on DNA from different mouse strains has also shown the pattern
of methylated Hpa II fragments (figure 8.6). Therefore it appears that the sequences
surrounding the target site are normally methylated in mouse cells.
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Figure 8.6 Southern blot analysis of the 3' region of the Cftr target site in
different mouse strains using methylation sensitive enzymes.
This Southern blot was carried out by Dr Donald Davidson using DNA extracted
from tail biopsies. The lanes labelled H refer to DNA digested with the methylation
sensitive Hpa II, and the lanes labelled M to that digested with the methylation
insensitive enzyme Msp I. The two lanes labelled E14 indicate DNA from an ES cell
line, and the remaining lane pairs DNA from different mouse strains.
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Although this analysis suggests that the Hygromycin-tk fusion gene and flanking
regions are methylated, it is by no means conclusive. If time had permitted, further
experiments would have been conducted to confirm these observations. In order to
determine that the Sal I site was intact in those cells whose DNA did not cut at the
site present in the targeting vector, the region of DNA containing this site could be
amplified by PCR. This amplification would copy the DNA sequence but not the
methylation, and therefore digestion of the resultant PCR product with the Sal I
restriction enzyme should determine whether this site was intact in these cells. A
comparison of clones whose selection resistance is indicative of expression or
inactivation of the fusion gene by Northern blot analysis should establish the
presence or absence of a mRNA transcript from this gene and provide more direct
evidence of any deficiencies in gene expression. The absence of bands, or
appearance of larger bands in the Hpa II digests when compared to the Msp I digests
might be attributed to incomplete or poor digestion of the DNA by the Hpa II
restriction enzyme. This possibility could be investigated by reprobing the filters
with a probe for a gene which is constitutionally non-methylated in ES cells, e.g.
Dihydroxyfolate reductase (Kafri et al. 1992). If the Hpa II restriction enzyme was
working efficiently and had cut all non-methylated DNA to completion, identical
bands should be seen between the Sal I and the Msp I digested DNA. However
despite the absence of this confirmatory data, these results do suggest that the
Hygromycin-tk fusion gene is methylated in the 'run' clones, in contrast to the 'hit'
clone from which they were derived.
Therefore, the difference in the methylation status of the Hygromycin-tk fusion gene
between the 'hit' clone and the RUN4 clones indicates as suggested previously, that
methylation of this region is responsible for the inactivation of the tk gene, and also
the failure of the restriction enzyme Sal I to cut at the site in the tk gene. The
presence of methylated DNA in the sequences flanking the site of integration of the
'hit and run' targeting vector must also be a contributory factor.
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8.6 DISCUSSION
The observation made in the previous chapter that all of the clones surviving
Gancyclovir selection still contained the integrated 'hit and run' targeting vector
suggested that the tk gene of the vector had been inactivated. This proposed
inactivation of the tk gene produced no obvious band size differences between the
Gancyclovir resistant 'run' clones and the 'hit' clone on a Southern blot. This loss of
gene activity occurred at a relatively high frequency, and the high numbers of
Gancyclovir resistant clones generated could be masking any which had arisen
through the desired mechanism of vector excision.
The experiments conducted in this chapter have shown that the RUN4 clones exhibit
a variety of selection resistant phenotypes which are associated with a functional or
inactive Hygromycin-tfc fusion gene. These clones appear to be mixed populations
with varying levels of cells exhibiting fusion gene activity. The degree to which
clone DNA would cut at the Sal I restriction site located in the region of the
Hygromycin-tfc gene encoding Gancyclovir sensitivity appeared to correlate with
Gancyclovir sensitivity. Resistance to Gancyclovir reflects loss of expression of this
gene and was accompanied by a failure of Sal I to cut at this site. The mixed
population of clones with respect to expression of the Hygromycin- tk fusion gene
was demonstrated by the ability of the same clone to generate both Gancyclovir
resistant cells and Hygromycin resistant cells, but never any cells which were
resistant to both selections when imposed simultaneously. This implies that the
fusion gene is functional but the activity is being switched on or off.
The observation that clones which had previously been selected on the basis of their
resistance to Gancyclovir could exhibit a sensitive phenotype, suggests either that the
selection had allowed cells expressing the tk gene to survive, or that the mechanism
of tk gene inactivation which had allowed these clones to survive the original
selection was reversible. Various observations confirmed the effectiveness of the
Gancyclovir selection, and the presence of cells with differing selection resistance
within the same clone population suggests that the latter might apply.
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The failure of the restriction enzyme Sal I to cut at the site in the region of the
Hygromycin-tk fusion gene that encodes resistance to Gancyclovir only in those cells
which had been selected in Gancyclovir suggested that the mechanism which was
responsible for loss of tk gene expression was also preventing the enzyme from
cutting. As mentioned previously, Sal I is a restriction enzyme which is known to be
unable to cut methylated CpG sequences. Many studies have correlated repression of
gene transcription with methylation of the cytosine of CpG dinucleotides which are
commonly clustered at the 5' end of genes, termed 'CpG islands' (Bird 1986; and
reviewed in Bird 1992; and Eden and Cedar, 1994). The exact mechanism by which
methylation represses gene expression is not known but it is thought that methylation
might suppress gene transcription by direct inhibition of transcription factor binding
(Becker et al. 1987), or indirectly through Methyl CpG-binding proteins (MeCPs)
which specifically bind to multiple symmetrically methylated CpGs (Boyes and Bird,
1991). Increased DNA methylation and decreased gene expression have also been
found to correlate with the formation of a 'closed' chromatin conformation which
may be inaccessible to the transcriptional machinery (Antequera et al. 1990).
Methylation of DNA is an epigenetic mechanism of gene alteration which does not
involve actual mutation of the DNA and is consequently reversible. It is therefore
possible that methylation-induced inactivation of the Hygromycin-r& fusion gene is
generating Gancyclovir resistant clones during selection for the 'run' event. Some or
all of the cells in this clone population could subsequently 'lose' this methylation
when the selection pressure for this phenotype is removed, which would in turn
remove the suppression of gene expression leading to a Gancyclovir sensitive
phenotype. Cooper et al. (1992) have described a similar 'switching' phenotype in a
mouse teratocarcinoma cell line, where clones lost and reacquired expression of the
aprt (adenine phosphoribosyltransferase) gene involved in the purine salvage
pathway. Analysis of these clones found that loss of aprt activity correlated with
reduction of aprt mRNA, resistance to nuclease digestion which is characteristic of
chromatin formation, and increased CpG island methylation, all of which are
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indicative of transcriptional suppression by methylation. The hsvtk gene is also
susceptible to methylation-induced gene inactivation. Graessmann et al. (1994) have
reported that methylation of promoter sequences of the hsvtk gene and even of non-
promoter CpG sequences located downstream in the coding sequences can suppress
its transcription. Therefore loss of Thymidine kinase gene activity through
methylation-induced suppression of the Hygromycin-/& fusion gene expression could
be an explanation for the variable Gancyclovir resistance of the 'run' clones.
A subsequent investigation into the methylation status of the RUN4 clones showed
that there were indeed differences between the 'hit' clone and the 'ran' clones which
had been selected in Gancyclovir. The Hygromycin-^ fusion gene of the 'run' clones
did appear to be methylated whereas that of the 'hit' clone did not. Therefore it
appears that Gancyclovir selection had selected cells in which the selection gene had
become methylated resulting in loss of tk gene expression.
The high frequency at which the Hygromycin-t& gene became methylated might be
explained by the observation that the genomic sequences flanking the target site are
usually methylated in mouse cells. The phenomenon of loss of gene expression when
placed adjacent to methylated sequences has been well documented and Kass et al.
(1993) have shown that this is probably a result of spread of chromatin formation
from the methylated region into an adjacent non-methylated region, thereby
inactivating any gene which is present. It has been proposed that methylation is not a
prerequisite for chromatin formation, and that methylation of DNA alone is not
sufficient to block hsvtk gene transcription (Buschhausen et al. 1987). The
methylation of DNA sequences which have been converted into an inactive
chromatin form has been suggested to occur during replication (Kass et al. 1993).
Therefore it is possible that the methylated sequences flanking the integrated 'hit and
run' targeting vector were in the inactive chromatin form which then spread into the
Hygromycin-f& fusion gene in some cells, thereby suppressing its transcription.
These cells would then become resistant to Gancyclovir and would be selected for
during the 'run' step. Replication of the fusion gene in this inactive chromatin
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formation in these Gancyclovir resistant clones might then result in its subsequent
methylation which was detected in this investigation by use of methylation-sensitive
enzymes. This theory could be confirmed further by screening the region of the Cftr
target site of these clones for the presence of sequences in the inactive chromatin
form which are characterised by a resistance to Msp I nuclease digestion (Keshet et
al. 1986). The chromatin structure of the promoter region of CFTR has been studied
(Koh et al. 1993), and its presence was found to correlate with expression levels in
cell lines in vitro. However, it is unlikely that the methylation and proposed
chromatin structure of sequences flanking exon 10 identified in this study exert an
effect upon expression of CFTR.
If the failure of these experiments to obtain clones in which the vector has excised is
due to the high background of methylation-induced loss of tk gene expression, this
does not explain why clones are obtained which appear to have excised the AF508
vector in similar experiments conducted in parallel in our lab. Since the AF508 'hit
and run' targeting vector utilises the same negative selection to select for loss of the
tk gene expression, and is integrated into the same region of Cftr, it would be
expected to also be susceptible to the same level of methylation-induced loss of tk
gene expression. The Gancyclovir resistant clones which appeared to have excised
the AF508 'hit and run' targeting vector had always reverted to wildtype, and did not
retain the AF508 mutation. Although the ratio of duplicated sequences does favour
loss of the mutation, retention of the AF508 mutation would have been expected in
20% of the clones. It is possible that the wildtype clones obtained with these AF508
'hit' clones represent wildtype cells which were already present before Gancyclovir
selection was imposed. The presence of such 'wildtype contamination' in the 'hit'
clone would not be apparent until a selection was applied which selected for cells
which did not contain the targeting vector. Due to the expected precision of the
excision process, it would not be possible to distinguish between wildtype cells and
cells which had previously been targeted but which had subsequently excised the
vector. The main difference between the AF508 'hit and run' targeting vector and the
AI506/7 vector is the positive selection gene. The AF508 vector utilises a Neomycin
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resistance gene to select for vector expression, whereas the AI506/7 utilises
Hygromycin. The absence of any wildtype cells from the Gancyclovir selection of
AI506/7 'hit' clones might reflect the difference in stringency of the positive
selections, with Hygromycin being more effective at eliminating any non-expressing
cells. The targeted AF508 'hit' clone which had given rise to the wildtype 'run'
clones was subsequently recloned by plating some cells out to generate clones from
single cells. Analysis of the resulting clones found that only 2 out of 7 clones
contained the targeted 'hit and run' vector, indicating that the AF508 'hit' clone had a
high level of contamination with wildtype cells. This would account for the high
number of Gancyclovir resistant clones obtained from this 'hit' which had appeared
to have excised the 'hit and run' targeting vector. Therefore, the similar AF508 'hit
and run' targeting vector could be susceptible to the same mechanism of methylation-
induced gene inactivation experienced by the AI506/7 'hit and run' targeting vector.
However this effect had been masked the high level of wildtype cells in the 'hit'
clone, which had given the impression that Gancyclovir selection had selected cells
in which the vector had excised. Subsequent Gancyclovir selection on the recloned
AF508 'hit' clone generated 'run' clones in which the 'hit and run' targeting vector
was present in all Gancyclovir resistant clones suggesting that this vector was also
subject to the same loss of tk gene expression as the AI506/7 targeting vector.
Therefore it appears that the inactive chromatin of methylated sequences flanking the
integrated 'hit and run' targeting vector had spread into the Hygromycin-tk fusion
gene at a high frequency during the 'run' stage. This inactivated its expression,
thereby rendering cells resistant to the Gancyclovir selection and enabling them to
survive the selection which had been imposed to select for cells which had lost tk
gene expression through vector excision. This does not exclude the possibility that
some cells are excising the targeting vector to become Gancyclovir resistant, as the
high background of methylated Gancyclovir resistant clones would obscure such an
event if it were occurring at a lower frequency.
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The experiments described so far have been unsuccessful in selecting clones which
have survived Gancyclovir selection through excision of the integrated 'hit and run'
targeting vector. The 'hit and run' technique was modified in light of the
observations made in previous experiments to try and overcome the problems
experienced to date.
9.2 RUN 7 RUN' EXPERIMENT
The failure of Gancyclovir selection to select any cells which had lost tk gene
expression through excision of the 'hit and run' targeting vector was thought to be due
to the high background of Gancyclovir resistant clones generated by a more frequent
mechanism of gene inactivation, obscuring the less frequent vector excision event.
An investigation into this phenomenon had shown that methylation-induced
suppression of tk gene expression was responsible for generating high numbers of
Gancyclovir resistant clones.
To try and cut down this high level of 'false positives', Gancyclovir resistant clones
obtained from selection for a 'run' event were screened for resistance to Hygromycin.
Clones which have become resistant to Gancyclovir through methylation inactivation
of the tk gene are likely to be mixed populations of expressing and non-expressing
cells, and so at least some cells from such a clone would grow in Hygromycin
selection. Clones which are resistant to Gancyclovir through vector excision would
not be able to reverse their phenotype and so would remain completely sensitive to
Hygromycin selection. This method of testing the Hygromycin sensitivity of
Gancyclovir resistant clones should allow the identification and elimination of those
still containing the targeting vector at an early stage, without the need to grow them
up for analysis. The removal of a requirement to grow up cells to obtain DNA for
Southern blotting in order to identify 'false positives' will allow more clones to be




A passage 30 culture of the HR5 'hit' clone 1.10 was grown up on Hygromycin
selection for 7 days and then used to set up a 'run' experiment. Cells were seeded at
a density of 1 X 105 cells per 100 mm plate onto twenty five plates containing a PEF
feeder layer, and seventy five plates in the absence of a feeder layer. Gancyclovir
selection was imposed onto half of the plates two days after plating, and the other
half three days after plating. The medium was replaced every three days until clones
were visible.
Once visible, clones were picked and screened by the following procedure (illustrated
in figure 9.1). The Gancyclovir resistant clones were picked, trypsinised, and seeded
between two wells of a ninety six well plate, one of which contained a PEF feeder
layer. Hygromycin selection was imposed upon the cells seeded in the absence of a
feeder layer, and the other well was maintained without selection. After four days,
the cells in Hygromycin selection were scored for Hygromycin resistance. Clones in
the wells which were not on Hygromycin selection were taken further only if all of
the cells in the corresponding well died in Hygromycin selection. Clones which did
grow in Hygromycin were discarded, as these were likely to represent cells which
still contain the 'hit and run' targeting vector. Clones which appeared to be
Hygromycin sensitive, were split into two more wells of a ninety six well plate when
confluent, and Hygromycin selection was imposed upon one of these wells for a
second time. This second Hygromycin step served to eliminate those clones which
had either appeared to be Hygromycin sensitive due to a failure of cells to grow for
reasons such as too low a cell density, or which had not yet reversed the DNA
methylation. Clones which still appeared to be completely sensitive to Hygromycin



























A large number of Gancyclovir resistant clones were generated in this experiment
from the plates in which cells were seeded onto PEF feeder layers. Plates in which
cells were plated in the absence of a feeder layer generated a very small number of
clones, considering the number of plates that were seeded (12 clones from 75 plates).
There did not appear to be any difference between the number of clones obtained
from the plates on which Gancyclovir selection was added two days after plating than
the plates on which it was imposed after three days. The number of Gancyclovir
clones which were picked are detailed in table 9.1.
One thousand Gancyclovir resistant clones in total were picked and screened for
Hygromycin resistance. The majority of clones were found to be Hygromycin
resistant and were discarded leaving 161 clones which appeared to be sensitive to
Hygromycin to be screened a second time. This number of clones was further
reduced by the second round of screening to just 14 which were consistently sensitive
to Hygromycin. These clones were grown up and analysed by Southern blot.
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9.2.2.2 Screening RUN7 clones for vector excision.
The Hygromycin sensitive, Gancyclovir resistant clones were analysed by probing
Xba I-Sal I digests with the 0.6EH probe which had been used previously to screen
for 'hit' clones in section 6.2.2.2 (figure 9.2). The presence of the integrated 'hit and
run' targeting vector in the target site is indicated by the appearance of an 8 kb band
above the 6 kb band of the wildtype allele. Methylation of the Sal I restriction site
present in the 'hit and run' vector inhibits Sal I from cutting at this site, and therefore
the 16.5 kb band which is generated by insertion of the targeting vector into the 6 kb
Xba I fragment is not reduced to 8 kb.
Figure 9.2 Screening RUN7 clones by Southern blot for vector excision.
DNA was digested with Xba I and Sal I and probed with 0.6EH probe. Lane 1 is the
non-transfected control and displays the single 6 kb wildtype band. Lane 2 is the
'hit' clone which has not been subjected to Gancyclovir selection and shows the 8 kb
band created by the integrated targeting vector as well as the 6 kb band of the
wildtype allele. Lanes 3 to 16 are the RUN7 clones. Lanes 3, 5, 14, and 16 contain
RUN7 clones displaying a single wildtype band indicative of vector excision.




When screened by this method, eight clones gave one or both of the 8 kb or 16 kb
bands indicative of the presence of the 'hit and run' targeting vector at the target site.
However, in contrast to all previous 'run' experiments, four clones did not have any
vector bands, and displayed just a single wildtype band. These four clones therefore
appear to be 'run' clones which have excised the 'hit and run' targeting vector. Three
of these clones originated upon plates which had been seeded with a PEF feeder
layer, and one from a plate which did not contain a PEF feeder layer. Three of the
four clones occurred upon different plates, indicating that they are not clonal and
represent at least three independent recombination events.
9.2.2.3 Screening RUN7 clones for retention ofM506/7 mutation.
The RUN7 clones were screened to determine whether vector excision had resulted
in loss of the mutation and reversion to a wildtype genotype, or whether the mutation
had been retained as the only alteration to Cftr.
Clone DNA was analysed by the same combination of digests and probe used to
identify the AI506//7 mutation in the targeted 'hit' clones (section 6.2.2.4), i.e.
digested with Ssp I and Eco RI, blotted and probed with the 0.8HE probe. The
presence of the AI506/7 mutation in the mutant exon introduces a unique Ssp I site
which generates a novel 0.8 kb band in addition to the 2.2 kb band generated by the
wildtype and non-mutant exon.
Analysis of the RUN7 clones showed that none of the clones which had excised the
vector had the 0.8 kb band indicating that they had not retained the AI506/7 mutation,
but had instead reverted to a wildtype status (figure 9.3).
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Figure 9.3 Screening RUN7 clones by Southern blot analysis for retention of the
AI506/7 mutation.
A Southern blot of Eco RI and Ssp I digested DNA was probed with the 0.8HE
probe. Lane 1 is the non-transfected control displaying the 2.2 kb wildtype band.
Lane 2 is the 'hit' which displays the 2.2 kb band generated by both the wildtype
allele and the non-mutant exon, along with the 0.8 kb band generated by the Ssp I site
of the mutation. (For a restriction map of these sites see figure 6.1). Lane 17
contains vector DNA only, demonstrating the 0.8 kb band generated by the mutation
carried by the vector sequences. Lanes 3 to 16 are the RUN7 clones, with lanes 3, 5,




This experiment has, for the first time generated clones which appeared to have
become Gancyclovir resistant through excision of the 'hit and run' targeting vector,
rather than through methylation-induced inactivation of the tk gene.
The results from previous experiments suggested that methylation-induced
inactivation of the tk gene is a common event in the targeted 'hit' clones, and that all
of the Gancyclovir resistant clones obtained to date had survived Gancyclovir
selection through this mechanism. It was proposed that the high numbers of these
methylated clones could be masking any which had become Gancyclovir resistant
through the desired mechanism of vector excision if this were occurring at a much
lower frequency. This experiment described an attempt to identify and eliminate
these methylated clones at an early stage, allowing a greater number of Gancyclovir
resistant clones to be screened, so that only those unlikely to be methylated would be
taken through to the analysis stage.
This modified experiment was successful in identifying four clones in which the
vector appeared to have excised. The majority of the remaining clones displayed the
16.5 kb band indicative of methylation of the Sal I site and probably represent clones
which are still methylated to such an extent that they remain completely sensitive to
Hygromycin. One clone did not display this 16.5 kb methylated band and perhaps
represents a clone in which the Hygromycin-t& has been inactivated by some other
mechanism, such as a point mutation in the promoter region.
Of the four 'run' clones obtained, three had been selected upon PEF feeder layers,
and one in the absence of a feeder layer. As many more Gancyclovir resistant clones
were generated from the cells seeded onto PEF feeder layer plates than were
analysed, an absolute frequency of vector excision cannot be calculated for these
clones. However, all of the clones arising on plates seeded in the absence of feeder
layers were analysed, and therefore a frequency of the 'run' event under these
conditions can be determined. These plates were seeded with a total of 7.5 X 106
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cells, and gave rise to twelve Gancyclovir resistant clones, of which one had
appeared to have excised the 'hit and run' targeting vector. This gives a frequency of
excision of the targeting vector in 1.3 X 10~7 cells plated. However, Gancyclovir
selection was imposed upon this plate 2 days after removal of Hygromycin selection,
and therefore this figure must be corrected for the increase in cell numbers during
this intervening period. The mean doubling time for ES cells growing exponentially
is approximately once every eighteen hours. In the 2 days between the different
selections, the cells should have doubled approximately 2.6 times. Therefore it can
be estimated that the cell numbers at the time of Gancyclovir selection were likely to
be 4.8 X 107 and therefore the frequency of vector excision would be 1 in 4.8 X 107
o
i.e. 2 X 10" cells. Although only a small proportion of the Gancyclovir resistant
clones arising on PEF feeder layers were analysed, a 'minimum' frequency of vector
excision can be calculated as we know that at least three 'true run' clones were
generated. The total number of cells seeded under these conditions was 2.5 X 106, of
which 14 plates had Gancyclovir added after 2 days, and 11 plates had it added after
3 days. Therefore after correcting for an overall increase in cell numbers to 2.9 X
107, it can be estimated that the frequency of vector excision under these conditions
must occur in at least 3 in 2.9 X 107 cells, i.e. 1.0 X 10"7 cells plated, and is likely to
be higher. This frequency is at least tenfold higher than for cells selected in the
absence of a PEF feeder layer. However far fewer Gancyclovir resistant clones were
generated on the plates which did not contain PEF feeder layers and therefore despite
the lower frequency of vector excision, it might be preferable to select cells in the
absence of PEF feeder layers in future experiments, as this lower 'false positive'
background should facilitate identification of true 'run' clones. The higher numbers
of Gancyclovir resistant clones, and the increased frequency of vector excision in
cells selected upon PEF feeder layers could simply be a reflection of the increased
plating efficiency under these conditions, or a reduced susceptibility to the 'bystander
effect' conferred by the more compact growth of ES cells upon PEF feeder layers.
n
This frequency of vector excision is comparable to that of 8 X 10" per cells plated
reported by Valancius and Smithies (1991), and 4.3 X 10"6 reported by Hasty et al.
(1991), when targeting the hprt locus. A higher frequency of 3.8 X 10"3 was reported
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by Hasty et al. (1991) when targeting the Hox 2.6 gene, suggesting that the frequency
of this recombination event may vary between loci.
Further analysis showed that the AI506/7 mutation was absent from the clones which
had appeared to have lost the targeting vector, indicating that the mutant exon had
excised along with the vector reverting the clones back to a wildtype status. Due to
the expected precision of the excision event, it is not possible to distinguish between
clones which have excised the 'hit and run' targeting vector and wild type cells which
have not been targeted. Therefore the possibility cannot be excluded that these
wildtype clones were not derived from targeted 'hit' cells but are the result of a low
level contamination of the 'hit' clone with wildtype cells. This however is unlikely,
as any wildtype cells should have been eliminated from the 'hit' clone population
during the Hygromycin selection which preceded the Gancyclovir selection. The
frequency of any wildtype cells in the 'hit' clone would be expected to be much
greater if the hit clone had not be subjected to Hygromycin selection for some period
of time. Therefore, the RUN2 and RUN3 experiments which utilised cells from a
'hit' clone which had been grown for a long period without Hygromycin selection
were likely to have a greater number of these wildtype cells in the population.
Although ten fold fewer Gancyclovir resistant clones were analysed in these
experiments, any wildtype cells which were present in the 'hit' clone population
would have been allowed to increase in numbers for some time, and would have been
expected to reach a detectable level. The complete absence of any clones with a
wildtype genotype in previous experiments suggests that the 'hit' clones were not
contaminated with a low level of wildtype cells. The only irrefutable evidence that
these clones had excised the targeting vector however, would be the retention of the
AI506/7 mutation.
The observation that all four 'run' clones appeared to have lost the mutation and
reverted back to a wildtype genotype was not entirely unexpected. The distribution
and size of the duplicated genomic regions is such that the region through which
recombination would result in retention of the AI506/7 mutation is smaller than the
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region through which recombination results in loss of the mutation, and therefore
mutation loss is favoured (figure 9.4). If recombination occurred at the same
frequency along the entire length of these DNA sequences, the size difference
between the two genomic regions of 0.7 kb compared to 3.5 kb would be expected to
result in retention of the AI506/7 mutation in 1 in 6 (17%) recombination events.
Therefore the observation that all four clones had lost the mutation is consistent with
the frequency of mutation loss predicted by the genomic structure.
This experiment was therefore successful in identifying the majority of clones which
were resistant to Gancyclovir through methylation-induced inactivation of the fusion
gene, without the need for Southern blot analysis. As predicted, the elimination of
such clones at an early stage enabled a greater number of clones to be screened, thus
allowing the identification of the very small number of clones which appeared to
Gancyclovir resistant through vector excision. Unfortunately none of the clones
which had excised the targeting vector retained the mutation, although this was
expected for such a small number of clones as the genomic structure of the targeted
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9.3 TARGETING Cftr WITH A MODIFIED HIT AND
RUN* TARGETING VECTOR
The 'hit and run' targeting vector used in all previous experiments favours loss of the
mutation during the 'run' step due to the greater length of the region through which
recombination results in loss of the mutant compared to that which results in excision
of the endogenous (non-mutant) exon (figure 9.4). A new vector was constructed by
Dr Paul Dickinson which has an increased region available for the recombination
event which would result in retention of the mutation. This was used to target Cftr to
generate 'hit' clones which could then be used to obtain 'run' clones which should
have a greater chance of retaining the mutation upon vector excision.
9.3.1 Method
9.3.1.1 Vector construction
The modified 'hit and run' targeting vector incorporated an additional 1.8 kb of
homologous genomic sequences which were inserted as an Eco RI fragment into the
Eco RI site just downstream of exon 10 (figure 9.5). This increases the region of
homology through which recombination will result in retention of the AI506/7
mutation from 0.7 kb to 2.5 kb, and although mutation loss is still favoured, the
mutation should be retained in 42% of 'true run' clones (assuming an equal
frequency of homologous recombination along the length of targeting DNA).
The modified 'hit and run' targeting vector does not utilise the Hygromycin-tk fusion
gene for selection resistance, but instead utilises the separate Neomycin and
Thymidine kinase genes expressed from separate tk promoters which had been used
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Figure 9.5 Distribution of genomic sequences of 'hit and run' targeting vectors.
(A) Structure of 'hit and run' targeting pHTHRAI507 vector used in previous
experiments. (B) Structure of 'hit and run' targeting vector pHRAI which
incorporates an additional 1.8 kb of homology to the target site. The genomic
sequences are indicated by the thick lines and exon 10 by the dark rectangle. The
presence of the AI506/7 mutation is indicated by AI. Plasmid sequences are denoted
by a diagonally hatched region, the Hygromycin-t/c fusion gene by a vertical lined
area, the neomycin gene by an area of trellis hatching, and the separate tk gene by the
open rectangle. The genomic regions available for recombination during a vector
excision event are indicated by the arrowed lines, with the outcome of each event
indicated beneath. The restriction sites for EcoRI are denoted by E.
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9.3.1.2 Targeting experiment HR6.
A passage 10 culture of CGR8 ES cells was grown up on PEF feeder layer, and 1 X
107 cells transfected by electroporation with 100 pg of Hpa 1 linearised targeting
vector pHRAI. The cells were plated into ten plates in the absence of a PEF feeder
layer at a density of 1 X 106 cells per plate, and G418 selection was applied at a
concentration of 200 pg/ml twenty four hours after transfection. The plates were fed
every three days, and once visible, clones were picked and grown up for analysis.
9.3.2 Results
9.3.2.1 Clone numbers.
The numbers of clones generated by this transfection were much lower than in
previous experiments using the 'hit and run' targeting vector pHTHRAI506/7.
Seventy six G418 resistant clones were obtained in total, giving a transfection
efficiency of 7.6 X 10"6. From the seventy six clones obtained, 32 were taken
through to Southern blot analysis.
9.3.2.2 Southern blot analysis for targeted clones.
The G418 resistant clones were analysed by Southern blot to detect those clones in
which the targeting vector had integrated through homologous recombination into the
target site. Clone DNA was digested by the enzyme Nco 7, blotted and probed with
the 1.3XH probe. This detects a 20 kb fragment of the wildtype allele and a 18 kb
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Analysis of the HR6 clones detected 4 clones which displayed both 20 and 18 kb
bands indicating that they were homologous recombinants (figure 9.7). The
identification of 4 correctly targeted clones out of 32 clones analysed gives a
targeting frequency of 1 in 7 (14%). All four clones originated upon different plates,
indicating that they arose from four independent homologous recombination events.
The wildtype and mutant bands were present at equal intensity, indicating the correct
dosage of a single copy of both the mutant and wildtype alleles.
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Figure 9.7 Screening experiment HR6 for targeted 'hit' clones.
Southern blot analysis of HR6 clone DNA digested with Nco I and probed with the
1.3XH probe. Lane 1 is the non-transfected control displaying the 20 kb band of the
wildtype allele. Lanes 2 to 21 are HR6 clones, with targeted 'hit' clones indicated in
lanes 9, 13, 17, and 21 by the presence of the additional 18 kb band created by
integration of the targeting vector into the target site.
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9.3.2.3 Screening the 'hit' clones for retention of the M506/7 mutation.
The correctly targeted clones were analysed for the presence of the mutation by
Southern blot utilising the same combination of digests and probe used to screen the
HR3 and HR5 'hit clones (sections 6.2.2.4 and 6.3.2.4), i.e. Eco RI and Ssp I digests
probed with the 0.8HE probe. This demonstrated that one of the 'hit' clones had
retained the AI506/7 mutation (figure 9.8) and therefore was suitable for use in the
'run' stage.
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Figure 9.8 Screening HR6 'hit' clones for the presence of the AI506/7 mutation.
Southern blot analysis of HR6 'hit' clones digested with Ssp 1-EcoRl and probed with
the 0.8HE probe. Lane 1 is the non-transfected control displaying the 2.2 kb band of
both the wildtype and non-mutant exon 10. Lane 6 contains vector DNA alone and
indicates the 0.8 kb band generated by the mutant exon. Lanes 2 to 5 contain HR6
'hit' clones, with the only clone retaining the mutation present in lane 2.
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9.3.3 Conclusions.
This experiment was successful in targeting Cftr with a modified version of the 'hit
and run' targeting vector used in previous experiments. Despite achieving a lower
transfection efficiency, the targeting frequency obtained with this modified vector
was the same as that obtained for the targeting experiment HR5. As discussed
previously (section 6.4), an increase in the length of the homology to the target site
carried by the targeting vector has been shown to increase the targeting frequency at a
locus. Therefore this modified 'hit and run' targeting vector which incorporates an
additional 1.8 kb of homologous sequence might have been expected to target Cftr at
a higher frequency than at the same frequency of 14% which had been obtained with
the previous vector.
One of these targeted clones had retained the mutation and is suitable for use in the
next stage, the selection for a 'run' event. These clones should still be vulnerable to
methylation-induced inactivation of the tk gene and therefore selection and analysis
of 'run' clones should be carried out using the modified procedure described in
section 9.2 to eliminate the majority of methylated clones. The increased length of
homology carried by these targeted clones should increase the frequency at which the
mutation is retained in a vector excision event, and perhaps allow clones to be
obtained which have retained the AI506/7 mutation as the only alteration to Cftr.
9.4 DISCUSSION
This chapter describes two attempts to overcome the problems encountered to date
with the 'run' step of the 'hit and run' targeting strategy.
The first approach was to modify the procedure of the 'run' step to identify and
eliminate those Gancyclovir resistant clones which had arisen through methylation-
induced inactivation of the tk gene at an early stage, without the need for Southern
blot analysis. By taking advantage of the apparent reversible nature of the fusion
gene inactivation, the procedure of screening clones after picking was successful in
identifying the majority of methylated clones. As predicted, a reduction in this 'false
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positive' Gancyclovir background allowed clones which had excised the targeting
vector to be identified.
The frequency at which the vector excised was determined as 2 X 10"8 for cells
selected in the absence of a PEF feeder layer, and at least 1 X 10"7 in cells selected in
the presence of a PEF feeder layer. If this frequency of vector excision had been
consistent throughout all of the previous 'run' experiments, the numbers of clones
analysed would not have been sufficient to have identified a recombination event.
Experiment RUN2 utilised 1.2 X 106 cells seeded onto PEFS for the 'run' step and
therefore might have generated a single vector excision event. However, less than
5% of the resulting Gancyclovir resistant clones were analysed, and consequently a
true 'run' clone was not detected. All other 'run' experiments used too few cells, and
did not analyse a large enough proportion of the resultant clones to identify a vector
excision event which was occurring at these frequencies. Therefore as predicted, the
frequency at which vector excision was occurring in these 'run' experiments was
very low, and was obscured by the large number of Gancyclovir resistant clones
generated by the higher frequency of methylation-induced inactivation of the
Hygromycin-t& fusion gene.
The larger number of 'run' clones analysed in this experiment identified four clones
which had excised the targeting vector. Unfortunately all of the clones which had
excised the targeting vector had reverted back to a wildtype genotype and had lost the
mutation. The distribution of the duplicated genomic sequences created by insertion
of the 'hit and run' targeting vector into Cftr is such that recombination resulting in
loss of the mutation is favoured, and retention of the mutation might be expected to
occur in approximately 1 in 6 recombination events. Therefore a greater number of
clones which had excised the targeting vector would be required to obtain one which
had retained the AI506/7 mutation. Based on the results of this experiment, this
might best be achieved by selecting at least 6 X 109 cells in the absence of a PEF
feeder layer, and analysing all of the resulting Gancyclovir resistant clones.
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The second approach overcoming the problems encountered too date was to modify
the 'hit and run' targeting vector. This was altered to increase the probability of
retention of the AI506/7 mutation in an excision event, thereby reducing the number
of 'true run' clones which must be obtained. The vector was enlarged by the addition
of an extra 2.5 kb of homology to the target site, thereby increasing the probability
that the mutation would be retained from 17% to 42% of 'run' clones.
This modified vector was targeted to Cftr at the high frequency of 14%, generating
four targeted clones. One of these 'hit' clones had retained the AI506/7 mutation
upon integration into the target site, and is therefore suitable for use in the next stage,
selection for a 'run' event. As this vector would still be subject to methylation-
induced inactivation of the Hygromycin-f& fusion gene, the procedure of screening
clones for methylation should be utilised.
Therefore future experiments which utilise the HR6 'hit' clone which has retained
the mutation for selection of the 'run' event, and which screen the resulting
Gancyclovir resistant clones by the modified procedure described in this chapter,
should identify more 'true run' clones which have a higher probability of retaining






The aim of this thesis was to create mouse models for cystic fibrosis which carried
subtle CF-associated mutations as the only alteration to the CF gene. This was to be
achieved by the introduction of precise mutations into ES cells in vitro through use of
the 'hit and run' gene targeting strategy. Mice could then be generated from such
targeted cells and used to study the mutant phenotype.
The first stage of the 'hit and run' targeting strategy was achieved with relative ease.
The 'hit and run' vector was targeted to exon 10 of Cftr at a high efficiency,
generating a number of 'hit' clones which had retained the mutation upon integration,
and which were therefore suitable for taking forward into the next stage. The results
of these targeting experiments, when combined with data from other experiments
also conducted in our laboratory, yielded important information regarding factors
which influence the targeting efficiency at this non-selectable locus. In addition, this
data also supported the theory that insertion vectors target more reliably and at a
higher frequency than replacement vectors (Dickinson et al. 1992). These
observations were of general interest, as previous reports had all been conducted at
the directly-selectable hprt locus (Thomas and Capecchi 1987., Hasty et al. 1991.,
Deng and Capecchi 1992).
Selection for the 'run' event of this targeting strategy proved extremely problematic.
Clones were found to survive the negative selection with the targeting vector intact,
and had become Gancyclovir resistant through a mechanism other than the desired
vector excision. This phenomenon was observed in many experiments and occurred
at a much higher frequency.
In order to overcome the problem of 'false positive' clones with the targeting vector
surviving the negative selection, the mechanism by which this occurred was
investigated. Analysis showed that the Hygromycin-r/c fusion gene of 'run' clones
which had been selected in Gancyclovir contained methylated sequences which were
absent in the non-selected 'hit' clone from which they were derived. This indicated
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that methylation-induced inactivation of the fusion gene was responsible for the loss
of Gancyclovir sensitivity in these 'run' clones. The presence of methylated
sequences flanking the target site in ES cells and different mouse strains implied that
these sequences were normally methylated, and that spread of methylation from this
region into the targeting vector was responsible for the loss of tk gene activity.
Once the mechanism of Hygromycin-tfc gene inactivation had been identified, a
strategy was devised to identify clones which had become Gancyclovir resistant
through this mechanism and eliminate them at an early stage of analysis. By taking
advantage of the reversible nature of methylation-induced gene inactivation, clones
which had become Gancyclovir resistant through this mechanism were identified by
their ability to give rise to Hygromycin resistant cells. Cells which had become
Gancyclovir resistant through the desired mechanism of vector excision were not
able to reverse their phenotype and remained sensitive to Hygromycin. This strategy
was successful in identifying four clones out of the one thousand screened, which had
excised the targeting vector. Unfortunately all four of these clones were found to
have excised the targeting vector and the mutant exon 10 to revert back to a wildtype
status. This outcome was unfortunate but not entirely unexpected as the distribution
of the duplicated genomic sequences was such that retention of the mutation might
only be expected in one out of six excision events.
To improve the probability of retaining the mutation in subsequent 'run'
experiments, the 'hit and run' targeting vector was modified by Dr Paul Dickinson to
increase the length of the genomic region carried by the vector. This increased the
region of homology available for the recombination event which would result in
retention of the mutation, and therefore increased the probability of obtaining a 'true
run' clone which has excised the vector and retained the mutation. This vector was
successfully targeted to exon 10 of Cftr, and generated one clone which had retained
the mutation upon integration and which was therefore suitable for use in the 'run'
stage. Screening of the resulting 'run' clones by the same modified procedure should
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allow the identification of clones which have excised the vector and retained the
mutation as the only alteration to Cftr.
10.2 DISCUSSION
This project was unsuccessful in introducing subtle mutations into Cftr in ES cells
using the 'hit and run' targeting strategy. This was due to the difficulty encountered
in identifying 'run' clones which had excised the vector from the large number of
'false positive' clones which had become Gancyclovir resistant through the more
frequent mechanism of methylation-induced inactivation of the selection genes.
The high frequency at which methylation inactivated the negative selection gene in
these experiments is likely to be a consequence of the presence of methylated
sequences at the target site, and therefore a property of the target region. This
propensity for methylation makes the use of negative selection genes at this locus
very difficult. A number of different groups have reported their intention to
introduce the AF508 mutation into exon 10 of ES cells, using either the 'hit and run'
targeting strategy (van Doorninck et al. 1993), or the double replacement strategy
which also utilises a negative selection step (Ratcliff et al. 1992., Koller et al. 1991).
In light of the findings of this investigation, it is perhaps not surprising therefore, that
there are currently no published reports of this being successfully accomplished.
Both the 'hit and run' targeting strategy and the double replacement strategy have
however, been used successfully to introduce subtle mutations into other loci. The
first account of use of the 'hit and run' targeting strategy to introduce mutations into
the hprt and Hox 2.6 locus reported that 38% of clones containing the vector survived
the negative selection (Hasty et al. 1991., Ramirez-Solis et al. 1993), and there have
also been reports of this phenomenon at other loci. Wu et al. (1994) reported that
32% of the clones surviving the negative selection still contained the vector when
targeting the murine type I collagen gene using the 'hit and run' targeting strategy, and
a lower figure of 22% was reported by Valancius and Smithies (1991) when targeting
hprt by the same strategy. The same problem has been reported for the second stage
of the double replacement strategy which also utilises a negative selection step.
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Askew et al. (1993) found that 92% of Gancyclovir resistant clones were 'false
positives' when targeting an ATPase locus, and Wu et al. (1994) reported that 40%
still contained the vector when targeting the murine type I collagen gene by the
double replacement technique. Although the mechanism giving rise to this loss of
sensitivity to the negative selection was not investigated in these cases, it is probable
that methylation induced gene inactivation was involved. In all cases, the loss of
sensitivity to the negative selection was not accompanied by any detectable alteration
to the targeted allele, however, no methylation sensitive restriction enzymes were
used to characterise the targeting event. Therefore it seems likely that the presence
and extent of the phenomenon of inactivation of negative selection genes when
inserted into genomic sequences is highly dependant upon the nature of the target
site. The difficulties described previously when introducing subtle mutations into
exon 10 by use of techniques which incorporate a negative selection step is therefore
probably a reflection of the greater susceptibility of sequences integrated into the
region around exon 10 of Cftr to become methylated.
Although this project was unsuccessful in generating mouse models for CF which
bear subtle CF-associated mutations, it has identified a problem area and led to a
modified selection protocol which should facilitate success. The demonstration that
clones which have excised the targeting vector can be obtained if a method of
reducing the high background of 'false positives' is utilised, has shown that excision
of the vector does occur but at a much lower frequency than inactivation of the fusion
gene by methylation. Therefore it should still be possible to obtain clones bearing
subtle mutations in Cftr by this technique, either by screening Gancyclovir resistant
clones for resistance to the positive selectable marker, or by using some other method
of identifying and eliminating 'false positive' clones. An alternative approach might
be to prevent methylation of the selection genes from occurring. Recently a short
sequence of DNA called an Spl element has been identified which appears to protect
CpG islands from methylation (Brandeis et al. 1994., Macleod et al. 1994).
Incorporation of this element into a |3-globin gene construct prevented the de novo
methylation seen in constructs lacking this sequence on transfection into ES cells.
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This effect was seen within a range of approximately 100 bp either side of the Spl
element, and therefore if included into a targeting vector near to the promoter, might
be sufficient to keep the promoter methylation-free, thereby preventing inactivation
of the negative selection gene.
10.3 OVERALL CONCLUSIONS
The overall conclusions from this thesis must be that the success of targeting a locus
is highly dependent upon the nature of each particular locus. This thesis has
described an attempt to introduce subtle mutations into exon 10 of Cftr in ES cells by
a proven technique which has been thwarted by the high frequency of de novo
methylation of vector sequences integrated into this region. This same effect has
been reported to varying degrees at other loci, and therefore the ease of achieving the
desired result with this targeting technique is highly locus-specific.
The subsequent modification of the 'hit and run' targeting technique has demonstrated
that despite the high frequency of methylation-induced gene inactivation, it is
possible to identify clones which have undergone the desired event of vector
excision. Therefore by utilising clones targeted with a vector which does not favour
mutation loss following vector excision, it is still feasible to obtain cells containing
CF-associated mutations as the only alteration to Cftr by the 'hit and run' gene
targeting technique.
10.4 FUTURE DIRECTIONS
Despite the difficulty experienced in introducing subtle mutations into Cftr, the
potential value of a mouse model created, justifies perseverance towards this end.
Modification of the 'hit and run' strategy, and use of clones targeted with greater
regions of homology is an obvious approach, however alternatives must be
considered. The double replacement strategy uses a different pathway to achieve the
same result and could therefore be utilised. However this also employs a negative
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selection step and is likely to be susceptible to the same high level of methylation
induced 'false positives'.
The presence of a negative selection gene at the target site in 'hit' clones generated in
these targeting experiments enables them to be used as the substrate for replacement
type targeting. Replacement of the integrated vector including the Hygromycin-t/c
selection genes could be attempted by transfecting 'hit' clones with homologous
genomic sequences which span the insertion, as in the second step of the double
replacement targeting strategy. The incoming DNA would carry the mutation to be
introduced, and through homologous recombination with the endogenous genomic
sequences, would replace the vector and duplicated exon 10 sequences. This event
would result in loss of the selection gene and could be selected for using
Gancyclovir. Although 'false positive' Gancyclovir resistant clones would also arise
in this strategy, the frequency of the replacement targeting event might be sufficiently
high to allow targeted clones to be identified.
Targeting with a replacement vector which has the non homologous sequences
inserted into an intron is another feasible approach. This strategy has been used by
Dr Steven Delaney (University of Queensland, Brisbane) to introduce the G551D
mutation into exon 11 of Cftr (S. Delaney, personal communication). The presence
of an expressed gene in an intron can affect expression, and a 30% reduction in
expression of the mutant allele is seen in the G551D mice. Reduced expression of a
null allele may be of no consequence, however it is an issue when attempting to
precisely model the phenotype of missense mutations of a human genetic disease.
This especially holds if phenotype/genotype correlations are to be made, and a
possible heterozygote advantage studied. One way to overcome this would be to use
a recombinase system such as lox and ere to remove plasmid sequences following
targeting. Although plasmid sequences are removed with this technique, it does not
create a precise alteration, as a 34 base pair sequence of a lox site remains at the
target site. Non-targeting strategies for introducing subtle mutations could also be
employed, such as crossing transgenes onto a null background. However, although
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this creates a model which expresses only the mutant allele of the transgene, it does
not model the mutation in its correct chromosomal context. Therefore, for
introduction of many of the CF-associated mutations it is worth pursuing the more
technically demanding techniques which introduce precise mutations identical to
those of the clinical condition.
In conclusion therefore, I believe that having identified the major problem
encountered in the 'hit and run' targeting strategy, the creation of mice bearing
specific, clinically-relevant mutations is now a realistic possibility. Unfortunately
time did not allow for the necessary modifications developed in this work to be fully
utilised to achieve this aim. However, the importance of models for CF justifies
further work towards this goal. Their use in resolving genotype/phenotype issues,
and evaluation of relocation strategies for mislocalised mutant proteins, will be of
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This thesis describes an attempt to create mouse models for Cystic fibrosis by gene
targeting. The following introduction seeks to give an overview of the nature of this
disease, and provide some insight into the many aspects still to be resolved .
Cystic fibrosis (CF) is the most common fatal autosomal recessive genetic disease of
the Caucasian population with about 1 in 2000 live births affected and therefore a
carrier frequency of around 1 in 22. It is characterised by defective chloride ion
transport and excessive mucus production in exocrine tissues which leads to a variety
of clinical consequences (Boat et al. 1989).
CF was first definitely reported by Fanconi in 1936 and a detailed clinical description
published by Andersen in 1938 describing the disease as 'cystic fibrosis of the
pancreas'. In 1945 Farber recognised the role of mucus in CF and suggested the
clinical symptoms were a consequence of disease of exocrine glands characterised by
failure to clear mucus secretions. To reflect the mucus involvement the disease was
renamed 'mucovisidosis', a name which is still in use in France, although it is has
been known as cystic fibrosis in many countries since the 1960s. High salt
concentration in saliva and sweat in CF was demonstrated by di Sant' Agnesi in 1953
and led to the development of the Gibson and Cooke 'sweat test', a diagnostic assay
still in use today (Gibson and Cooke, 1959).
Al.1.1 Clinical and Pathological Features
The range and severity of symptoms associated with CF varies considerably and
consequently so does the age of diagnosis. Previously, CF patients did not usually
survive their teenage years and were cared for by paediatric specialists.
Improvements in the care and management of CF have led to a concurrent
improvement in life expectancy and it has been projected that a CF patient born in
1990 can expect an average life span of 40 years, double that of 20 years ago ( Elborn
et al. 1991 ).
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Meconium ileus, a failure to pass meconium following birth, occurs in 5-10% of CF
cases and is virtually diagnostic for the disease. It was thought to result from failure
of pancreatic secretion leading to non-digestion of intraluminal contents also perhaps
combined with dehydration, resulting in a bowel obstruction. However it has been
shown that in some cases, the occurrence of meconium ileus does not always
correlate with pancreatic insufficiency (Tizzano and Buchwald, 1992). Beyond the
newborn period, bowel obstruction with incompletely digested contents can occur
and is termed 'meconium ileus equivalent'. Treatment ofmeconium ileus usually
involves a gastrografin enema but occasionally requires surgical intervention
(Docherty et al. 1992).
In many cases of CF an absence of pancreatic secretions is observed as a
consequence of obstruction of the pancreatic ducts with inspissated mucus followed
by dilation and ultimately destruction of acinar cells and their replacement with
fibrous tissue. The lack of pancreatic digestive enzymes leads to a variety of
digestive disorders such as steatorrhoea which often manifests as a failure to gain
weight. Diabetes, although endocrinic in nature, is sometimes a complication of CF
and has been attributed to disturbance of islet architecture by acinar destruction and
fibrosis. Pancreatic insufficiency in CF is rarely life-threatening and can be managed
to a certain extent by pancreatic enzyme supplementation.
Lung infection and the subsequent tissue damage is the major cause of premature
death in CF (Elborn and Shale 1990). There is great variation in age of onset,
severity and course of lung disease between affected individuals. Although antibiotic
treatment may suppress infection to a certain extent, it cannot easily be eradicated
and there is an inevitable decline in lung function with time. Lung disease in CF
arises as a result of the production of excessive viscous mucus which cannot be
cleared from the lungs and so provides an environment which is easily colonised by
opportunistic pathogens. Histological abnormalities such as submucosal gland
hypertrophy and mucus cell hyperplasia are detectable within the first few days of
life, prior to micro-organism colonisation, indicating that mucus accumulation is the
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primary event. Repeated endobronchial infection initiates a continuous inflammatory
response involving both humoral and cellular responses. Prolonged stimulation of
host defences by micro-organisms and their antigenic by-products leads to the
accumulation of cytotoxic by-products such as oxidants, proteases and lipid products,
all of which are damaging to the pulmonary epithelia. Infection of this damaged
tissue re-stimulates the inflammatory response leading to a vicious circle of infection,
inflammation, and lung injury. Chronic pulmonary infection and lung injury
eventually culminates in respiratory failure associated with pulmonary hypertension
and cor pulmonale.
Fertility is much reduced in CF patients, especially in the male. Greater than 95% of
males have altered Wolffian duct structures, commonly congenital bilateral absence
of the vas deferens (CBAVD) and are therefore azoospermic (Denning et al. 1968.,
Kaplan et al. 1968). It has been suggested that this might arise as a result of blockage
of the Wolffian duct structures with inspissated secretions during foetal development
causing gradual occlusion of the male genital tract. Motile sperm are however
present in the epididymis of patients with this condition, and fertilisation can be
achieved in vitro through use of the Microscopic Epididymal Sperm Aspiration
(MESA) technique (Oates et al. 1992). Congenital bilateral absence of the vas
deferens accounts for 1-2% of all cases of male infertility (Jequier et al. 1985), and it
has been reported that a high number (64%) of healthy but infertile males presenting
with CBAVD at infertility clinics carried at least one detectable CF mutation
(Anguiano et al. 1992., Rigot et al. 1991). This has lead to the suggestion that these
cases represented a mild, primarily genital form of CF, and the recommendation that
CF mutational analysis should be carried out on any patients with CBAVD and their
families, prior to sperm aspiration to remedy infertility. The relationship between CF
and CBAVD has been further investigated by Osborne et al. (1993), who also found
an increased frequency of CFTR mutations in CBAVD patients, with the majority
having only one detectable CF mutation. The bioelectric properties of the nasal
epithelium of these patients indicated a defect in chloride ion transport, however this
defect was distinct from that displayed by individuals with CF. They suggest that
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these patients might harbour a different class of mutations such as those in the
promoter region or at other regulatory sites which affect the expression level of the
gene and are not so easily detected. The low level of CFTR expression resulting
from such mutations might be sufficient to prevent disease in all but the most
susceptible organs such as the testis, where CFTR is expressed at all stages of human
foetal development (Tizzano et al. 1993., Trezise et al. 1993). Therefore the
relationship between CBAVD and CF is still unclear, but CFTR remains implicated
in its aetiology.
Female CF patients are generally more fertile than males with around 75% able to
sustain pregnancies (Cohen et al. 1980). Poor health status and thick cervical mucus
often hinder conception, and the physical stress imposed by pregnancy is often
detrimental to the health of the mother (Boat 1989., Kotloff et al. 1992).
Other complications of CF can include cirrhosis of the liver and arthropathy (a form
of joint disease). The psychosocial consequences of living with a life-threatening and
incurable disease which imposes a demanding daily regime of physiotherapy and
drug therapy are far reaching. The poor prognosis of patients contracting the highly
infective Pseudomonas cepacia (recently renamed Burkholdaria cepacia), has led to
the segregation of patients with positive sputum cultures both inside and outside of
the hospital environment (Smith et al. 1993., Govan et al. 1993) This is particularly
stressful as previously, patients had been encouraged to socialise and many facilities
and associations have been set up to encourage this. Living with infertility can also
have psychological complications, especially if the patient is in relatively good
health.
Diagnosis of CF is usually suggested from the clinical features and then confirmed by
the sweat test (Gibson and Cooke 1959), and/or a test for immunoreactive trypsin
(IRT) (Ryley et al. 1981). For the sweat test, sweating is induced by passing a small
current into the skin of the forearm through a pilocarpine-soaked filter paper. The
resulting sweat is collected, 100 mg of which is needed for a reliable result, and the
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chloride concentration measured. A concentration greater than 60 meq/litre is
indicative of CF but not in itself diagnostic. The IRT test was developed primarily
for screening neonates where difficulty in obtaining sufficient quantities of sweat is
often experienced. The presence of immunoreactive trypsin in the blood caused by
leak-back of trypsin from an obstructed pancreas is detected using immunoassay
techniques.
Al.1.2 The Basic Defect In CF
The first insight into the basic biochemical defect of CF arose in 1981 when Knowles
et al. reported that the potential differences (PD) across nasal and airway epithelia in
CF patients of all ages and stages of the disease were elevated, approximately twice
that of normal controls. The application of amiloride, an inhibitor of active sodium
absorption, resulted in a decrease in PD in both normal and CF epithelia. However
this decrease was much greater in CF epithelia, indicating that sodium absorption
was elevated in CF. The role of chloride transport in CF became apparent in 1983
when Quinton demonstrated abnormally low chloride permeability in CF sweat
ducts. This would result in poor sodium chloride reabsorption from sweat and thus
accounts for the high sweat salt concentration characteristic of CF. This result was
quickly followed by demonstration of reduced chloride permeability in CF nasal
mucosa (Knowles et al. 1983).
Since these early studies, reduced chloride permeability has been shown in most
affected epithelia (Welsh 1990), and increased sodium transport in airway epithelia
(Knowles et al. 1986., Cotton et al. 1987). The defective chloride permeability was
localised to the apical membrane (Widdicombe et al. 1985), and results in vivo
confirmed by experimentation with primary and immortalised cultures of CF
epithelial cells in vitro (Stutts et al. 1985., Jetten et al. 1989).
In 1986, Welsh and Liedtke suggested that the chloride impermeability was a result
of defective chloride channel regulation as they had found that normal and CF airway
epithelia contain chloride channels with identical properties, however, chloride
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channels in CF epithelia (unlike normal epithelia) did not open in patch-clamp
experiments in the cell attached form. Furthermore, the isoprenaline-stimulated
increase in intracellular cAMP response was normal in both, and the calcium-
dependent stimulus-response coupling was intact as demonstrated by activation of
calcium-dependent potassium channels. Thus they concluded that regulation of
chloride channels at a site distal to cAMP accumulation is defective in CF.
Using the Patch-Clamp technique, Frizzell et al. (1986), showed that the (3-
adrenergic-stimulated cAMP-induced activation of chloride channel activity was
defective in CF, and suggested that defective phosphorylation of the channel by a
protein kinase may be involved. The role of protein kinase phosphorylation in
chloride channel activation became apparent when it was shown that the catalytic
subunit of cAMP-dependent protein kinase plus ATP could activate chloride
channels in excised membrane patches of normal, but not CF epithelia (Schoumacher
et al. 1987., Li et al. 1988). This suggested that the block in cAMP-mediated
activation of CF chloride channels lay distal to induction of cAMP-dependent protein
kinase activation, and so might be a defect in the chloride channel itself or an
associated regulatory protein. Further work using patch-clamp (Hwang et al. 1989)
or 125F efflux techniques (Li et al. 1989) to measure channel activation, showed that
both protein kinase A and protein kinase C could activate chloride channels in
normal airway epithelia but not CF airway epithelia.
In September 1989, the study of CF changed dramatically with the cloning of the CF
gene (Rommens et al. 1989., Riordan et al. 1989., Kerem, et al. 1989). Initially,
homology to a family of transport proteins suggested that the gene product (CFTR)
was itself a transporter and not a chloride channel (Hyde et al. 1990., Ringe and
Petsko, 1990). The subsequent availability of CFTR cDNA spawned a whole host of
expression studies involving the expression of CFTR in many different cell types in
vitro which suggested that CFTR was in fact a chloride channel (Rich et al. 1990.,
Kartnereta/. 1991., Bear et al. 1991., Anderson et al. 1991., Tabcharani et al.
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1991), as expression of CFTR in these cells coincided with the appearance of
regulated chloride channel activity not previously detected.
This classification of CFTR as a chloride ion channel created more controversy. An
ion channel has certain unique features including ion selectivity, single channel
conductance, and blocker sensitivity, by which it can be identified, however, previous
studies had not all agreed on the 'signature' of the CFTR chloride channel. Some
studies reported a 30pS-50pS outwardly-rectifying chloride channel (ORCC), and
others a much smaller 1 OpS chloride channel with a linear current-voltage
relationship (reviewed in Frizzell and Cliff 1991). Three different chloride
conductances had been identified in chloride-secreting epithelial cells (Cliff and
Frizzell, 1990), and it was unclear which was defective in CF (the possibility of
CFTR being responsible for more than one conductance deemed unlikely).
Doubt was cast on the role of the outwardly-rectifying chloride channel in CF, when
it was shown that there was no correlation between CFTR expression and the density
of ORCC in human epithelial cell lines (Ward et al. 1991). Further proof that CFTR
is a chloride channel was demonstrated by the appearance of new chloride channel
activity in many different cell types in vitro when transfected with CFTR cDNA, also
brought forward evidence against the ORCC (Tabcharani et al. 1991., Rich et al.
1991., Anderson et al. 1991., Bear et al. 1991). Characterisation of the single
channel properties of chloride channels in cells expressing recombinant CFTR by
Berger et al. (1991), identified a lOpS chloride channel with a linear current-voltage
relationship.
Definitive proof that CFTR was indeed a chloride channel came from the
reconstitution studies of Bear et al. (1992), who studied the function of highly
purified CFTR when incorporated into an artificial liposome bilayer. The chloride
channel activity thus demonstrated ended not only speculation on the function of
CFTR, but also the role of ORCC in CF as the chloride channel exhibited the lOpS
current and the linear current-voltage relationship of the non-rectifying channel.
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Therefore it was concluded that the ORCC probably had little to do with the CFTR
chloride channel, and that earlier observations were 'unfortunate' (Higgins and Hyde,
1991).
This state of affairs remained until Egan et al. (1992) published evidence that not
only are CFTR and the ORCC distinct chloride channels, but CFTR can regulate the
ORCC. They arrived at this conclusion from the observation that the ORCC could
not be activated by protein kinase A in cells lacking CFTR, but this activation was
restored on expression of CFTR. Subsequent studies on CF 'knockout' mice which
lack CFTR (discussed later), reported the presence of ORCC in mouse epithelial cells
indicating that CFTR and ORCC are indeed distinct chloride channels (Gabriel et al.
1993). The failure of protein kinase A to regulate ORCC in these epithelial cells
lacking CFTR further supports the suggestion that they are regulated by CFTR. The
early data of Welsh and Fiedtke (1986) and Frizzell (1986) which suggested that it is
regulation of the CF chloride channel and not the channel itself which is defective,
can perhaps be explained by them studying the ORCC instead of CFTR.
Therefore, the basis of CF is defective chloride ion transport by the 1 OpS chloride ion
channel which has a linear current-voltage relationship. A defect in this chloride ion
channel may have many indirect but far-reaching effects including defective
regulation of other chloride ion channels.
Al.1.3 Cloning The CF Gene
The CF gene was successfully cloned by a method known as 'positional cloning' or
'reverse genetics', which searches for linkage of a chromosomal region with the
disease in question, and does not require a knowledge of the biochemical nature of
the disease.
The first steps towards assignment of the CF gene to a particular chromosome arose
when linkage was demonstrated to the enzyme paraoxonase (Eiberg et al. 1985),
followed by linkage to the polymorphic marker DOCR1-917 (Tsui et al. 1985).
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Further polymorphic markers, met and pJ3.11 (D7S8) were isolated, and the CF gene
located to the long arm of chromosome 7 (White et al. 1985., Wainwright et al.
1985). A collaboration of several groups typing over 200 families showed that the
met and D7S8 markers flanked the CF gene (Beaudet et al. 1986). This set the stage
for novel cloning strategies to begin searching between these markers which were
separated by 1600 kb of DNA.
One such attempt used met oncogenic transformation of cells in chromosome-
mediated gene transfer to produce a somatic cell hybrid containing 3 Mbp of human
DNA from the supposed CF locus (Scambler et al. 1986). This was then scanned for
the presence of CpG islands which are characteristic of the 5' end of genes (Bird
1986). With this method they found a candidate gene at the predicted location which
they named the Int-1 related protein (Estivill et al. 1987). Flowever this gene did not
meet the criteria for validation of a candidate gene as the nature of the gene product,
a secreted growth factor, and it's pattern of expression did not fit that predicted for
the CF gene, and furthermore no mutations in this gene in CF patients could be
detected (Wainwright et al. 1988). Then conclusive proof that this was not the CF
gene arose when recombination between the gene and CF was reported (Berger et al.
1987, Farrall et al. 1988).
Using saturation cloning, Rommens et al. (1988), discovered two more polymorphic
markers which lay inside the met and D7S8 markers and determined that the orders
and distances were as followed:
met< >D7S34Ck >D7S 122< >D7S8
500 kb 10 kb 980 kb
Using these markers as the starting points, Collins et al. (1987) used the chromosome
jumping technique to move between the markers. The first two jumps brought them
to the CpG island of the Int-1 gene, confirmation that they were moving in the right
direction. Further jumps 'filled in' with chromosome walking led them to a region
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which had maximum linkage disequilibrium with CF. Within this region a search
was conducted for sequences which showed cross-species conservation indicative of
functional DNA. This produced a candidate gene segment encoding a 6.2 kb
transcript which had a short sequence of open reading frame preceded by a CpG
island, and therefore some hallmarks of a gene (Rommens et al. 1989). Despite these
favourable signs, the RNA transcript could not be detected in tissues predicted to
express the CF gene product. The breakthrough came when a sweat gland cDNA
library was searched and resulted in the identification of a 6.5 kb transcript with a
pattern of expression that was restricted to exocrine tissues. Sequentially isolated
cDNAs eventually led to a series of overlapping clones containing the entire coding
region of the gene but construction of a complete cDNA was very problematic
(Riordan et al. 1989). This gene was encoded by 250 kb of DNA, with 27 exons, and
from which a protein of 1480 amino acids was translated. Expression was found to
be higher in those tissues severely affected in CF, but no size difference was detected
in the CF transcript. Confirmation that this was indeed the CF gene was
demonstrated by the presence of mutations in this gene of individuals with CF but
not in normal controls. Therefore this gene was validated as the CF gene as it
fulfilled three essential criteria;
1. The gene was in the correct location and had no detectable recombination
with the disease.
2. The nature of the gene product was consistent with the disease and had an
appropriate pattern of expression.
3. Consistent mutations were found within this gene. The disequilibrium for
one particular haplotype had suggested a common mutation, and the A
F508 mutation was subsequently found to be present on 70% of CF
chromosomes.
Al.1.4 The Structure Of CFTR
Sequence analysis of the CF gene, named the Cystic Fibrosis Transmembrane
Conductance Regulator, (CFTR) predicted an encoded protein of 1480 amino acids
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with a molecular mass of 168 kd. The main structural features of this protein (Figure
1.1) deduced from amino acid sequence analysis were characteristic of a membrane
bound protein due to the presence of two hydrophobic repeated motifs consisting of
six oc-helical sequences, typical of membrane spanning domains (MSD) (Riordan et
al. 1989). Each membrane spanning domain is followed by a large hydrophilic
region predicted to lie on the cytoplasmic side of the membrane, which has sequences
resembling nucleotide binding domains (NBDs). These structural characteristics of
CFTR have similarities to a family of ATP-dependent transport proteins called the
ATP binding cassette proteins (ABC). The most notable similarity being to the
multiple drug resistant (MDR) proteins and the yeast STE6 protein, all of which
import or export molecules across cell membranes in a process requiring ATP
hydrolysis (Fliggins 1989). There is one feature of CFTR which appears to be
unique, that of the presence of a highly charged hydrophilic region lying in the
middle of the protein in the cytoplasmic domain, the R domain. This region contains
many polar residues and has multiple potential phosphorylation sites.
Al.1.5 The Function Of CFTR
CFTR is a chloride channel. This is the conclusion that has been reached over the
period since the CF gene was cloned. There has been much debate over the function
of CFTR, and even now that there is general agreement on the role of CFTR as a
chloride channel, the prospect of additional functions for CFTR has arisen.
The first evidence supporting the role of CFTR as a chloride channel was put forward
by Rich et al. 1990, who showed that expression of CFTR, but not mutant CFTR,
corrects the chloride transport defect in cultured CF epithelial cells. Expression of
CFTR in vitro was shown to generate a cAMP activated chloride channel which was
absent in those transfected with AF508 cDNA and in nontransfected controls
(Anderson et al. 1991). Similarly, Kartner et al. (1991) reported generation of a
chloride channel in Sf9 insect cells upon transfection with CFTR cDNA, and
Tabcharani et al. (1991) observed the appearance of a chloride channel activity in
CHO cells upon stable transfection with CFTR cDNA. In addition, regulation of the
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CHO channel was shown to be exerted by cAMP-dependent phosphorylation by
protein kinases. Translation of CFTR RNA in the Xenopus oocyte expression system
resulted in a chloride selective current arising from a channel activated by protein
kinase A (Bear et al. 1991). Translation of this RNA had no affect on the activity of
the endogenous chloride channels and so strengthened the argument that CFTR itself
was a chloride channel, rather than a regulatory protein which modulates other
chloride channels.
The anion selectivity of CFTR-generated chloride channels was determined by
Anderson et al. (1991). They found that the introduction of mutations into
transmembrane domain-coding sequences altered the anion selectivity of the chloride
channel, and was therefore consistent with the role of CFTR as a chloride channel.
The most convincing evidence was that of Bear et al. (1992), who reconstituted
highly purified CFTR into artificial lipid bilayers. Using patch-clamp analyses, they
observed cAMP-regulated currents similar to those recorded for CFTR-transfected
cells, which could only be attributed to CFTR as no other protein was present.
If CFTR is a chloride channel, how does it carry out this function? It is thought that
the transmembrane domains form a pore across the plasma membrane through which
ions can pass. Alteration of the amino acids within this domain alters the anion
selectivity of this channel (Anderson et al. 1992), indicating that the transmembrane
domain both selects and conducts ions across the membrane.
The R domain, which lies between the two membrane spanning domains, is a feature
of CFTR which is not shared by any known ABC protein. It is thought to regulate
the chloride channel activity of CFTR, as its deletion generates chloride channels
which are constitutively open (Rich et al. 1991). The poor cross species conservation
of this region (Tucker et al. 1992), and the observation that no missense mutations
altering the R domain have been associated with CF, suggests that the mechanism of
channel activity regulation by this region is non-specific. It has been proposed that
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CFTR channel activity is inhibited by a conformational change in the R domain,
resulting in 'plugging' of the ion pore (Rich et al. 1991., Kartner et al. 1991., Cheng
et al. 1991 ). This has been supported by the recent work of Dulhanty and Riordan
(1994), who observed a structural change in CFTR following phosphorylation, which
was indicative of a reduction in the a-helical content. The R domain is highly
charged, and potential phosphorylation sites have been identified which if mutated,
prevent cAMP dependent phosphorylation and activation of the chloride channel
(Cheng et al. 1991). However, phosphorylation of the R domain alone does not
activate the chloride channel, as binding of ATP by the nucleotide binding domains
also appears to be required (Anderson et al. 1991). Furthermore, not all of the
phosphorylation sites are required for activation of channel activity, and mutational
studies have shown that the presence of a single site is sufficient for channel
activation (Cheng et al. 1991).
The nucleotide binding domains (NBDs) which follow each membrane spanning
domain, share extensive homology with the NBDs of other ABC transporter proteins
(Higgins 1989). They contain Walker A and B sequences which interact with
nucleotides (Walker et al. 1982), and have been shown to interact with ATP to
regulate the opening and closing of CFTR chloride channels (Thomas et al. 1991.,
Anderson et al. 1991., Hartman et al. 1992). It has been found that there is a
concentration of missense mutations in the first NBD, and a lack of a similar cluster
in the second NBD, suggesting a difference in functional importance (Tsui and
Buchwald 1991., Kerem et al. 1990., Cutting et al. 1990). Missense mutations are
particularly informative as only one amino acid is altered in the mutant protein, and
the observation that almost all missense mutations in CFTR occur in regions which
are conserved between human, mouse and cow emphasise their functional
significance (Dean et al. 1990., Diamond et al. 1991). This is supported by the
expression studies of Gregory et al. (1991), studying the effect of CF mutations on
the maturation and function of CFTR in Cos cells. They found that missense
mutations in the first NBD almost always resulted in a lack of maturation or
functional activity, but there was rarely any adverse effect seen with mutations in the
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second NBD. Anderson and Welsh (1992) described further evidence for the
functional non-equivalency of NBD 1 and NBD2. They demonstrated that ATP can
bind to both NBDs, but that ADP binds to NBD2 only. This resulted in inhibition of
chloride channel activity, which was abolished by mutations in NBD2. They
suggested that ADP inhibits CFTR by competing with ATP at NBD2, and that the
ATP : ADP ratio may be more important than absolute ATP concentration for
regulating CFTR. Quinton and Reddy (1992) developed this hypothesis further by
demonstrating that nonhydrolysable ATP analogues could stimulate CFTR in human
sweat ducts following activation by cAMP, suggesting that binding rather than
hydrolysis of ATP was required for CFTR chloride channel activity. Coupled with
the observation that intracellular ATP concentrations must be around physiological
concentrations for activation by this apparent non-hydolysable mechanism, this has
led to the idea that by binding ATP and ADP, CFTR is either 'sensing' the energy
level of the cell (ATP Vs ADP), or the cellular ATP concentration itself and it is this
which regulates CFTR activity (Wine and Silverstein 1992).
The significance of the repeated structural motifs of CFTR was investigated by
Sheppard et al. (1994). They investigated the functionality of mutant CFTR
consisting of MSD1 and NBD1, plus the R domain as some members of the ABC
transporter protein family are known to contain a single membrane spanning domain
and a single nucleotide binding domain (Hyde et al. 1990). They found that this
mutant CFTR was capable of forming a regulated chloride channel which had many
properties in common with wildtype CFTR. The mutant channel, like wild type, was
regulated by PKA phosphorylation, although some activity was seen in the absence
of PKA phosphorylation. This activation was reminiscent of that seen with mutant
CFTR lacking part of the R domain (Rich et al. 1991), and suggests that the R
domain interacts with NBD2 which was absent in this mutant form of CFTR. An
inhibitory role for NBD2 was implied by the observation that ATP was more potent
in stimulating channel activity in the mutant protein lacking NBD2. The ion
conducting properties of this mutant CFTR were similar to those of wildtype CFTR,
exhibiting identical anion selectivity, anion-to-cation permeability, single channel
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conductance, and linear current-voltage relationship. This implies that the sequences
in MSD1 are sufficient to form a regulated chloride ion channel, and questions the
function of NBD2. Sheppard et al. (1994) speculate that NBD2 may be important for
stabilising CFTR or localising it to the apical membrane, due to the observation that
in this expression system fewer channels were generated by the mutant CFTR than
compared to wildtype, despite production of large amounts of the mutant protein.
However, these results suggest that the majority of sequences required to form a
regulated chloride ion channel are present in the amino-terminal portion of CFTR.
Therefore it does appear that CFTR is a chloride channel, but does it have additional
functions and are chloride ions the only molecules transported? The closely related
human multidrug resistance P-glycoprotein has many structural similarities with
CFTR, and belongs to the same group of ATP binding cassette (ABC) proteins. This
protein has been found to be bifunctional, acting both as a pump which actively
transports cytotoxic drugs out of the cell, and as a volume-regulated chloride channel
(Valverde et al. 1992., Gill et al. 1992). By analogy, this raises the possibility of a
dual function for CFTR. Hasegawa et al. (1992), demonstrated that CFTR can form
a multifunctional aqueous channel capable of transporting anions, water and small
solutes, and this was followed by evidence that fluid transport across airway epithelia
was indeed defective in CF (Jiang et al. 1993). Tabcharani et al. (1993), have shown
that CFTR functions as a multi-ion pore, transporting more than one anion
simultaneously. In addition, they demonstrated that some naturally occurring CF
mutations associated with a mild phenotype, reduces the channel to a single ion pore
with a concurrent 50% reduction in conductance. Therefore it appears that CFTR
may have more roles than simply transporting chloride ions.
CFTR has also been implicated in other cellular functions. Bradbury et al. (1992)
observed an absence of cAMP-dependent regulation of endocytosis and exocytosis in
pancreatic cells derived from a CF patient, which was restored upon transfection with
wildtype CFTR cDNA. This suggests a role for CFTR in regulation of membrane
recycling which is an important way for cells to control both secretion and placement
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of proteins on their surface (Baringa, 1992). Barasch et al. (1991), reported that
acidification of intracellular organelles such as the Golgi network, prelysosomes and
endosomes was also defective in CF cells, and Lukacs et al. (1992) have reported that
CFTR is present and functional in endosomes. The possibility that CFTR may be
multifunctional may be important for understanding the relationship between this
single gene defect and the many facets of this disease, as many of the clinical
manifestations cannot be directly attributed to a simple defect in chloride ion
transport. In particular, the abnormal composition of CF mucus which lacks sialic
acid in the oligosaccharides, and the increased sulphation does not correlate directly
with abnormal chloride ion transport (Baringa 1992., Richardson and Alton 1993),
and might be more easily attributed to defective acidification of intracellular
organelles.
Al.1.6 CF Mutations
Al.1.6.1 The spectrum ofCF mutations.
Following identification of the CF gene, a consortium was formed, The Cystic
Fibrosis Genetic Analysis Consortium, consisting of 90 laboratories from 26
countries. This was set up to coordinate the accumulation of information on the
identification of new mutations and their population frequencies resulting in a large
pool of information. To date, over 400 disease mutations have been identified (, The
Cystic Fibrosis Genetic Analysis Consortium 1994), almost half of which are
missense mutations. Non-sense, frameshift, and splice site mutations occur in
roughly equal proportions, but few large deletions have been reported. No promoter
mutations have been found, although this probably reflects a bias of mutation
detection methods rather than an absence of such mutations.
Of all mutant CF chromosomes examined so far, 67% have been found to carry a
three base pair (phenylalanine) deletion at position 508 (AF508). The frequency of
this mutation varies in each population, and there is a clear Northwest to Southeast
gradient of its frequency across Europe (De Braekeleer and Daigneault 1992), with
the highest frequency reported in Copenhagen and Stockholm (CF Genetic Analysis
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Consortium 1990). A study of AF508 chromosomes from fifteen European regions
using three intragenic markers demonstrated that this mutation has a single origin,
and probably arose more than 52,000 years ago (Morral et al. 1994). Haplotype
analysis suggests that the AF508 mutation originated in a population genetically
distinct from any present day European population, and spread into Europe at
different periods, hence the differing frequencies in Europe. It has been proposed
that the mutation was first introduced during the Palaeolithic period, which may
account for the high frequency of this mutation (80% CF chromosomes) associated
with the ancestral haplotype present in Basques which are thought to be a
Palaeolithic population (Bertranpetit and Cavalli-Sforza 1991., Casals et al. 1992).
The presence of the AF508 mutation at the high frequency of 1.4% (2% of
chromosomes carry a CF mutation, 70% of which are the AF508 mutation) might be
attributed to a founder effect, or alternatively, may imply an advantage to being a
carrier, termed 'heterozygote advantage' (Knudson et al. 1967). This could be
ascribed directly to the presence of a single CF mutation, or to an advantage
conferred by closely linked loci (Wagner and Cavalli-Sforza 1975). It has been
proposed that CF heterozygotes may have an advantage in surviving Cholera which is
characterised by excessive secretion of chloride and fluid in the intestine in response
to the Cholera toxin (Rodman and Zamudio 1991). This was tested by Gabriel et al.
(1994) using a mouse model for CF. They observed that mice homozygous for a null
mutation in CFTR did not secrete fluid in response to Cholera toxin, but mice
heterozygous for the null mutation secreted only 50% of the fluid volume lost by
wildtype mice in response to the toxin. This reduced response in heterozygotes
implies that they may be better able to survive the diarrhoea and resultant water loss
associated with Cholera.
Different mutations can predominate in different populations, e.g. 90% of CF
mutations in the Danish population are AF508 (CF Genetic Analysis Consortium
1990), whereas only 22% are accounted for by AF508 in the Ashkenazi Jewish
population where the W1282X mutation predominates (approximately 60% of CF
chromosomes), (Shoshani et al. 1992., Lerer et al. 1992). The isolated nature of
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some communities contributes to the high frequency of certain CF mutations within
these communities which is not seen in the general population, as demonstrated by
the Hutterite community where the otherwise extremely rare Ml 101K mutation
accounts for 69% of CF chromosomes (Zielenski et al. 1993).
Al.1.6.2 Screening for CF mutations.
The large number of CF mutations and their variant frequencies makes detection of
100% of mutations within a population impossible, and therefore creates a dilemma
for advocates of population screening programmes. Initially screening could detect
only 70% of CF carriers thus identifying only 50% of at risk couples, a level that
many found unacceptably low (Roberts 1990., Beaudet 1990., Gilbert 1989).
Significant improvements have been made in the detection of CF mutations in
various populations (Shoshani et al. 1992., Super and Schwarz 1992., Cheadle et al.
1992), with the highest rate of detection of 98% reported by Ferec et al. (1992) in a
Celtic population. Pilot studies have reported a favourable response to CF carrier
screening (Watson 1991., Decruyenaere et al. 1992) although this varied with
cultural beliefs (Miller et al. 1992). There is great debate over how screening should
be delivered to the population. Screening the population in general has the advantage
that carriers are identified before pregnancy and so have time to consider the
consequences of being a CF carrier and decide their future reproductive plans.
However, with time, the significance of being a carrier may be forgotten or confused,
and this type of screening often has a low take-up rate (Watson et al. 1991). Another
mode, that of screening women attending antenatal clinics have been found to have a
much higher take-up rate (Mennie et al. 1992), but has the disadvantage that carriers
are only identified after a pregnancy has been initiated, and allows very little time for
decision-making. A third type of screening, commonly called 'cascade' screening,
uses a CF patient as a starting point from which all immediate relatives are tested.
The relatives of anyone testing positive are subsequently tested, and so on, resulting
in a cascade effect (Super et al. 1992). The advantage of this method is the high
take-up rate, and the targeting of screening to those most at risk. Whatever the
method of screening, the importance of effective counselling is shown in a study of
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Marteau et al. (1992) who found that carriers of the recessive genetic disease Tay-
Sachs identified in a screening programme viewed their future health prospects in
more negative terms. Also, a pilot screening project in Greece for
Haemoglobinopathies (Stamatoyannopoulus 1974) resulted in stigmatisation of
carriers by their community and they were considered only suitable for marriage by
other carriers!
Al.1.6.3 Correlation ofgenotype with phenotype.
There is a great range of symptoms and degrees of severity associated with CF, and
their correlation with a particular genotype has often been attempted. The ability to
predict the course and severity of the disease for each individual would be of
enormous value both for informed decision-making following a positive prenatal
diagnosis for CF, and for counselling and care of an affected individual. A recent
report from The Cystic Fibrosis Genotype-Phenotype Consortium (1993), attempted
to correlate the phenotypes of approximately 62% of CF patients with their genotype.
They concluded that 'the only prognostic value of genotypic information is for the
prediction of pancreatic status'. The association that has become apparent is the
correlation of so called 'severe' alleles and pancreatic insufficiency (PI) (Kristidis et
al. 1992). One such severe allele is AF508 which, in the homozygous state, has been
frequently correlated with pancreatic insufficiency (Kerem et al. 1990., Santis et al.
1990., Pignatti 1991). When CF individuals are homozygous for a severe mutation
or have two different severe mutations, then they are usually PI. Individuals with a
severe and a 'mild' mutation e.g. R117H, are usually pancreatic sufficient (Johansen
et al. 1991., Kristidis et al. 1992., Osbourne et al. 1992., Ferec et al. 1993). The mild
mutation being dominant over the severe mutation. Four mutations have been
designated severe, these are AF508, G542X, R553X, and W1282X, and prenatal and
prognostic counselling for homozygotes and compound heterozygotes should advise
of longterm PI (CF Genotype-Phenotype Consortium, 1993). A reduced risk of
meconium ileus has been reported for the G55 ID mutation (Hamosh et al. 1992).
Homozygosity for AF508 has also been associated with an earlier age of diagnosis
(Kerem et al. 1990., Hamosh et al. 1992), but has not been found to correlate with
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severity of pulmonary disease (Santamaria et al. 1992., Santis et al. 1990). The
conclusion of the CF Genotype-Phenotype Consortium is that severity and course of
pulmonary disease are not predicted by genotype, and they suggest that factors other
than CF genotype affect the pulmonary phenotype. Kiesewetter et al. (1993) reported
that the variation of the phenotype of CF patients carrying at least one R117H
mutation in association with another CF mutation correlated with the chromosomal
background. Correlation between CF mutations and other aspects of CF have been
attempted but no clear picture has emerged. Dodge (1991) cautions that the
contribution of non-genetic factors must not be overlooked, especially as identical
twins with different health status' have been reported, and that there will always be
great variability in exposure to infection.
Al.1.6.4 The effect ofCF mutations on CFTR function.
The consequences of AF508 mutation on CFTR function has been extensively
studied. Cheng et al. (1990) studied the expression of mutant AF508 CFTR cDNA in
Cos cells and observed that mature CFTR was absent in these cells. Instead, an
incompletely glycosylated form was detected which they suggested was a result of
incomplete CFTR processing in the endoplasmic reticulum (ER) resulting in its
degradation and therefore absence at the correct cellular location. The AF508 allele
has been shown to be expressed at the same level as the normal allele in the
respiratory tract (Trapnell et al. 1991) indicating that transcription ofmutant CFTR is
not defective. Further study into the processing and intracellular location of AF508
CFTR produced conflicting results. Studies examining the maturation and function
of mutant CFTR expressed in transfected cells in vitro (Gregory et al. 1991.,
Dalemans et al. 1992), agreed with those of Cheng et al. Nevertheless, other studies
detected correct localisation of AF508 CFTR in the plasma membrane (Sarkadi et al.
1992), and chloride channel activity when AF508 cDNA was expressed in Xenopus
oocytes (Drumm et al. 1991), Vero cells (Dalemans et al. 1991), and Sf9 insect cells
(Bear et al. 1992). A subsequent publication was able to reconcile these differences
by demonstrating that the processing of mutant CFTR is temperature sensitive
(Denning et al. 1992). They showed that processing of AF508 CFTR reverts to wild
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type as the temperature is lowered, thereby explaining the differences seen in
processing and localisation in experiments using oocytes and insect cells which are
typically conducted at lower temperatures. The anomalous results of the experiments
using Vero cells were obtained in a very high expression system and therefore might
be a result of some protein escaping ER 'quality control mechanisms' and reaching
the plasma membrane where it could generate some chloride channel activity. This
was confirmed by an important observation that the AF508 mutation was also
mislocalised in sweat gland biopsies taken from CF patients (Kartner et al. 1992).
This led to speculation that the basis of defective CFTR channel activity of AF508
mutants might be entirely attributable to its mislocalisation which if overcome, might
have sufficient activity to correct the defect. This was confirmed by Li et al. (1993)
who demonstrated that AF508 mutant CFTR exhibited phosphorylation-regulated
chloride channel activity similar to that of wildtype CFTR when reconstituted into
lipid bilayers. Yang et al. (1993), followed this by showing that incubation of L cells
transfected with AF508 cDNA at 26°C for 48 hours elicited an electrophysiological
response which was absent in cells incubated at the higher temperature of 37°C. This
observation is of great importance for the treatment of CF, as it implies that if AF508
CFTR could be relocated to the plasma membrane, the mutant protein should exhibit
enough chloride channel activity to ameliorate or even correct the CF defect.
Although defective processing is also observed with other CF mutations, this is not
the sole mechanism by which CF-causing mutations exert an effect. Welsh and
Smith (1993) have divided CF mutations into four classes based upon their effect on
CFTR biosynthesis and function (table 1.1, and figure 1.2):
Class I includes all CF mutations which result in defective protein production. This
might be due to the presence of premature termination signals, the production of
unstable mRNA, or severely truncated or aberrant protein which is unstable and
quickly degraded. All mutations of this type have the net result that no detectable
CFTR protein is produced.
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Class II mutations are those which fail to progress through the biosynthetic pathway
and traffic to the correct cellular location, and includes the AF508 mutation. The
basis of the defect caused by this class of mutations is the absence of CFTR at the
plasma membrane.
Class III mutations are processed correctly, and do reach the plasma membrane, but
exhibit defective regulation of the chloride channel activity. These mutations have
been found to be located in the nucleotide binding domains, and NBD1 in particular
which is consistent with its proposed greater participation in the regulation of CFTR
than NBD2.
Class IV mutations affect the conductance of CFTR and have found to be located in
MSD1. These are mutations which do not affect the processing or localisation of the
mutant protein, but reduce the CFTR current.
There appears to be some correlation between the mechanism by which CF mutations
disrupt CFTR function and the severity of pancreatic disease (Welsh and Smith
1993). Sheppard et al. (1993) have shown that mutant CFTR containing mutations
associated with mild pancreatic disease retains significant apical chloride channel
activity when expressed in epithelial cells. This residual chloride channel activity
would explain the dominant nature of mild mutations when combined with a severe
allele in compound heterozygotes.
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Table 1.2 Classes of CFTR Mutations That Cause CF
CLASS DEFECT EXAMPLES DOMAIN FREQUENCY CLINICAL
STATUS
I NO PROTEIN
Nonsense mutations G542X NBD1 3.4 PI
Frameshift mutations 3905 insT NBD2 2.1 PI
Splice site mutations 621+G—>T MSD1 1.3 PI
n PROCESSING Ai506/7 NBD1 0.5 PI
AF508 NBD1 67.2 PI
S5491 NBD1 RARE
S549R NBD1 0.3 PI
A559T NBD1 RARE
N1303K NBD2 1.8 PI
III REGULATION G551D NBD1 2.4 PI
G551S NBD1 RARE PS
G1244E NBD2 RARE PI
S1255P NBD2 RARE PI
G1349D NBD2 RARE PI
IV CONDUCTION R117H MSD1 0.8 PS
R334W MSD1 0.4 PS
R347P MSD1 0.5 PS
(Taken from Welsh and Smith 1993).
Frequency of mutations is expressed as percentage of all CF mutations.
NBD refers to nucleotide binding domain, MSD membrane spanning domain, PI
pancreatic insufficiency, and PS pancreatic sufficiency.
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Al.1.7 The Expression Of CFTR
Cell-specific expression of CFTR was studied by Trezise and Buchwald (1991) using
labelled antisense RNA probes for in situ analysis on rat tissue sections. They found
that CFTR was specifically expressed in the ductal cells of the pancreas and salivary
glands, and that there were decreasing gradients of expression in the intestine along
the crypt-villus, proximal-distal axes. CFTR expression was also detected at low
levels in the mucosa and submucosa of the bronchi and bronchioles of the lung, with
the highest expression being detected in the sub-mucosal glands. Expression in the
testis was found to be regulated during the cycle of the seminiferous epithelia, and
implies that CFTR plays a role in spermatogenesis thereby contributing to CF
infertility.
The localisation of CFTR has been studied immunocytochemically using antibodies
raised against CFTR. Great difficulty has been experienced in raising antibodies to
CFTR and in achieving a uniform pattern of expression. Crawford et al. (1991)
found abundant CFTR in epithelial cells including those lining the sweat ducts, small
pancreatic ducts, and intestinal crypts. The level of CFTR in lung epithelia was again
found to be surprisingly low, but was abundant in kidney tubule epithelia. The
protein appeared to be restricted to the apical membranes of cells, a feature also
described by Cohn et al. 1991., Denning et al. 1992., and Zeitlin et al. 1992., which,
along with tissue distribution is consistent with its proposed role as a chloride
channel.
Expression of CFTR during foetal development has also been studied, using in situ
techniques to detect mRNA (Tizzano et al. 1993., Trezise et al. 1993). This
demonstrated expression of CFTR in all major organs known to be affected in CF,
with an expression pattern which broadly matched that of the adult. However, these
studies also identified some interesting differences between adult and foetus CFTR
expression. The level of CFTR expression in the foetal lung epithelium was higher
than that seen in adults, and led to the suggestion that CFTR might fulfil a different
role in the aqueous environment of the foetal lung (Tizzano et al. 1993). In addition,
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there was a conspicuous lack of expression in the foetal sub-mucosal glands, which is
the site of highest expression in the adult. Expression of CFTR in reproductive
tissues varied between males and females. No expression was detected in the first
and second trimester of foetal development in females, however significant
expression was apparent in uterine, cervix and fallopian tube epithelia in the third
trimester. In males, a low level of expression was detected in the epididymis
epithelia at all stages. However, no expression of CFTR was detected in ovary or
testis at any stage of foetal development.
Although CFTR has been shown to be expressed in all tissues affected by the disease
process of CF, the levels of expression do not appear to correlate with the degree of
pathology. However, there is no reason to presume that the major sites of disease
pathology would exhibit the highest levels of expression, as each tissue and organ
might have differential expression requirements (Porteous and Dorin 1993).
Alternatively, the variation in disease pathology might be more a reflection of
varying tissue vulnerability to defective chloride transport, or the consequent luminar
blockage.
Al.1.8 Cross Species Analysis
Cross species analysis of CFTR sequences has demonstrated a high level of
conservation indicating that CFTR has been highly conserved throughout evolution.
Murine CFTR has an overall identity to human of 78.3% at the amino acid level,
which increases to 89.6% if conservative changes are included (Yorifuji et al. 1991.,
Kelley et al. 1992). Analysis of rat CFTR indicates a nucleotide sequence identity of
80.5%, and an amino acid sequence identity of 75.5% (Trezise et al. 1992), which is
similar to that of 77.4% reported for Xenopus laevis at the amino acid level, and
72% for dogfish CFTR (Marshall et al. 1991). Analysis and comparison of many
diverse species such as mouse, rat, Guinea pig, rabbit, sheep, cow, pig, dogfish,
marmoset, and Xenopus laevis, has identified that the highest levels of sequence
conservation are always seen in the regions encoding the first membrane spanning
domain and the first nucleotide binding domain (Marshall et al. 1991., Gasparini et
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al. 1991., Yorifuji et al. 1991Diamond et al. 1991., Kelley et al. 1992., Trezise et
al. 1992., and Tucker et al. 1992). The region which is consistently least conserved
across species is the R domain. This endorses the predictions of CFTR functional
assays which suggest that MSD1 and NBD1 play an important role in regulation of
CFTR chloride channel activity through specific interactions, whereas regulation of
CFTR by the R domain occurs through a 'steric' non-specific mechanism. In
addition it has been observed that in dogfish, mouse, and cow, almost all of the
missense CF-causing mutations in humans occur at conserved sites. This high level
of cross species conservation, and in particular conservation of the sites of human
missense mutations, augurs well for studying the disease in an animal model.
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